Omega Healthcare Investors (OHI) 10-Q3 Nov 222022 Q3 Quarterly reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2022	Oct. 31, 2022
Document and Entity Information [Abstract]
Document Type	10-Q
Document Period End Date	Sep. 30, 2022
Document Fiscal Year Focus	2022
Entity Registrant Name	OMEGA HEALTHCARE INVESTORS, INC.
Entity Central Index Key	0000888491
Current Fiscal Year End Date	--12-31
Document Quarterly Report	true
Document Transition Report	false
Entity Incorporation, State or Country Code	MD
Entity File Number	1-11316
Entity Tax Identification Number	38-3041398
Entity Common Stock Shares Outstanding		234,182,805
Amendment Flag	false
Document Fiscal Period Focus	Q3
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Address, Address Line One	303 International Circle, Suite 200
Entity Address, City or Town	Hunt Valley
Entity Address, State or Province	MD
Entity Address, Postal Zip Code	21030
City Area Code	410
Local Phone Number	427-1700
Title of 12(b) Security	Common Stock
Trading Symbol	OHI
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Real estate assets
Buildings and improvements	$ 7,217,231	$ 7,448,126
Land	908,424	916,328
Furniture and equipment	498,473	511,271
Construction in progress	84,884	74,062
Total real estate assets	8,709,012	8,949,787
Less accumulated depreciation	(2,246,659)	(2,160,696)
Real estate assets - net	6,462,353	6,789,091
Investments in direct financing leases - net	10,560	10,873
Mortgage notes receivable - net	669,533	835,086
Total	7,142,446	7,635,050
Other investments - net	608,190	469,884
Investments in unconsolidated joint ventures	176,556	194,687
Assets held for sale	190,723	261,151
Total investments	8,117,915	8,560,772
Cash and cash equivalents	134,855	20,534
Restricted cash	3,323	3,877
Contractual receivables - net	9,945	11,259
Other receivables and lease inducements	266,890	251,815
Goodwill	648,948	651,417
Other assets	293,829	138,804
Total assets	9,475,705	9,638,478
LIABILITIES AND EQUITY
Revolving credit facility	17,861
Secured borrowings	368,405	362,081
Senior notes and other unsecured borrowings - net	4,898,609	4,891,455
Accrued expenses and other liabilities	295,454	276,716
Total liabilities	5,580,329	5,530,252
Equity:
Preferred stock $1.00 par value authorized - 20,000 shares, issued and outstanding - none
Common stock $0.10 par value authorized - 350,000 shares, issued and outstanding - 234,176 shares as of September 30, 2022 and 239,061 shares as of December 31, 2021	23,417	23,906
Additional paid-in capital	6,305,089	6,427,566
Cumulative net earnings	3,392,822	3,011,474
Cumulative dividends paid	(6,029,603)	(5,553,908)
Accumulated other comprehensive income (loss)	6,243	(2,200)
Total stockholders' equity	3,697,968	3,906,838
Noncontrolling interest	197,408	201,388
Total equity	3,895,376	4,108,226
Total liabilities and equity	$ 9,475,705	$ 9,638,478

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parentheticals) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Statement Of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 1	$ 1
Preferred stock, shares authorized	20,000,000	20,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.10	$ 0.10
Common stock, shares authorized	350,000,000	350,000,000
Common stock, shares issued	234,176,000	239,061,000
Common stock, shares outstanding	234,176,000	239,061,000

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues
Rental income	$ 207,588	$ 247,164	$ 635,899	$ 705,880
Income from direct financing leases	256	257	768	772
Mortgage interest income	17,234	23,047	57,380	70,693
Other investment income	14,110	10,780	36,481	34,245
Miscellaneous income	242	424	2,866	1,270
Total revenues	239,430	281,672	733,394	812,860
Expenses
Depreciation and amortization	82,709	86,097	248,668	256,745
General and administrative	18,242	15,372	53,402	46,724
Real estate taxes	4,175	3,272	11,495	9,002
Acquisition, merger and transition related costs	185		5,658	1,814
Impairment on real estate properties	10,015	4,942	21,221	42,453
Recovery on direct financing leases				(717)
Provision for credit losses	4,106	25,511	4,367	28,023
Interest expense	58,238	58,979	174,755	176,379
Total expenses	177,670	194,173	519,566	560,423
Other income (expense)
Other (expense) income - net	(176)	(767)	(5,038)	4
Loss on debt extinguishment	(376)	(642)	(389)	(30,707)
Gain on assets sold - net	40,930	56,169	179,747	160,634
Total other income	40,378	54,760	174,320	129,931
Income before income tax expense and income from unconsolidated joint ventures	102,138	142,259	388,148	382,368
Income tax expense	(1,191)	(976)	(3,535)	(2,873)
Income from unconsolidated joint ventures	4,117	1,552	7,522	14,569
Net income	105,064	142,835	392,135	394,064
Net income attributable to noncontrolling interest	(2,790)	(3,888)	(10,787)	(10,616)
Net income available to common stockholders	$ 102,274	$ 138,947	$ 381,348	$ 383,448
Basic:
Net income available to common stockholders	$ 0.44	$ 0.58	$ 1.61	$ 1.62
Diluted:
Net income	$ 0.43	$ 0.58	$ 1.60	$ 1.62

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 105,064	$ 142,835	$ 392,135	$ 394,064
Other comprehensive income (loss):
Foreign currency translation	(14,753)	(5,027)	(47,903)	(2,901)
Cash flow hedges	17,573	1,895	56,595	17,529
Total other comprehensive income (loss)	2,820	(3,132)	8,692	14,628
Comprehensive income	107,884	139,703	400,827	408,692
Comprehensive income attributable to noncontrolling interest	(2,868)	(3,803)	(11,036)	(11,000)
Comprehensive income attributable to common stockholders	$ 105,016	$ 135,900	$ 389,791	$ 397,692

CONSOLIDATED STATEMENTS OF EQUI

CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Total Stockholders' Equity [Member]	Common Stock Par Value	Additional Paid-in Capital	Cumulative Net Earnings [Member]	Cumulative Dividends	Accumulated Other Comprehensive Income (Loss)[Member]	Noncontrolling Interest [Member]	Total
Beginning balance at Dec. 31, 2020	$ 3,841,876	$ 23,119	$ 6,152,887	$ 2,594,735	$ (4,916,097)	$ (12,768)	$ 194,731	$ 4,036,607
Increase (Decrease) In Stockholders' Equity [Roll Forward]
Stock related compensation	17,032		17,032					17,032
Issuance of common stock	272,429	771	271,658					272,429
Common dividends declared (per share)	(477,187)				(477,187)			(477,187)
Vesting/exercising of Omega OP Units	(16,966)		(16,966)				16,966
Conversion and redemption of Omega OP Units to common stock	1,112	3	1,109				(1,112)
Omega OP Units distributions							(20,105)	(20,105)
Other comprehensive income (loss)	14,244					14,244	384	14,628
Net income	383,448			383,448			10,616	394,064
Balance ending at Sep. 30, 2021	4,035,988	23,893	6,425,720	2,978,183	(5,393,284)	1,476	201,480	4,237,468
Beginning balance at Jun. 30, 2021	4,012,061	23,756	6,377,238	2,839,236	(5,232,692)	4,523	197,965	4,210,026
Increase (Decrease) In Stockholders' Equity [Roll Forward]
Stock related compensation	5,750		5,750					5,750
Issuance of common stock	47,706	134	47,572					47,706
Common dividends declared (per share)	(160,592)				(160,592)			(160,592)
Vesting/exercising of Omega OP Units	(5,596)		(5,596)				5,596
Conversion and redemption of Omega OP Units to common stock	759	3	756				(759)
Omega OP Units distributions							(5,125)	(5,125)
Other comprehensive income (loss)	(3,047)					(3,047)	(85)	(3,132)
Net income	138,947			138,947			3,888	142,835
Balance ending at Sep. 30, 2021	4,035,988	23,893	6,425,720	2,978,183	(5,393,284)	1,476	201,480	4,237,468
Beginning balance at Dec. 31, 2021	3,906,838	23,906	6,427,566	3,011,474	(5,553,908)	(2,200)	201,388	4,108,226
Increase (Decrease) In Stockholders' Equity [Roll Forward]
Stock related compensation	20,652		20,652					20,652
Issuance of common stock	5,825	32	5,793					5,825
Repurchase of common stock	(142,267)	(521)	(141,746)					(142,267)
Common dividends declared (per share)	(475,695)				(475,695)			(475,695)
Vesting/exercising of Omega OP Units	(7,176)		(7,176)				7,176
Conversion and redemption of Omega OP Units to common stock							(9,704)	(9,704)
Omega OP Units distributions							(15,418)	(15,418)
Capital contribution from noncontrolling interest holder in consolidated JV							2,930	2,930
Other comprehensive income (loss)	8,443					8,443	249	8,692
Net income	381,348			381,348			10,787	392,135
Balance ending at Sep. 30, 2022	3,697,968	23,417	6,305,089	3,392,822	(6,029,603)	6,243	197,408	3,895,376
Beginning balance at Jun. 30, 2022	3,741,097	23,410	6,295,907	3,290,548	(5,872,269)	3,501	199,615	3,940,712
Increase (Decrease) In Stockholders' Equity [Roll Forward]
Stock related compensation	6,855		6,855					6,855
Issuance of common stock	2,334	7	2,327					2,334
Common dividends declared (per share)	(157,334)				(157,334)			(157,334)
Omega OP Units distributions							(5,080)	(5,080)
Capital contribution from noncontrolling interest holder in consolidated JV							5	5
Other comprehensive income (loss)	2,742					2,742	78	2,820
Net income	102,274			102,274			2,790	105,064
Balance ending at Sep. 30, 2022	$ 3,697,968	$ 23,417	$ 6,305,089	$ 3,392,822	$ (6,029,603)	$ 6,243	$ 197,408	$ 3,895,376

CONSOLIDATED STATEMENTS OF EQ_2

CONSOLIDATED STATEMENTS OF EQUITY (Parentheticals) - $ / shares	3 Months Ended					9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Increase (Decrease) In Stockholders' Equity [Roll Forward]
Dividend per Common Share	$ 0.67	$ 0.67	$ 0.67	$ 0.67	$ 0.67	$ 2.01	$ 2.01

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities
Net income	$ 392,135	$ 394,064
Adjustment to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	248,668	256,745
Impairment on real estate properties	21,221	42,453
Recovery on direct financing leases		(717)
Provision for rental income	28,625	22,357
Provision for credit losses	4,367	28,023
Amortization of deferred financing costs and loss on debt extinguishment	10,086	39,832
Accretion of direct financing leases	57	37
Stock-based compensation expense	20,515	16,913
Gain on assets sold - net	(179,747)	(160,634)
Amortization of acquired in-place leases - net	(3,560)	(8,452)
Effective yield payable on mortgage notes	1,537	1,085
Interest paid-in-kind	(6,979)	(5,422)
Income from unconsolidated joint ventures	(2,601)	(1,530)
Change in operating assets and liabilities - net:
Contractual receivables	1,313	(6,250)
Straight-line rent receivables	(54,563)	(38,401)
Lease inducements	5,780	4,556
Other operating assets and liabilities	(14,809)	(19,052)
Net cash provided by operating activities	472,045	565,607
Cash flows from investing activities
Acquisition of real estate	(141,361)	(615,907)
Acquisition deposit - net		2,500
Net proceeds from sale of real estate investments	438,279	310,849
Investments in construction in progress	(12,753)	(91,923)
Proceeds from sale of direct financing lease and related trust		717
Placement of mortgage loans	(9,030)	(84,012)
Collection of mortgage principal	187,161	44,039
Investments in unconsolidated joint ventures	(113)	(10,484)
Distributions from unconsolidated joint ventures in excess of earnings	1,335	17,671
Capital improvements to real estate investments	(37,721)	(28,955)
Receipts from insurance proceeds	658	5,948
Investments in other investments	(305,223)	(94,222)
Proceeds from other investments	151,189	91,627
Net cash provided by (used in) investing activities	272,421	(452,152)
Cash flows from financing activities
Proceeds from long-term borrowings	597,403	2,220,128
Payments of long-term borrowings	(587,394)	(2,121,429)
Payments of financing related costs	(389)	(48,934)
Net proceeds from issuance of common stock	5,825	272,429
Repurchase of common stock	(142,267)
Dividends paid	(475,557)	(477,068)
Noncontrolling members' contributions to consolidated joint venture	27
Redemption of Omega OP Units	(9,704)
Distributions to Omega OP Unit Holders	(15,418)	(20,105)
Net cash used in financing activities	(627,474)	(174,979)
Effect of foreign currency translation on cash, cash equivalents and restricted cash	(3,225)	(29)
Increase (decrease) in cash, cash equivalents and restricted cash	113,767	(61,553)
Cash, cash equivalents and restricted cash at beginning of period	24,411	167,558
Cash, cash equivalents and restricted cash at end of period	$ 138,178	$ 106,005

BASIS OF PRESENTATION AND SIGNI

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES	Sep. 30, 2022
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES	NOTE 1 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Business Overview and Organization Omega Healthcare Investors, Inc. (“Parent”) is a Maryland corporation that, together with its consolidated subsidiaries (collectively, “Omega,” the “Company,” “we,” “our,” or “us”) invests in healthcare-related real estate properties located in the United States (“U.S.”) and the United Kingdom (“U.K.”). Our core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (“SNFs”), assisted living facilities (“ALFs”), and to a lesser extent, independent living facilities (“ILFs”), rehabilitation and acute care facilities (“specialty facilities”) and medical office buildings. Our core portfolio consists of long-term “triple net” leases and mortgage loans with healthcare operating companies and affiliates (collectively, our “operators”). In addition to our core investments, we make loans to operators and/or their principals. From time to time, we also acquire equity interests in joint ventures or entities that support the long-term healthcare industry and our operators. Omega has elected to be taxed as a real estate investment trust (“REIT”) for federal income tax purposes and is structured as an umbrella partnership REIT (“UPREIT”) under which all of Omega’s assets are owned directly or indirectly by, and all of Omega’s operations are conducted directly or indirectly through, its operating partnership subsidiary, OHI Healthcare Properties Limited Partnership (collectively with its subsidiaries, “Omega OP”). Omega has exclusive control over Omega OP’s day-to-day management pursuant to the partnership agreement governing Omega OP. As of September 30, 2022, Parent owned approximately 97% of the issued and outstanding units of partnership interest in Omega OP (“Omega OP Units”), and other investors owned approximately 3% of the outstanding Omega OP Units. Basis of Presentation and Principles of Consolidation The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and do not include all the information and notes required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements. In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for the interim periods reported herein are not necessarily indicative of results to be expected for the full year. These unaudited consolidated financial statements should be read in conjunction with the financial statements and the footnotes thereto included in our Annual Report on Form 10-K Omega’s consolidated financial statements include the accounts of (i) Parent, (ii) all direct and indirect wholly owned subsidiaries of Omega, including Omega OP, (iii) other entities in which Omega or Omega OP has a majority voting interest and control and (iv) variable interest entities (“VIEs”) of which Omega is the primary beneficiary. All intercompany transactions and balances have been eliminated in consolidation, and Omega’s net earnings are reduced by the portion of net earnings attributable to noncontrolling interests. Segments We conduct our operations and report financial results as one business segment. The presentation of financial results as one reportable segment is consistent with the way we operate our business and is consistent with the manner in which our Chief Operating Decision Maker (CODM), our Chief Executive Officer, evaluates performance and makes resource and operating decisions for the business. Reclassification Certain line items on our Consolidated Balance Sheets have been reclassified to conform to the current period presentation. Risks and Uncertainties including COVID-19 The Company is subject to certain risks and uncertainties affecting the healthcare industry, including those stemming from the novel coronavirus (“COVID-19”) global pandemic described below, which has disproportionately impacted the senior care sector, as well as those stemming from healthcare legislation and changing regulation by federal, state and local governments. Additionally, we are subject to risks and uncertainties as a result of changes affecting operators of nursing home facilities due to the actions of governmental agencies and insurers to limit the rising cost of healthcare services. Recent Accounting Pronouncements ASU – 2022-02, Financial Instruments – Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures On March 31, 2022, the FASB issued ASU 2022-02, which eliminates the recognition and measurement guidance for troubled debt restructurings (“TDRs”) and requires additional disclosures for certain loan modifications. ASU 2022-02 also requires entities to disclose gross write-offs of financing receivables and net investments in leases by year of origination. Omega elected to early adopt ASU 2022-02 on a prospective basis effective January 1, 2022. In the second quarter of 2022, we had one loan modification to a borrower experiencing financial difficulty pursuant to ASU 2022-02, Guardian Healthcare (“Guardian”), that requires additional disclosures. The required disclosures for this loan are included in Note 4 – Contractual Receivables and Other Receivables and Lease Inducements and Note 5 – Mortgage Notes Receivable. We have disclosed our gross write-offs of financing receivables and direct financing leases by year of origination in Note 7 – Allowance for Credit Losses. ASU – 2020-04, Financial Instruments – Reference Rate Reform (Topic 848) On March 12, 2020, the FASB issued ASU 2020-04, which contains optional practical expedients for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting for contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”). The guidance may be elected over time until December 31, 2022, as reference rate reform activities occur. The Company has several derivative instruments (See Note 16 – Derivatives and Hedging), a $1.45 billion senior unsecured multicurrency revolving credit facility, and a $50.0 million senior unsecured term loan facility (See Note 15 – Borrowing Activities and Arrangements) that reference LIBOR. During the first quarter of 2020, we elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for future LIBOR indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. Application of these expedients preserves the presentation of derivatives consistent with past presentation. Our credit facilities that reference LIBOR contain customary LIBOR replacement language, including, but not limited to, the use of rates based on the secured overnight financing rate. The Company continues to evaluate: (i) how the transition away from LIBOR will impact the Company, (ii) whether any additional optional expedients provided by the standards will be adopted, and (iii) the impact that adopting ASU 2020-04 will have on our consolidated financial statements.

REAL ESTATE ASSETS

REAL ESTATE ASSETS	9 Months Ended
REAL ESTATE ASSETS	Sep. 30, 2022
REAL ESTATE ASSETS [Abstract]
REAL ESTATE ASSETS	NOTE 2 – REAL ESTATE ASSETS Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (in thousands) (in thousands) Rental income – operating leases $ 203,456 $ 243,831 $ 624,844 $ 697,140 Variable lease income – operating leases 4,132 3,333 11,055 8,740 Total rental income $ 207,588 $ 247,164 $ 635,899 $ 705,880 Our variable lease income primarily represents the reimbursement of real estate taxes and ground lease expenses by operators that Omega pays directly. Asset Acquisitions The following table summarizes the asset acquisitions that occurred during the nine months ended September 30, 2022: Number of Total Real Estate Initial Facilities Assets Acquired Annual Period SNF ALF Specialty Country/State (in millions) Cash Yield (1) Q1 — 1 — U.K. $ 8.7 (2) 8.0 % Q1 — 1 — U.K. 5.0 8.0 % Q1 — 27 — U.K. 86.6 (2) 8.0 % Q1 1 — — MD 8.2 (3) 9.5 % Q3 — 4 — U.K. 28.2 8.0 % Total 1 33 — $ 136.7 (1) Initial annual cash yield reflects the initial annual contractual cash rent divided by the purchase price. (2) The total consideration paid for the one -facility U.K. acquisition and the 27 -facility U.K. acquisition was $8.2 million and $100.0 million, respectively. In connection with these acquisitions, we allocated $0.5 million of the purchase consideration to a deferred tax liability related to the one-facility U.K. acquisition, and $13.4 million to a deferred tax asset related to the 27 -facility U.K. acquisition. See Note 13 – Taxes for additional information. (3) Total consideration for the one -facility Maryland acquisition was paid on December 30, 2021, but the closing of the acquisition did not occur until January 1, 2022.

ASSETS HELD FOR SALE, DISPOSITI

ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS	9 Months Ended
ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS	Sep. 30, 2022
ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS [Abstract]
ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS	NOTE 3 – ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS Periodically we sell facilities to reduce our exposure to certain operators, geographies and non-strategic assets or due to the exercise of a tenant purchase option. The following is a summary of our assets held for sale: September 30, December 31, 2022 2021 Number of facilities held for sale 34 41 Amount of assets held for sale (in thousands) $ 190,723 $ 261,151 During the three months ended September 30, 2022, we reclassified 20 facilities that were leased and operated by Agemo Holdings, LLC (“Agemo”) to assets held for sale in connection with our restructuring negotiations surrounding Agemo’s lease agreement. Nineteen of these facilities were subsequently sold during the fourth quarter of 2022 for aggregate gross cash proceeds of $315.8 million. Asset Sales During the three and nine months ended September 30, 2022, we sold four and 44 facilities, subject to operating leases, for $51.4 million and $438.3 million in net cash proceeds, respectively. As a result of these sales, we recognized net gains of $40.9 million and $179.7 million during the three and nine months ended September 30, 2022, respectively. Our 2022 sales were primarily driven by restructuring transactions and negotiations related to our lease agreements with the following operators: Gulf Coast Health Care LLC (together with certain affiliates “Gulf Coast”), Guardian Healthcare (“Guardian”) and Agemo. In the first quarter of 2022, we sold 22 facilities that were previously leased and operated by Gulf Coast. The net cash proceeds from the sale, including related costs accrued for as of the end of the third quarter, were $303.9 million, and we recognized a net gain of $113.5 million. The agreement includes an earnout clause pursuant to which the buyer is obligated to pay an additional $18.7 million to Omega if certain financial metrics are achieved at the facilities in the three years following the sale. As we have determined it is not probable that we will receive any additional funds, we have not recorded any income related to the earnout clause. During the first and second quarter of 2022, we sold nine total facilities that were leased to Guardian for $39.5 million in net proceeds, which resulted in a net gain of $13.7 million. In the third quarter of 2022, we sold two facilities that were previously leased to Agemo for $42.6 million in net proceeds, which resulted in a net gain of $35.6 million. Real Estate Impairments During the three and nine months ended September 30, 2022, we recorded impairments on four and ten facilities of $10.0 million and $21.2 million, respectively. Of the $21.2 million, $3.5 million related to two facilities that were classified as held for sale (and subsequently sold) for which the carrying values exceeded the estimated fair values less costs to sell, and $17.7 million related to eight held-for-use facilities for which the carrying value exceeded the fair value. The impairments recorded on four facilities during the three months ended September 30, 2022 relate to the 2.2% Operator discussed in Note 4 – Contractual Receivables and Other Receivables and Lease Inducements. To estimate the fair value of the facilities for the impairments noted above, we utilized a market approach that considered binding sale agreements (a Level 1 input), or non-binding offers from unrelated third parties and/or broker quotes (a Level 3 input).

CONTRACTUAL RECEIVABLES AND OTH

CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS	9 Months Ended
	Sep. 30, 2022
CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS [Abstract]
CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS	NOTE 4 – CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS Contractual receivables relate to the amounts currently owed to us under the terms of our lease and loan agreements. Effective yield interest receivables relate to the difference between the interest income recognized on an effective yield basis over the term of the loan agreement and the interest currently due to us according to the contractual agreement. Straight-line rent receivables relate to the difference between the rental revenue recognized on a straight-line basis and the amounts currently due to us according to the contractual agreement. Lease inducements result from value provided by us to the lessee, at the inception, modification or renewal of the lease, and are amortized as a reduction of rental income over the non-cancellable lease term. A summary of our net receivables and lease inducements by type is as follows: September 30, December 31, 2022 2021 (in thousands) Contractual receivables – net $ 9,945 $ 11,259 Effective yield interest receivables $ 6,208 $ 9,590 Straight-line rent receivables 173,266 148,455 Lease inducements 87,416 93,770 Other receivables and lease inducements $ 266,890 $ 251,815 Cash basis operators and straight-line receivable write-offs We also wrote-off $3.2 million of straight-line rent receivable balances through rental income during the nine months ended September 30, 2022, as a result of transitioning 6 facilities between existing operators in the first quarter of 2022. Operator updates Agemo Agemo continued to not pay contractual rent and interest due under its lease and loan agreements during the nine months ended September 30, 2022. Agemo is on a cash basis of revenue recognition for lease purposes, so no rental income was recorded related to Agemo during the three and nine months ended September 30, 2022. Additionally, no interest income was recognized during the three and nine months ended September 30, 2022 on the two loans with Agemo because these loans are on non-accrual status and we are utilizing the cost recovery method, under which any payments, if received, are applied against the principal amount. See Note 6 – Other Investments. For the nine months ended September 30, 2021, revenue from Agemo represented approximately 4.7% of our total revenues (excluding the impact of write-offs). On September 30, 2021, the Company entered a forbearance agreement related to Agemo’s defaults under its lease and loan agreements. The forbearance period under the agreement has been extended multiple times and the most recent amendment on October 31, 2022 extended the forbearance period through November 30, 2022 Guardian Guardian did not make rent and interest payments under its lease and loan agreements during the first quarter of 2022 but resumed paying contractual rent and interest during the second quarter of 2022 and continued such payments in the third quarter of 2022, in accordance with the restructuring terms discussed further below. Guardian is on a cash basis of revenue recognition for lease purposes, and we recorded rental income of $3.7 million and $7.5 million for the three and nine months ended September 30, 2022, respectively, for the contractual rent payments that were received. Additionally, as discussed further in Note 5 – Mortgage Notes Receivable, no mortgage interest income has been recognized on the Guardian mortgage loan during the three and nine months ended September 30, 2022, as we are accounting for this loan under the cost recovery method. During the first and second quarters of 2022, we completed significant restructuring activities related to the Guardian lease and loan portfolio. In the first quarter of 2022, we transitioned eight facilities previously leased to Guardian to two other operators as part of the planned restructuring. Additionally, during the six months ended June 30, 2022, we sold nine facilities previously leased to Guardian and three facilities previously subject to the Guardian mortgage loan. In the second quarter of 2022, we agreed to a formal restructuring agreement, master lease amendments and mortgage loan amendments with Guardian. As part of the restructuring agreement and related agreements, Omega agreed to, among other things: ● Extend the lease and loan maturity dates from January 31, 2027 to December 31, 2031 and allow Guardian the option to extend the maturity date for both the lease and loan through September 30, 2034 , subject to certain conditions; ● reduce the combined rent and mortgage interest to an aggregate $24.0 million per year as of July 1, 2022 ( $15.0 million in rent and $9.0 million in interest) with annual escalators of 2.25% beginning in January 2023; and ● allow Guardian to retrospectively defer $18.0 million of aggregate contractual rent and interest that it failed to pay from October 2021 through March 2022 (consisting of $12.2 million of deferred rent and $5.8 of million deferred interest), with repayment required beginning after September 30, 2024, based on certain financial metrics, and in full by December 31, 2031, or the earlier termination of the lease for any reason. As of September 30, 2022, we have $7.4 million of letters of credit from Guardian as collateral. Revenue from Guardian represented approximately 1.0% and 3.2% of our total revenues (excluding the impact of straight-line write-offs) for the nine months ended September 30, 2022 and 2021, respectively. 3.7% Operator From January through March 2022, an operator (the “3.7% Operator”) representing 3.7% and 3.3% of total revenue (excluding the impact of write-offs) for the nine months ended September 30, 2022 and 2021, respectively, did not pay its contractual amounts due under its lease agreement. In March 2022, the lease with the 3.7% Operator was amended to allow for a short-term rent deferral for January through March 2022. The deferred rent balance accrues interest monthly at a rate of 5% per annum. The 3.7% Operator paid the contractual amount due under its lease agreement from April 2022 through September 2022. Omega holds a $1.0 million letter of credit and a $150 thousand security deposit from the 3.7% Operator as collateral under its lease agreement. The 3.7% Operator remains on a straight-line basis of revenue recognition. In July 2018, we entered into a $20.0 million revolving credit facility with the 3.7% Operator, and the 3.7% Operator paid contractual interest under the facility from January through September 2022. The 3.7% Operator drew $4.0 million under the facility during the second quarter of 2022, and the line of credit under the facility was fully drawn as of June 30, 2022. As of September 30, 2022, the total outstanding principal due under the credit facility remains $20.0 million. The credit facility is secured by a first lien on the 3.7% Operator’s accounts receivable. 1.4% Operator In March 2022, an operator (the “1.4% Operator”), representing 1.4% and 2.1% of total revenue (excluding the impact of write-offs) for the nine months ended September 30, 2022 and 2021, respectively, did not pay its contractual amounts due under its lease agreement. In April 2022, the lease with the 1.4% Operator was amended to allow the operator to apply its $2.0 million security deposit toward payment of March 2022 rent and to allow for a short-term rent deferral for April 2022 with regular rent payments required to resume in May 2022. The 1.4% Operator paid contractual rent in May 2022, but it failed to pay the full contractual rent for June 2022 on a timely basis. We placed the 1.4% Operator on a cash basis of revenue recognition during the second quarter of 2022, as collection of substantially all contractual lease payments due from the operator was no longer deemed probable. As a result, we wrote-off approximately $8.3 million of straight-line rent receivables through rental income. During the three months ended September 30, 2022, the 1.4% Operator made partial contractual rent payments of $2.5 million in the aggregate, which were recorded in rental income. 2.2% Operator In June 2022, an operator (the “2.2% Operator”), representing 2.2% and 2.0% of total revenue (excluding the impact of write-offs) for the nine months ended September 30, 2022 and 2021, respectively, short-paid the contractual rent amount due under its lease agreement by $0.6 million. In July 2022, we drew the full $5.4 million letter of credit that was held as collateral from the 2.2% Operator and applied $0.6 million of the proceeds to pay the unpaid portion of June 2022 rent. In the third quarter of 2022, the 2.2% Operator continued to short-pay the contractual amount due under its lease agreement. As such, we applied $3.3 million of the remaining proceeds of the letter of credit to pay the unpaid portion of July, August and September 2022 rent. We are in discussions to sell or release to another operator a portion of the facilities included in the 2.2% Operator’s master lease. We placed the 2.2% Operator on a cash basis of revenue recognition during the third quarter of 2022, as collection of substantially all contractual lease payments due from the operator was no longer deemed probable. As a result of placing the 2.2% Operator on a cash basis, we wrote-off approximately $10.5 million of straight-line rent receivables and lease inducements through rental income. As of September 30, 2022, $1.5 million of proceeds from the letter of credit remain as collateral to the master lease. 0.5% Operator In June 2022, we placed an operator (the “0.5% Operator”), representing approximately 0.5% of total revenue (excluding the impact of write-offs) for the nine months ended September 30, 2022 and 2021, respectively, on a cash basis of revenue recognition. The change in our evaluation of the collectability of future rent payments due from the 0.5% Operator was a result of information received from the operator during the second quarter of 2022 regarding substantial doubt as to its ability to continue as a going concern. As a result of placing the 0.5% Operator on a cash basis, we wrote-off approximately $2.1 million of straight-line rent receivables through rental income. All facilities included in the 0.5% Operator’s master lease are included in assets held for sale as of September 30, 2022. Other Operators During the nine months ended September 30, 2022, we allowed four other operators, representing an aggregate 2.8% and 3.1% of total revenue (excluding the impact of write-offs) for the nine months ended September 30, 2022 and 2021, respectively, to apply an aggregate of $3.4 million of their security deposits to pay rent to accommodate short term liquidity issues, with regular rent payments required to resume shortly thereafter. These operators also are required to begin replenishing their security deposits in 2023. Additionally, we granted two of these operators short-term deferrals for a portion of their respective rent due during the nine months ended September 30, 2022. As of September 30, 2022, two of the four operators that were allowed to apply security deposits to rent are current on their respective lease obligations. The two operators that are not current on contractual obligations are on a cash basis of revenue recognition as of September 30, 2022. We placed one of the operators on a cash basis of revenue recognition during the third quarter of 2022. As a result of placing that operator on a cash basis during the third quarter of 2022, we wrote-off approximately $2.6 million of straight-line rent receivables through rental income.

MORTGAGE NOTES RECEIVABLE

MORTGAGE NOTES RECEIVABLE	9 Months Ended
MORTGAGE NOTES RECEIVABLE	Sep. 30, 2022
Mortgage Notes Receivable [Abstract]
MORTGAGE NOTES RECEIVABLE	NOTE 5 – MORTGAGE NOTES RECEIVABLE As of September 30, 2022, mortgage notes receivable relate to seven fixed rate mortgage notes on 52 facilities. The mortgage notes are secured by first mortgage liens on the borrowers’ underlying real estate and personal property. The mortgage notes receivable relate to facilities located in six states that are operated by six independent healthcare operating companies. We monitor compliance with the terms of our mortgages and when necessary have initiated collection, foreclosure and other proceedings with respect to certain outstanding mortgage notes. The principal amounts outstanding of mortgage notes receivable, net of allowances, were as follows: September 30, December 31, 2022 2021 (in thousands) Mortgage note due 2031; interest at 11.02% $ 78,309 $ 103,762 Mortgage notes due 2030; interest at 10.96% (1) 503,440 653,564 Other mortgage notes outstanding (2) 149,641 151,361 Mortgage notes receivable, gross 731,390 908,687 Allowance for credit losses on mortgage notes receivable (61,857) (73,601) Total mortgage notes receivable – net $ 669,533 $ 835,086 (1) Approximates the weighted average interest rate on 37 facilities as of September 30, 2022. (2) Other mortgage notes outstanding have a weighted average interest rate of 8.85% per annum as of September 30, 2022 and maturity dates ranging from 2023 through 2032 . Mortgage Note due 2031 As discussed in Note 4 – Contractual Receivables and Other Receivables and Lease Inducements, Guardian did not make rent and interest payments under its lease and loan agreements during the first quarter of 2022 but resumed making contractual rent and interest payments during the second and third quarters of 2022, in accordance with the restructuring terms agreed to in the second quarter of 2022. The mortgage loan is on non-accrual status and is being accounted for under the cost recovery method, so the $2.3 million and $3.7 million of interest payments that we received during the three and nine months ended September 30, 2022, respectively, were applied directly against the principal balance outstanding. On February 15, 2022, Guardian completed the sale of three facilities subject to the Guardian mortgage loan with Omega. Concurrent with the sale, Omega agreed to release the mortgage liens on these facilities in exchange for a partial paydown of $21.7 million. In connection with the partial paydown, we recorded a $5.1 million recovery for credit losses in the first quarter of 2022 related to the Guardian mortgage loan. In the second quarter of 2022, we agreed to a formal restructuring agreement and amendments to the master lease and mortgage loan with Guardian, which among other adjustments, extended the loan maturity and allowed for the deferral of certain contractual interest as discussed in Note 4 – Contractual Receivables and Other Receivables and Lease Inducements. These amendments were treated as a loan modification. In the third quarter of 2022, we reserved an additional $1.0 million through provision for credit losses due to a decrease in the estimated fair value of the four facilities that are collateral under the mortgage. As of September 30, 2022, the amortized cost basis of the Guardian mortgage loan is $78.3 million, which represents 10.8% of the total amortized cost basis of all mortgage receivables. As of September 30, 2022, the mortgage loan is secured by three SNFs and one ALF located in Pennsylvania. Mortgage Notes due 2030 On June 30, 2022, Ciena Healthcare (“Ciena”) repaid $57.1 million under the $415.0 million amortizing mortgage (the “Ciena Master Mortgage”), $15.1 million under the $44.7 million mortgage and $41.5 million under four additional mortgages. Concurrent with these repayments, we released the mortgage liens on six facilities in exchange for the partial repayment and extended the maturity date of all of the Ciena mortgage notes to June 30, 2030 (with exception of two loans with an aggregate principal balance of $37.7 million with maturity dates in 2022 and 2023). On September 9, 2022, Ciena repaid $35.3 million under the Ciena Master Mortgage and $9.5 million under three additional mortgages. Concurrently with these partial repayments, we released the mortgage liens on two facilities in exchange for such partial repayments.

OTHER INVESTMENTS

OTHER INVESTMENTS	9 Months Ended
OTHER INVESTMENTS	Sep. 30, 2022
OTHER INVESTMENTS [Abstract]
OTHER INVESTMENTS	NOTE 6 – OTHER INVESTMENTS Our other investments consist of fixed and variable rate loans to our operators and/or their principals. These loans may be either unsecured or secured by the collateral of the borrower. A number of the secured loans are collateralized by leasehold mortgages on, or assignments or pledges of the membership interest in, the related properties, corporate guarantees and/or personal guarantees. We deem these to be “real estate related loans” that are included as qualifying assets under our quarterly REIT asset tests. As of September 30, 2022, we had 39 loans with 20 different operators. A summary of our other investments is as follows: September 30, December 31, 2022 2021 (in thousands) Other investment notes due 2024; interest at 13.17% (1) $ 96,456 $ 90,752 Other investment note due 2030; interest at 7.00% 236,218 201,613 Other investment note due 2024; interest at 12.00% (2) — 40,232 Other investment notes due 2022-2025; interest at 12.03% (1) 44,200 9,992 Other investment notes outstanding (3) 20,000 12,084 Real estate related loans – other investments, gross 396,874 354,673 Other investment notes due 2024-2025; interest at 8.12% (1) 55,791 55,791 Other investment notes due 2022-2028; interest at 10.49% (1) 53,560 22,142 Other investment notes outstanding (4) 163,026 106,672 Non-real estate related loans – other investments, gross 272,377 184,605 Total other investments, gross 669,251 539,278 Allowance for credit losses on other investments (61,061) (69,394) Total other investments – net $ 608,190 $ 469,884 (1) Approximates the weighted average interest rate as of September 30, 2022. (2) During the third quarter of 2022, this loan was fully repaid. (3) As of September 30, 2022, includes one real estate related loan with an interest rate of 12.00% and a maturity date of December 2, 2027 . (4) Other investment notes that are non-real estate related loans have a weighted average interest rate of 8.20% as of September 30, 2022 with maturity dates ranging from 2022 through 2032 (with $10.5 million maturing in the remainder of 2022). Interest revenue on other investment loans is included within other investment income on the Consolidated Statement of Operations. A summary of our other investments income by real estate and non-real estate loans, as defined above, is as follows: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (in thousands) (in thousands) Real estate related loans – interest income $ 10,566 $ 8,036 $ 27,987 $ 23,628 Non-real estate related loans – interest income 3,544 2,744 8,494 10,617 Total other investment income $ 14,110 $ 10,780 $ 36,481 $ 34,245 Other investment note due 2030 On June 22, 2022, we amended the secured revolving credit facility with Maplewood Senior Living (together with its affiliates, “Maplewood”) to increase the maximum commitment under the facility from $220.5 million to $250.5 million. Advances made under this facility bear interest at a fixed rate of 7% per annum, and the facility matures on June 30, 2030. As of September 30, 2022, $236.2 million remains outstanding on this credit facility to Maplewood. Maplewood was determined to be a VIE when this loan was originated in 2020. Please see further discussion in Note 8 – Variable Interest Entities. Other investment notes due 2024-2025 Agemo continued to not pay contractual rent under its lease agreement and interest on the Agemo WC Loan and the Agemo Term Loan during the nine months ended September 30, 2022. We have continued to monitor the fair value of the collateral associated with the Agemo WC Loan on a quarterly basis. During the three and nine months ended September 30, 2022, we recorded an additional provision for credit losses of $4.8 million and $10.8 million, respectively, related to the Agemo WC Loan because of a reduction in the fair value of the underlying collateral assets supporting the current carrying values. As discussed in Note 4 – Contractual Receivables and Other Receivables and Lease Inducements, the Company is currently in ongoing negotiations to restructure and amend Agemo’s lease and loan agreements. Other investment notes due 2022-2025 Other investment notes due 2022-2028 In connection with the $35.6 million mezzanine loan discussed above, we also entered into a short-term $90.0 million revolving line of credit with the same operator to finance working capital requirements of the new operations. The line of credit consists of two Other investment notes outstanding – real estate related loans Preferred Equity Investment in Joint Venture - $20 million On June 2, 2022, we made a $20.0 million preferred equity investment, which is treated as a loan for accounting purposes, in a new real estate joint venture that was formed to acquire an acute care hospital in New York. Omega’s preferred equity investment bears a 12% return per annum and must be mandatorily redeemed by the joint venture at the earlier of December 2027 or the occurrence of certain significant events within the joint venture. We have determined that the joint venture is a VIE, but we are not the primary beneficiary as we do not have the power to direct the activities that most significantly impact the joint venture’s economic performance. Please see further discussion in Note 8 – Variable Interest Entities. Other investment notes outstanding – non-real estate related loans Working Capital Loan $20 million Term Loan $25 million Mezzanine Loan - $40 million On September 1, 2022, we entered into a $40.0 million mezzanine loan with a new operator. The loan bears interest at a fixed rate of 12% per annum and matures on September 14, 2027. The loan also requires semi-annual principal payments of $1.7 million in January and July, commencing on January 1, 2023, and additional payments contingent on the occurrence of certain conditions. The loan is secured by an equity interest in subsidiaries of the operator. Revolving Credit Facility - $45 million On August 25, 2022, the Company amended the terms of a $15 million revolving credit facility that was previously issued in July 2019, bearing interest at a fixed rate of 7.5% per annum and maturing on July 8, 2022. This revolving credit facility was subsequently amended during the nine months ended September 30, 2022 to increase the maximum principal to $45 million, extend the maturity date to December 31, 2024 and require monthly principal payments of $0.5 million beginning in July 2022, which increase to $1.0 million in November 2022, to $1.5 million in June 2023 and to $2.5 million in October 2023.

ALLOWANCE FOR CREDIT LOSSES

ALLOWANCE FOR CREDIT LOSSES	9 Months Ended
ALLOWANCE FOR CREDIT LOSSES	Sep. 30, 2022
Receivables [Abstract]
ALLOWANCE FOR CREDIT LOSSES	NOTE 7 – ALLOWANCE FOR CREDIT LOSSES A rollforward of our allowance for credit losses for the nine months ended September 30, 2022 is as follows: Rating Financial Statement Line Item Allowance for Credit Loss as of December 31, 2021 Provision (recovery) for Credit Loss for the nine months ended September 30, 2022 Write-offs charged against allowance for the nine months ended September 30, 2022 Allowance for Credit Loss as of September 30, 2022 (in thousands) 2 Mortgage notes receivable $ 15 $ (3) $ — $ 12 3 Mortgage notes receivable 1,973 (345) — 1,628 4 Mortgage notes receivable 19,461 (5,746) — 13,715 5 Mortgage notes receivable 135 (86) — 49 6 Mortgage notes receivable 52,017 (5,564) (1) — 46,453 Sub-total 73,601 (11,744) — 61,857 3 Investment in direct financing leases 530 (530) — — 4 Investment in direct financing leases - 785 — 785 Sub-total 530 255 — 785 1 Other investments — 212 — 212 2 Other investments 29 247 — 276 3 Other investments 4,600 3,010 (2) — 7,610 4 Other investments 1,172 157 — 1,329 5 Other investments 7,861 12,522 (3) — 20,383 6 Other investments 55,732 (5) (1,966) (4) (22,515) (5) 31,251 Sub-total 69,394 14,182 (22,515) 61,061 2 Off-balance sheet note commitments 7 94 — 101 3 Off-balance sheet note commitments 458 (209) — 249 4 Off-balance sheet note commitments 216 (216) — — 4 Off-balance sheet mortgage commitments 117 (102) — 15 6 Off-balance sheet note commitments 143 (7) 2,107 (6) (2,250) (7) — Sub-total 941 1,674 (2,250) 365 Total $ 144,466 $ 4,367 $ (24,765) $ 124,068 (1) Amount relates to the recoveries, net of provision, recorded on the Guardian mortgage loan during the nine months ended September 30, 2022. See Note 5 – Mortgage Notes Receivable for additional information on the recoveries recorded. (2) Reflects additional provisions of $0.9 million and $3.2 million recorded on the $20 million WC loan during the three and nine months ended September 30, 2022 as discussed in Note 6 – Other Investments. (3) Reflects additional provisions of $4.8 million and $10.8 million recorded on the Agemo WC Loan during the three and nine months ended September 30, 2022. See Note 6 – Other Investments for additional information on the Agemo WC Loan provision. (4) During the three and nine months ended September 30, 2022, we received $0.5 million and $2.0 million, respectively, of interest and fee payments from Gulf Coast under the $25.0 million senior secured DIP facility, the outstanding principal of which was fully reserved against in the fourth quarter of 2021. The DIP facility is on non-accrual status, and the payments received in the three and nine months ended September 30, 2022 have been applied against the outstanding principal using the cost recovery method. In the three and nine months ended September 30, 2022, we recorded a recovery for credit loss equal to the amount of payments applied against the principal. (5) During the third quarter of 2022, we wrote-off the loan balance and reserve for two loans (the $25.0 million senior secured DIP facility and one other loan) that expired during the quarter which had previously been fully reserved. (6) During the second quarter of 2022, we recorded an additional reserve of $2.2 million related to the remaining commitment under the $25.0 million senior secured DIP facility. (7) During the third quarter of 2022, the remaining commitment under the $25.0 million senior secured DIP facility was funded, and the facility expired, which resulted in a write-off of the loan and reserve balances. A rollforward of our allowance for credit losses for the nine months ended September 30, 2021 is as follows: Rating Financial Statement Line Item Allowance for Credit Loss at December 31, 2020 Provision (recovery) for Credit Loss for the nine months ended September 30, 2021 Write-offs charged against allowance for the nine months ended September 30, 2021 Allowance for Credit Loss as of September 30, 2021 (in thousands) 2 Mortgage notes receivable $ 88 $ (65) $ — $ 23 3 Mortgage notes receivable 954 1,603 — 2,557 4 Mortgage notes receivable 26,865 (1,825) (1) — 25,040 5 Mortgage notes receivable 433 9,025 (1) — 9,458 6 Mortgage notes receivable 4,905 — — 4,905 Sub-total 33,245 8,738 — 41,983 3 Investment in direct financing leases 694 (35) — 659 Sub-total 694 (35) — 659 2 Other investments 94 (38) — 56 3 Other investments 5,113 628 — 5,741 4 Other investments 24,397 (22,675) (2) — 1,722 5 Other investments 1,853 6,260 (3) (95) 8,018 6 Other investments — 35,954 (2) — 35,954 Sub-total 31,457 20,129 (95) 51,491 2 Off-balance sheet note commitments 116 (90) — 26 3 Off-balance sheet note commitments 2,305 (1,300) — 1,005 4 Off-balance sheet note commitments — 373 — 373 4 Off-balance sheet mortgage commitments 24 208 — 232 Sub-total 2,445 (809) — 1,636 Total $ 67,841 $ 28,023 $ (95) $ 95,769 (1) Amount reflects the movement of reserves associated with our mortgage loan with Guardian due to a reduction of our internal risk rating from a 4 to a 5 on the loan in the third quarter of 2021. (2) Amount reflects the movement of $27.2 million of reserves from Other Investments with a rating of 4 to Other Investments with a rating of 6 as a result of a reduction of our internal credit rating from a 4 to a 6 on the Agemo Term Loan and one other loan during the third quarter of 2021. The provision for Other Investments with a rating of 6 also reflects $8.8 million of additional allowance recorded in the third quarter of 2021 to fully reserve the remaining carrying value of the Agemo Term Loan. (3) The provision includes an additional $7.9 million of allowance recorded on the Agemo WC Loan during the third quarter of 2021. We also reduced the internal rating on the Agemo WC Loan from a 4 to a 5 during the third quarter of 2021. A summary of our amortized cost basis by year of origination and credit quality indicator is as follows: Rating Financial Statement Line Item 2022 2021 2020 2019 2018 2017 2016 & older Revolving Loans Balance as of September 30, 2022 (in thousands) 1 Mortgage notes receivable $ — $ — $ — $ — $ — $ — $ 64,243 $ — $ 64,243 2 Mortgage notes receivable — — 21,325 — — — — — 21,325 3 Mortgage notes receivable — 72,420 — — — — — — 72,420 4 Mortgage notes receivable 122 25,021 89,501 5,084 29,147 11,291 321,948 — 482,114 5 Mortgage notes receivable — — — — — — 6,602 — 6,602 6 Mortgage notes receivable — — — — — — 84,686 — 84,686 Sub-total 122 97,441 110,826 5,084 29,147 11,291 477,479 — 731,390 4 Investment in direct financing leases — — — — — — 11,345 — 11,345 Sub-total — — — — — — 11,345 — 11,345 1 Other Investments 20,000 — — — — — — — 20,000 2 Other investments 30,000 — — — — — — 51,799 81,799 3 Other investments 35,600 — — 14,563 10,800 — 1,756 251,565 314,284 4 Other investments 39,614 — — 2,422 96,456 — 1,000 20,000 159,492 5 Other investments 25,000 8,235 — — 24,548 — — — 57,783 6 Other investments — — — — 4,650 — 31,243 — 35,893 Sub-total 150,214 8,235 — 16,985 136,454 — 33,999 323,364 669,251 Total $ 150,336 $ 105,676 $ 110,826 $ 22,069 $ 165,601 $ 11,291 $ 522,823 $ 323,364 $ 1,411,986 Year to date gross write-offs $ — $ (18,052) $ — $ — $ (4,463) $ — $ — $ — $ (22,515) Interest Receivable on Mortgage and Other Investment Loans We have elected the practical expedient to exclude interest receivable from our allowance for credit losses. As of September 30, 2022, $10.0 million of contractual interest receivable is recorded in contractual receivables – net, and $6.2 million of effective yield interest receivables is recorded in other receivables and lease inducements on our Consolidated Balance Sheets, both of which are excluded from our allowance for credit losses. We write-off interest receivable to provision for credit losses in the period we determine the interest is no longer considered collectible.

VARIABLE INTEREST ENTITIES

VARIABLE INTEREST ENTITIES	9 Months Ended
VARIABLE INTEREST ENTITIES	Sep. 30, 2022
Variable Interest Entities [Abstract]
VARIABLE INTEREST ENTITIES	NOTE 8 – VARIABLE INTEREST ENTITIES Unconsolidated Variable Interest Entities We hold variable interests in several VIEs through our investing and financing activities, which are not consolidated, as we have concluded that we are not the primary beneficiary of these entities as we do not have the power to direct activities that most significantly impact the VIE’s economic performance and/or the variable interest we hold does not obligate us to absorb losses or provide us with the right to receive benefits from the VIE which could potentially be significant. Below is a summary of our assets, liabilities and collateral associated with these unconsolidated VIEs as of September 30, 2022 and December 31, 2021: September 30, December 31, 2022 2021 (in thousands) Assets Real estate assets – net $ 988,173 $ 1,144,851 Assets held for sale 129,239 191,016 Other investments – net 264,473 230,768 Contractual receivables – net 1,485 1,227 Other receivables and lease inducements 29,311 22,795 Other assets 746 — Total assets 1,413,427 1,590,657 Liabilities Net in-place lease liability (286) (305) Security deposit (4,829) (4,715) Contingent liability (43,915) (43,915) Other liabilities (746) — Total liabilities (49,776) (48,935) Collateral Letters of credit — — Personal guarantee (48,000) (48,000) Other collateral (1) (1,117,412) (1,335,867) Total collateral (1,165,412) (1,383,867) Maximum exposure to loss $ 198,239 $ 157,855 (1) Amount excludes accounts receivable that Omega has a security interest in as collateral under the two working capital loans with operators that are unconsolidated VIEs. The fair value of the accounts receivable available to Omega was $8.3 million and $29.2 million as of September 30, 2022 and December 31, 2021, respectively. In determining our maximum exposure to loss from the unconsolidated VIEs, we considered the underlying carrying value of the real estate subject to leases with the operator and other collateral, if any, supporting our other investments, which may include accounts receivable, security deposits, letters of credit or personal guarantees, if any, as well as other liabilities recognized with respect to these operators. The table below reflects our total revenues from the operators that are considered unconsolidated VIEs for the three and nine months ended September 30, 2022 and 2021: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Revenue Rental income $ 21,120 $ 33,392 $ 63,222 $ 95,292 Other investment income 4,839 3,551 12,940 11,726 Total $ 25,959 $ 36,943 $ 76,162 $ 107,018 Consolidated VIEs During the first quarter of 2022, we entered into a joint venture, which owns two ALFs, for a $3.2 million cash contribution, representing 52.4% of the outstanding equity of the joint venture. We also sold an ALF to the joint venture

INVESTMENT IN JOINT VENTURES

INVESTMENT IN JOINT VENTURES	9 Months Ended
INVESTMENT IN JOINT VENTURES	Sep. 30, 2022
INVESTMENTS IN JOINT VENTURES [Abstract]
INVESTMENTS IN JOINT VENTURES	NOTE 9 – INVESTMENTS IN JOINT VENTURES Unconsolidated Joint Ventures The following is a summary of our investments in unconsolidated joint ventures (dollars in thousands): Carrying Amount Ownership Initial Investment Facility Facilities at September 30, December 31, Entity % Date Investment (1) Type 9/30/2022 2022 2021 Second Spring Healthcare Investments 15% 11/1/2016 $ 50,032 SNF — $ 10,849 $ 11,355 Second Spring II LLC 15% 3/10/2021 10,330 SNF — — 8 Lakeway Realty, L.L.C. 51% 5/17/2019 73,834 Specialty facility 1 70,465 71,286 Cindat Joint Venture 49% 12/18/2019 105,688 ALF 65 94,870 111,792 OMG Senior Housing, LLC 50% 12/6/2019 — Specialty facility 1 — — OH CHS SNP, Inc. 9% 12/20/2019 1,013 N/A N/A 372 246 $ 240,897 $ 176,556 $ 194,687 (1) Our investment includes our transaction costs, if any. Three Months Ended September 30, Nine Months Ended September 30, Entity 2022 2021 2022 2021 (in thousands) Second Spring Healthcare Investments (1) $ 300 $ 309 $ 882 $ 12,013 Second Spring II LLC — (1) (2) (757) Lakeway Realty, L.L.C. 656 637 1,976 1,923 Cindat Joint Venture 3,339 707 4,972 1,839 OMG Senior Housing, LLC (140) (105) (319) (309) OH CHS SNP, Inc. (38) 5 13 (140) Total $ 4,117 $ 1,552 $ 7,522 $ 14,569 (1) The income from this unconsolidated joint venture for the nine months ended September 30, 2021 includes a $14.9 million gain on sale of real estate investments. Asset Management Fees We receive asset management fees from certain joint ventures for services provided. For the three months ended September 30, 2022 and 2021, we recognized approximately $0.1 million and $0.2 million, respectively, of asset management fees. For the nine months ended September 30, 2022 and 2021, we recognized approximately $0.5 million and $0.7 million, respectively, of asset management fees. These fees are included in miscellaneous income in the accompanying Consolidated Statements of Operations.

GOODWILL AND OTHER INTANGIBLES

GOODWILL AND OTHER INTANGIBLES	9 Months Ended
GOODWILL AND OTHER INTANGIBLES	Sep. 30, 2022
Goodwill and Other Intangibles [Abstract]
GOODWILL AND OTHER INTANGIBLES	NOTE 10 – GOODWILL AND OTHER INTANGIBLES The following is a summary of our goodwill as of September 30, 2022 and December 31, 2021: (in thousands) Balance as of December 31, 2021 $ 651,417 Foreign currency translation (2,469) Balance as of September 30, 2022 $ 648,948 The following is a summary of our intangibles as of September 30, 2022 and December 31, 2021: September 30, December 31, 2022 2021 (in thousands) Assets: Above market leases $ 5,929 $ 5,929 Accumulated amortization (4,445) (4,313) Net above market leases $ 1,484 $ 1,616 Liabilities: Below market leases $ 71,072 $ 66,324 Accumulated amortization (47,093) (38,091) Net below market leases $ 23,979 $ 28,233 Above market leases, net of accumulated amortization, are included in other assets on our Consolidated Balance Sheets. Below market leases, net of accumulated amortization, are included in accrued expenses and other liabilities on our Consolidated Balance Sheets. The net amortization related to the above and below market leases is included in our Consolidated Statements of Operations as an adjustment to rental income. For the three months ended September 30, 2022 and 2021, our net amortization related to intangibles was $1.0 million and $1.1 million, respectively. For the nine months ended September 30, 2022 and 2021, our net amortization related to intangibles was $3.6 million and $8.5 million, respectively. The estimated net amortization related to these intangibles for the remainder of 2022 and the next four years is as follows: remainder of 2022 – $ 1.0 million; 2023 – $3.9 million; 2024 – $3.7 million; 2025 – $3.5 million and 2026 – $2.7 million. As of September 30, 2022, the weighted average remaining amortization period of above market lease assets is approximately ten years and below market lease liabilities is approximately seven years.

CONCENTRATION OF RISK

CONCENTRATION OF RISK	9 Months Ended
CONCENTRATION OF RISK	Sep. 30, 2022
Concentration of Risk [Abstract]
CONCENTRATION OF RISK	NOTE 11 – CONCENTRATION OF RISK As of September 30, 2022, our portfolio of real estate investments (including properties associated with mortgages, direct financing leases, assets held for sale and consolidated joint ventures) consisted of 941 healthcare facilities, located in 42 states and the U.K. and operated by 65 third-party operators. Our investment in these facilities, net of impairments and allowances, totaled approximately $9.6 billion at September 30, 2022, with approximately 97% of our real estate investments related to long-term healthcare facilities. Our portfolio is made up of (i) 650 SNFs, 167 ALFs, 20 ILFs, 16 specialty facilities and two medical office buildings, (ii) fixed rate mortgages on 48 SNFs, two ALFs and two specialty facilities, and (iii) 34 facilities that are held for sale. At September 30, 2022, we also held other investments of approximately $608.2 million, consisting primarily of secured loans to third-party operators of our facilities and $176.6 million of investments in six unconsolidated joint ventures. At September 30, 2022, we had investments with two operators or managers that approximated or exceeded 10% of our total investments: Maplewood and LaVie. Maplewood generated approximately 9.3% and 7.9% of our total revenues for the three months ended September 30, 2022 and 2021, respectively, and 9.1% and 7.7% of our total revenues for the nine months ended September 30, 2022 and 2021, respectively. LaVie generated approximately 11.5% and 9.3% of our total revenues for the three months ended September 30, 2022 and 2021, respectively, and 11.4% and 9.3% of our total revenues for the nine months ended September 30, 2022 and 2021, respectively. At September 30, 2022, the three states in which we had our highest concentration of investments were Florida (13.1%), Texas (10.3%) and Indiana (6.6%).

STOCKHOLDERS EQUITY

STOCKHOLDERS EQUITY	9 Months Ended
STOCKHOLDERS EQUITY	Sep. 30, 2022
Stockholders Equity [Abstract]
STOCKHOLDERS EQUITY	NOTE 12 – STOCKHOLDERS’ EQUITY $500 Million Stock Repurchase Program On January 27, 2022, the Company authorized the repurchase of up to $500 million of our outstanding common stock from time to time through March 2025. The Company is authorized to repurchase shares of its common stock in open market and privately negotiated transactions, pursuant to Rule 10b5-1 trading plans or in any other manner as determined by the Company’s management and in accordance with applicable law. The timing and amount of stock repurchases will be determined, in management’s discretion, based on a variety of factors, including but not limited to market conditions, other capital management needs and opportunities and corporate and regulatory considerations. The Company has no obligation to repurchase any amount of its common stock, and such repurchases, if any, may be discontinued at any time. Under Maryland law, shares repurchased become authorized but unissued shares. The Company reduced the common stock at par value and to the extent the cost acquired exceeds par value, it is recorded through additional paid-in capital on our Consolidated Balance Sheets and Consolidated Statements of Equity. The following is a summary of the shares repurchased for the three and nine months ended September 30, 2022 (in millions except average price per share): Average Price Period Ended Shares Repurchased Per Share (1) Repurchase Cost (1) Three Months Ended September 30, 2022 — $ — $ — Nine Months Ended September 30, 2022 5.2 27.32 142.3 (1) Average price per share and repurchase cost includes the cost of commissions. Dividends The following is a summary of our declared cash dividends on common stock: Record Payment Dividend per Date Date Common Share February 7, 2022 February 15, 2022 $ 0.67 May 2, 2022 May 13, 2022 0.67 August 1, 2022 August 15, 2022 0.67 November 1, 2022 November 15, 2022 0.67 Dividend Reinvestment and Common Stock Purchase Plan The following is a summary of the shares issued under the Dividend Reinvestment and Common Stock Purchase Plan for the three and nine months ended September 30, 2022 and 2021 (in millions): Period Ended Shares issued Gross Proceeds Three Months Ended September 30, 2021 1.3 $ 47.2 Three Months Ended September 30, 2022 0.1 2.4 Nine Months Ended September 30, 2021 3.3 124.5 Nine Months Ended September 30, 2022 0.3 7.0 At-The-Market Offering Programs The following is a summary of the shares issued under our former $500 million 2015 At-The-Market Offering Program (“2015 ATM Program”) and our current $1.0 billion 2021 At-The-Market Offering Program (“2021 ATM Program”) for the three and nine months ended September 30, 2022 and 2021 (in millions except average price per share): Average Net Price Period Ended Shares issued Per Share (1) Gross Proceeds Commissions Net Proceeds Three Months Ended September 30, 2021 0.1 $ 32.82 $ 1.3 $ 0.1 $ 1.2 Three Months Ended September 30, 2022 — — — — — Nine Months Ended September 30, 2021 4.2 36.56 155.1 3.3 151.8 Nine Months Ended September 30, 2022 — — — — — (1) Represents the average price per share after commissions. We did not utilize the forward provisions under the 2021 ATM Program during the nine months ended September 30, 2022. Accumulated Other Comprehensive Income (Loss) The following is a summary of our accumulated other comprehensive income (loss), net of tax where applicable: As of and for the As of and for the Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in thousands) Foreign Currency Translation: Beginning balance $ (79,670) $ (13,608) $ (24,012) $ (18,427) Translation loss (45,873) (12,646) (100,253) (8,515) Realized (loss) gain (153) (18) (1,431) 670 Ending balance (125,696) (26,272) (125,696) (26,272) Derivative Instruments: Cash flow hedges: Beginning balance 69,429 33,352 30,407 17,718 Unrealized gain 16,499 1,116 53,481 15,407 Realized gain (1) 1,074 779 3,114 2,122 Ending balance 87,002 35,247 87,002 35,247 Net investment hedges: Beginning balance 12,920 (16,024) (9,588) (13,331) Unrealized gain 31,273 7,637 53,781 4,944 Ending balance 44,193 (8,387) 44,193 (8,387) Total accumulated other comprehensive income before noncontrolling interest 5,499 588 5,499 588 Add: portion included in noncontrolling interest 744 888 744 888 Total accumulated other comprehensive income for Omega $ 6,243 $ 1,476 $ 6,243 $ 1,476 (1) Recorded in interest expense on the Consolidated Statements of Operations.

TAXES

TAXES	9 Months Ended
TAXES	Sep. 30, 2022
Taxes [Abstract]
TAXES	NOTE 13 – TAXES Omega was organized, has operated and intends to continue to operate in a manner that enables Omega to qualify for taxation as a REIT under Sections 856 through 860 of the Code. On a quarterly and annual basis, we perform several analyses to test our compliance within the REIT taxation rules. If we fail to meet the requirements for qualification as a REIT in any tax year, we will be subject to federal income tax on our taxable income at regular corporate rates and may not be able to qualify as a REIT for the four We are also subject to federal taxation of 100% of the net income derived from the sale or other disposition of property, other than foreclosure property, that we held primarily for sale to customers in the ordinary course of a trade or business. We believe that we do not hold assets for sale to customers in the ordinary course of business and that none of the assets currently held for sale or that have been sold would be considered a prohibited transaction within the REIT taxation rules. As a REIT under the Code, we generally will not be subject to federal income taxes on the REIT taxable income that we distribute to stockholders, subject to certain exceptions. In 2021, we distributed dividends in excess of our taxable income. We currently own stock in certain subsidiary REITs. These subsidiaries are required to individually satisfy all of the rules for qualification as a REIT. If we fail to meet the requirements for qualification as a REIT for any of these subsidiaries, it may cause Omega to fail the requirements for qualification as a REIT also. We have elected to treat certain of our active subsidiaries as taxable REIT subsidiaries (“TRSs”). Our domestic TRSs are subject to federal, state and local income taxes at the applicable corporate rates. Our foreign TRSs are subject to foreign income taxes and may cause us to be subject to current-year income inclusion relating to ownership of a controlled foreign corporation for U.S. income tax purposes. As of September 30, 2022, one of our domestic TRSs that is subject to income taxes at the applicable corporate rates had a net operating loss (“NOL”) carry-forward of approximately $10.2 million. Our domestic NOL carry-forward was fully reserved as of September 30, 2022, with a valuation allowance due to uncertainties regarding realization. Under current law, NOL carry-forwards generated up through December 31, 2017, may be carried forward for no more than 20 years, and NOL carry-forwards generated in taxable years ended after December 31, 2017, may be carried forward indefinitely. We do not anticipate that such changes will materially impact the computation of Omega’s taxable income, or the taxable income of any Omega entity, including our TRSs. As discussed in Note 2 – Real Estate Assets, in connection with the acquisition of one U.K. entity in the first quarter of 2022, we acquired foreign net operating losses of $55.0 million resulting in a NOL deferred tax asset of $13.4 million. The NOLs have no expiration date and may be available to offset future taxable income. We believe these foreign NOLs are realizable under a “more likely than not” measurement and have not recorded a valuation allowance against the deferred tax asset. The following is a summary of deferred tax assets and liabilities (which are recorded in other assets and accrued expenses and other liabilities, respectively, in our Consolidated Balance Sheets): September 30, December 31, 2022 2021 (in thousands) U.S. Federal net operating loss carryforward $ 2,138 $ 2,221 Valuation allowance on deferred tax asset (2,138) (2,221) Foreign net operating loss carryforward 10,456 — Foreign deferred tax liability (1) (5,331) (8,200) Net deferred tax asset (liability) $ 5,125 $ (8,200) (1) The deferred tax liability primarily resulted from inherited basis differences resulting from our acquisition of entities in the U.K. Subsequent adjustments to these accounts result from GAAP to tax differences related to depreciation, indexation and revenue recognition. The following is a summary of our provision for income taxes: Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in millions) Provision for federal, state and local income taxes $ 0.3 $ 0.4 $ 0.9 $ 1.0 Provision for foreign income taxes 0.9 0.6 2.6 1.9 Total provision for income taxes (1) $ 1.2 $ 1.0 $ 3.5 $ 2.9 (1) The above amounts do not include gross receipts or franchise taxes payable to certain states and municipalities.

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	9 Months Ended
STOCK-BASED COMPENSATION	Sep. 30, 2022
Stock-Based Compensation [Abstract]
STOCK-BASED COMPENSATION	NOTE 14 – STOCK-BASED COMPENSATION The following is a summary of our stock-based compensation expense for the three and nine months ended September 30, 2022 and 2021, respectively: Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in thousands) Stock-based compensation expense $ 6,809 $ 5,706 $ 20,515 $ 16,913 Stock-based compensation expense is included within general and administrative expenses on our Consolidated Statements of Operations. We granted 31,685 time-based restricted stock units (“RSUs”) and 170,294 time-based profits interest units (“PIUs”) during the first quarter of 2022 to certain officers and key employees, and those units vest on December 31, 2024 (three years after the grant date), subject to continued employment and vesting in certain other events. We also granted 1,545,070 performance-based PIUs during the first quarter of 2022 to certain officers and key employees, which are earned based on the level of performance over the performance period (normally three years) and vest quarterly in the four Time-based and performance-based grants made to named executive officers and key employees that meet certain conditions under the Company’s retirement policy (length of service, age, etc.) vest on an accelerated basis pursuant to the 2018 Stock Incentive Plan.

BORROWING ACTIVITIES AND ARRANG

BORROWING ACTIVITIES AND ARRANGEMENTS	9 Months Ended
BORROWING ACTIVITIES AND ARRANGEMENTS	Sep. 30, 2022
BORROWING ACTIVITIES AND ARRANGEMENTS [Abstract]
BORROWING ACTIVITIES AND ARRANGEMENTS	NOTE 15 – BORROWING ACTIVITIES AND ARRANGEMENTS The following is a summary of our borrowings: Annual Interest Rate as of September 30, September 30, December 31, Maturity 2022 2022 2021 (in thousands) Secured borrowings: HUD mortgages (1)(2) 2046 - 2052 3.01 % $ 346,606 $ 359,806 2023 term loan (3) 2023 6.75 % 2,161 2,275 2024 term loan (4) 2024 8.02 % 19,638 — Total secured borrowings 368,405 362,081 Unsecured borrowings: Revolving credit facility (5)(6) 2025 4.32 % 17,861 — Senior notes and other unsecured borrowings: 2023 notes (5) 2023 4.375 % 350,000 350,000 2024 notes (5) 2024 4.950 % 400,000 400,000 2025 notes (5) 2025 4.500 % 400,000 400,000 2026 notes (5) 2026 5.250 % 600,000 600,000 2027 notes (5) 2027 4.500 % 700,000 700,000 2028 notes (5) 2028 4.750 % 550,000 550,000 2029 notes (5) 2029 3.625 % 500,000 500,000 2031 notes (5) 2031 3.375 % 700,000 700,000 2033 notes (5) 2033 3.250 % 700,000 700,000 OP term loan (7)(8) 2025 4.57 % 50,000 50,000 Deferred financing costs – net (23,451) (26,980) Discount – net (27,940) (31,565) Total senior notes and other unsecured borrowings – net 4,898,609 4,891,455 Total unsecured borrowings – net 4,916,470 4,891,455 Total secured and unsecured borrowings – net (9)(10) $ 5,284,875 $ 5,253,536 (1) Reflects the weighted average annual contractual interest rate on the mortgages at September 30, 2022. Secured by real estate assets with a net carrying value of $505.9 million as of September 30, 2022. During the third quarter of 2022, we paid approximately $7.9 million to retire one mortgage loan guaranteed by HUD that was assumed in 2019 and had a fixed interest rate of 2.92% per annum with a maturity date in 2051 . The payoff included a $0.4 million prepayment fee which is included in loss on debt extinguishment on our Consolidated Statement of Operations. (2) Wholly owned subsidiaries of Omega OP are the obligor on these borrowings. (3) Borrowing is the debt of a consolidated joint venture. (4) Borrowing is the debt of the consolidated joint venture discussed in Note 8 – Variable Interest Entities which was formed in the first quarter of 2022. The borrowing is secured by two ALFs, which are owned by the joint venture. (5) Guaranteed by Omega OP. (6) As of September 30, 2022, borrowings under Omega’s $1.45 billion senior unsecured multicurrency revolving credit facility consisted of £16.0 million British Pounds Sterling (“GBP”). The applicable interest rate on the US Dollar tranche and on the GBP borrowings under the alternative currency tranche of the credit facility were 4.32% and 3.51% as of September 30, 2022, respectively. (7) Omega OP is the obligor on this borrowing. (8) The interest rate swaps, that were cash flow hedges of Omega OP’s $50.0 million senior unsecured term loan facility’s (the “OP term loan”) interest payments and that effectively fixed the interest rate at 3.29% , matured on February 10, 2022 . (9) All borrowings are direct borrowings of Parent unless otherwise noted. (10) Certain of our other secured and unsecured borrowings are subject to customary affirmative and negative covenants, including financial covenants. As of September 30, 2022 and December 31, 2021, we were in compliance with all applicable covenants for our borrowings .

DERIVATIVES AND HEDGING

DERIVATIVES AND HEDGING	9 Months Ended
DERIVATIVES AND HEDGING	Sep. 30, 2022
DERIVATIVES AND HEDGING [Abstract]
DERIVATIVES AND HEDGING	NOTE 16 – DERIVATIVES AND HEDGING We are exposed to, among other risks, the impact of changes in foreign currency exchange rates as a result of our investments in the U.K. and interest rate risk related to our capital structure. As a matter of policy, we do not use derivatives for trading or speculative purposes. Our risk management program is designed to manage the exposure and volatility arising from these risks, and utilizes foreign currency forward contracts, interest rate swaps and debt issued in foreign currencies to offset a portion of these risks. As of September 30, 2022, we have five forward starting swaps with $400.0 million in notional value, indexed to 3-month LIBOR, that were issued at a weighted average fixed rate of 0.8675% and are designated as cash flow hedges. Additionally, we have six foreign currency forward contracts with £250.0 million in notional valued issued at a weighted average GBP-USD forward rate of 1.3641 (including the two new foreign currency forwards discussed below) that are designated as net investment hedges. On May 17, 2022, we entered into two new foreign currency forward contracts with notional amounts totaling £76.0 million and a GBP-USD forward rate of 1.3071, each of which mature on May 21, 2029. These currency forward contracts hedge a portion of our net investments in U.K. subsidiaries and our U.K. joint venture. On February 10, 2022, two of our interest rate swaps that we entered into in May 2019 with aggregate notional amounts of $50.0 million matured. These interest rate swap contracts were designated as hedges against our exposure to changes in interest payment cash flow fluctuations in the variable interest rates on the OP term loan. The location and fair value of derivative instruments designated as hedges, at the respective balance sheet dates, were as follows: September 30, December 31, 2022 2021 Cash flow hedges: (in thousands) Other assets $ 92,561 $ 32,849 Accrued expenses and other liabilities $ — $ 96 Net investment hedges: Other assets $ 60,536 $ 6,754 The fair value of the forward starting swaps and foreign currency forwards is derived from observable market data such as yield curves and foreign exchange rates and represents a Level 2 measurement on the fair value hierarchy.

FINANCIAL INSTRUMENTS

FINANCIAL INSTRUMENTS	9 Months Ended
FINANCIAL INSTRUMENTS	Sep. 30, 2022
Financial Instruments [Abstract]
FINANCIAL INSTRUMENTS	NOTE 17 – FINANCIAL INSTRUMENTS The net carrying amount of cash and cash equivalents, restricted cash, contractual receivables, other assets and accrued expenses and other liabilities reported in the Consolidated Balance Sheets approximates fair value because of the short maturity of these instruments (Level 1). At September 30, 2022 and December 31, 2021, the net carrying amounts and fair values of our other financial instruments were as follows: September 30, 2022 December 31, 2021 Carrying Fair Carrying Fair Amount Value Amount Value (in thousands) Assets: Investments in direct financing leases – net $ 10,560 $ 10,560 $ 10,873 $ 10,873 Mortgage notes receivable – net 669,533 671,387 835,086 869,715 Other investments – net 608,190 614,646 469,884 476,664 Total $ 1,288,283 $ 1,296,593 $ 1,315,843 $ 1,357,252 Liabilities: Revolving credit facility $ 17,861 $ 17,861 $ — $ — 2023 term loan 2,161 2,161 2,275 2,275 2024 term loan 19,638 19,750 — — OP term loan 49,737 50,000 49,661 50,000 4.375% notes due 2023 – net 349,527 348,366 349,100 365,243 4.95% notes due 2024 – net 398,483 395,592 397,725 427,184 4.50% notes due 2025 – net 398,256 389,844 397,685 427,440 5.25% notes due 2026 – net 597,671 580,884 597,142 667,524 4.50% notes due 2027 – net 693,472 649,523 692,374 766,003 4.75% notes due 2028 – net 544,664 504,383 543,908 607,249 3.625% notes due 2029 – net 491,588 406,855 490,681 519,430 3.375% notes due 2031 – net 684,935 533,484 683,592 705,810 3.25% notes due 2033 – net 690,276 493,640 689,587 683,151 HUD mortgages – net 346,606 269,508 359,806 394,284 Total $ 5,284,875 $ 4,661,851 $ 5,253,536 $ 5,615,593 Fair value estimates are subjective in nature and are dependent on a number of important assumptions, including estimates of future cash flows, risks, discount rates and relevant comparable market information associated with each financial instrument (see Note 2 – Summary of Significant Accounting Policies in our Annual Report on Form 10-K The following methods and assumptions were used in estimating fair value disclosures for financial instruments. ● Mortgage notes receivable: The fair value of the mortgage notes receivables are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3). ● Other investments: Other investments are primarily comprised of notes receivable. The fair values of notes receivable are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3). ● Revolving credit facility, OP term loan, 2023 term loan and 2024 term loan: The carrying amount of these approximate fair value because the borrowings are interest rate adjusted. Differences between carrying value and the fair value in the table above are due to the inclusion of deferred financing costs in the carrying value. ● Senior notes: The fair value of the senior unsecured notes payable was estimated based on (Level 1) publicly available trading prices. ● HUD mortgages: The fair value of our borrowings under HUD debt agreements are estimated using an expected present value technique based on quotes obtained by HUD debt brokers (Level 2).

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
COMMITMENTS AND CONTINGENCIES	Sep. 30, 2022
COMMITMENTS AND CONTINGENCIES [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 18 – COMMITMENTS AND CONTINGENCIES Litigation Shareholder Litigation The Company and certain of its officers, C. Taylor Pickett, Robert O. Stephenson, and Daniel J. Booth Following a mediation, the plaintiffs and defendants reached an agreement in principle in October 2022 on a settlement of the Securities Class Action. The Company recorded a $31 million legal reserve related to the Securities Class Action in the third quarter of 2022, which is included within accrued expenses and other liabilities on the Consolidated Balance Sheets. As the Company anticipates that the settlement proceeds will be paid by insurance, we concurrently recorded a receivable for $31 million within other assets on the Consolidated Balance Sheet, and consequently there is no impact to the Consolidated Statement of Operations related to this matter. The settlement agreement in principle is subject to negotiation of a definitive settlement agreement, and also subject to the approval of the District Court. The District Court has suspended deadlines under the Scheduling Order in the case, pending a definitive agreement and the court approval process. Certain derivative actions have also been brought against the officers named in the Securities Class Action, and certain current and former directors of the Company, alleging claims relating to the matters at issue in the Securities Class Action. These derivative actions are currently stayed pending certain developments in the Securities Class Action. In 2018, Stourbridge Investments LLC, a purported stockholder of the Company, filed a derivative action purportedly on behalf of the Company in the U.S. District Court for the Southern District of New York, alleging violations of Section 14(a) of the Exchange Act and state-law claims including breach of fiduciary duty. The complaint alleges, among other things, that the named defendants are responsible for the Company’s failure to disclose the financial condition of Orianna Health Systems, the alleged non-disclosures that are also the subject of the Securities Class Action described above. The plaintiff did not make a demand on the Company to bring the action prior to filing it, but rather alleges that demand would have been futile. The case has been stayed pending the entry of judgment or a voluntary dismissal with prejudice in the Securities Class Action. In 2019, purported stockholder Phillip Swan by his counsel, and stockholders Tom Bradley and Sarah Smith by their counsel, filed derivative actions in the Baltimore City Circuit Court of Maryland, purportedly on behalf of the Company, asserting claims for breach of fiduciary duty, waste of corporate assets and unjust enrichment against the named defendants. Those actions have been consolidated and stayed in the Maryland court pending completion of fact discovery in the Securities Class Action. Prior to filing suit, each of these stockholders had made demands on the Board of Directors in 2018 that the Company bring such lawsuits. After an investigation and due consideration, and in the exercise of its business judgment, the Board of Directors determined that it is not in the best interests of the Company to commence litigation against any current or former officers or directors based on the matters raised in the demands. In addition, in late 2020, Robert Wojcik, a purported shareholder of the Company, filed a derivative action in the U.S. District Court for the District of Maryland, purportedly on behalf of the Company, asserting violations of Section 14(a) of the Exchange Act, Sections 10(b) and 21D of the Exchange Act, as well as claims for breach of fiduciary duty, unjust enrichment, abuse of control, gross mismanagement, and waste of corporate assets. Wojcik also did not make a demand on the Company prior to filing suit. The case has been stayed pending the entry of judgment or a voluntary dismissal with prejudice in the Securities Class Action. The Company believes that the claims asserted against it in these lawsuits are without merit. Other Gulf Coast Subordinated Debt In August 2021, we filed suit in the Circuit Court for Baltimore County (the “Court”) against the holders of certain Subordinated Debt associated with our Gulf Coast master lease agreement, following an assertion by the holders that our prior exercise of offset rights in connection with Gulf Coast’s non-payment of rent had resulted in defaults under the terms of the Subordinated Debt. The suit seeks a declaratory judgment to, among other items, declare that the aggregate amount of unpaid rent due from Gulf Coast under the master lease agreement exceeds all amounts which otherwise would be due and owing by an indirect subsidiary of Omega (“Omega Obligor”) under the Subordinated Debt, and that all principal and interest due and owing under the Subordinated Debt may be (and was) offset in full as of December 31, 2021. In October 2021, the defendants in the case filed a motion to dismiss for lack of personal jurisdiction. On November 2, 2022, the Court indicated its intention to grant the noteholders’ motion to dismiss for lack of personal jurisdiction. A decision has not been made whether to appeal this order, if it is issued. While Omega believes Omega Obligor is entitled to the enforcement of the offset rights sought in the action, Omega cannot predict the outcome of the declaratory judgment action, irrespective of whether it is ultimately litigated in the Court or, if the order granting the motion to dismiss for lack of personal jurisdiction is issued, or if it is issued and upheld on appeal in another court. Lakeway Realty, L.L.C. In September 2016, MedEquities received a Civil Investigative Demand (“CID”) from the U.S. Department of Justice (“DOJ”), which indicates that it is conducting an investigation regarding alleged violations of the False Claims Act, Stark Law and Anti-Kickback Statute in connection with claims that may have been submitted to Medicare and other federal payors for services rendered to patients at Lakeway Hospital or by providers with financial relationships with Lakeway Hospital. As a result of the acquisition of MedEquities, the Company owns a 51% interest in an unconsolidated limited liability company that owns Lakeway Hospital, Lakeway Realty, L.L.C. The CID requested certain documents and information related to the acquisition and ownership of Lakeway Hospital through Lakeway Realty, L.L.C. The Company has learned that the DOJ is investigating, among other items, MedEquities’ conduct in connection with its investigation of financial relationships related to Lakeway Hospital, including allegations by the DOJ that these relationships violate and continue to violate the Anti-Kickback Statute and, as a result, related claims submitted to federal payors violated and continue to violate the False Claims Act. The Company is cooperating fully with the DOJ in connection with the CID and has produced all of the information that has been requested to date. On September 29, 2020, the Department of Justice announced it had reached a settlement of a False Claims Act case with Lakeway Regional Medical Center wherein Lakeway Regional Medical Center agreed to pay $1.1 million for inducing certain physicians to refer patients by offering a low risk and high return investment in the form of a joint venture to purchase and then lease back the hospital to Lakeway Regional Medical Center. A MedEquities subsidiary was a party to this transaction but was not included in settlement discussions, and we understand that the settlement did not fully resolve the investigation referenced in the CID. The documents relating to the settlement are not publicly available. While the Company believes that the acquisition, ownership and leasing of Lakeway Hospital through the Lakeway Partnership was and is in compliance with all applicable laws, in the second quarter of 2022, the Company recorded a $3.0 million legal reserve related to this matter which is included within accrued expenses and other liabilities on the Consolidated Balance Sheets with the related expense included in other (expense) income – net on the Consolidated Statements of Operations. Other In addition, we are subject to various other legal proceedings, claims and other actions arising out of the normal course of business. While any legal proceeding or claim has an element of uncertainty, management believes that the outcome of each lawsuit, claim or legal proceeding that is pending or threatened, or all of them combined, will not have a material adverse effect on our consolidated financial position or results of operations. Indemnification Agreements In connection with certain facility transitions, we have agreed to indemnify certain operators in certain events. As of September 30, 2022, our maximum funding commitment under these indemnification agreements was approximately $3.9 million. Claims under these indemnification agreements generally may be made within 18 months to 72 months of the transition date. These indemnification agreements were provided to certain operators in connection with facility transitions and generally would be applicable in the event that the prior operators do not perform under their transition agreements. Commitments We have committed to fund the construction of new leased and mortgaged facilities, capital improvements and other commitments. We expect the funding of these commitments to be completed over the next several years. Our remaining commitments at September 30, 2022, are outlined in the table below (in thousands): Construction and capital expenditure mortgage loan commitments $ 10,381 Lessor construction and capital commitments under lease agreements 189,757 Other investment loan commitments (1) 88,004 Total remaining commitments (2) $ 288,142 (1) This amount includes $60.0 million related to the $90 million short-term revolving line of credit discussed in Note 6 – Other Investments. (2) Includes finance costs .

EARNINGS PER SHARE

EARNINGS PER SHARE	9 Months Ended
EARNINGS PER SHARE	Sep. 30, 2022
Earnings per Share [Abstract]
EARNINGS PER SHARE	NOTE 19 – EARNINGS PER SHARE The following tables set forth the computation of basic and diluted earnings per share: Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in thousands, except per share amounts) Numerator: Net income $ 105,064 $ 142,835 $ 392,135 $ 394,064 Deduct: net income attributable to noncontrolling interests (2,790) (3,888) (10,787) (10,616) Net income available to common stockholders $ 102,274 $ 138,947 $ 381,348 $ 383,448 Denominator: Denominator for basic earnings per share 234,788 239,282 236,721 236,027 Effect of dilutive securities: Common stock equivalents 1,744 634 1,138 903 Noncontrolling interest – Omega OP Units 6,752 6,701 6,863 6,547 Denominator for diluted earnings per share 243,284 246,617 244,722 243,477 Earnings per share – basic: Net income available to common stockholders $ 0.44 $ 0.58 $ 1.61 $ 1.62 Earnings per share – diluted: Net income $ 0.43 $ 0.58 $ 1.60 $ 1.62

SUPPLEMENTAL DISCLOSURE TO CONS

SUPPLEMENTAL DISCLOSURE TO CONSOLIDATED STATEMENTS OF CASH FLOWS	9 Months Ended
	Sep. 30, 2022
Supplemental Cash Flow Elements [Abstract]
SUPPLEMENTAL DISCLOSURE TO CONSOLIDATED STATEMENTS OF CASH FLOWS	NOTE 20 – SUPPLEMENTAL DISCLOSURE TO CONSOLIDATED STATEMENTS OF CASH FLOWS The following are supplemental disclosures to the Consolidated Statements of Cash Flows for the nine months ended September 30, 2022 and 2021: Nine Months Ended September 30, 2022 2021 (in thousands) Reconciliation of cash and cash equivalents and restricted cash: Cash and cash equivalents $ 134,855 $ 102,664 Restricted cash 3,323 3,341 Cash, cash equivalents and restricted cash at end of period $ 138,178 $ 106,005 Supplemental information: Interest paid during the period, net of amounts capitalized $ 171,057 $ 166,934 Taxes paid during the period $ 4,627 $ 5,028 Non-cash investing activities: Non-cash acquisition of real estate $ (9,818) $ (49,857) Non-cash placement of mortgages $ — $ (7,000) Non-cash collection of mortgage principal $ — $ 49,587 Non-cash proceeds from other investments $ — $ 7,000 Non-cash financing activities: Non-cash contribution from noncontrolling interest holder in consolidated joint venture $ 2,903 $ — Change in fair value of cash flow hedges $ 113,590 $ 28,450 Remeasurement of debt denominated in a foreign currency $ (5,462) $ 3,010

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
SUBSEQUENT EVENTS	Sep. 30, 2022
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 21 – SUBSEQUENT EVENTS In the fourth quarter of 2022, the Company entered into three unsecured loans with principal amounts of $17.0 million, $2.5 million and $5.0 million. The $17 million loan and $2.5 million loan bear interest at 9% and mature on September 30, 2027. The $5.0 million loan bears interest at 10% and matures on October 29, 2027. All three loans require quarterly principal payments commencing on January 3, 2022. As discussed in Note 3 – Assets Held For Sale, Dispositions and Impairments and Note 4 – Contractual Receivables and Other Receivables and Lease Inducements, in the fourth quarter of 2022 we sold 19 facilities that were leased and operated by Agemo in connection with our restructuring negotiations surrounding Agemo’s lease and loan agreements.

BASIS OF PRESENTATION AND SIG_2

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2022
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and do not include all the information and notes required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements. In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The results of operations for the interim periods reported herein are not necessarily indicative of results to be expected for the full year. These unaudited consolidated financial statements should be read in conjunction with the financial statements and the footnotes thereto included in our Annual Report on Form 10-K Omega’s consolidated financial statements include the accounts of (i) Parent, (ii) all direct and indirect wholly owned subsidiaries of Omega, including Omega OP, (iii) other entities in which Omega or Omega OP has a majority voting interest and control and (iv) variable interest entities (“VIEs”) of which Omega is the primary beneficiary. All intercompany transactions and balances have been eliminated in consolidation, and Omega’s net earnings are reduced by the portion of net earnings attributable to noncontrolling interests.
Risks and Uncertainties including COVID-19	Risks and Uncertainties including COVID-19 The Company is subject to certain risks and uncertainties affecting the healthcare industry, including those stemming from the novel coronavirus (“COVID-19”) global pandemic described below, which has disproportionately impacted the senior care sector, as well as those stemming from healthcare legislation and changing regulation by federal, state and local governments. Additionally, we are subject to risks and uncertainties as a result of changes affecting operators of nursing home facilities due to the actions of governmental agencies and insurers to limit the rising cost of healthcare services.
Segments	Segments We conduct our operations and report financial results as one business segment. The presentation of financial results as one reportable segment is consistent with the way we operate our business and is consistent with the manner in which our Chief Operating Decision Maker (CODM), our Chief Executive Officer, evaluates performance and makes resource and operating decisions for the business.
Reclassification	Reclassification Certain line items on our Consolidated Balance Sheets have been reclassified to conform to the current period presentation.
Recent Accounting Pronouncements	Recent Accounting Pronouncements ASU – 2022-02, Financial Instruments – Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures On March 31, 2022, the FASB issued ASU 2022-02, which eliminates the recognition and measurement guidance for troubled debt restructurings (“TDRs”) and requires additional disclosures for certain loan modifications. ASU 2022-02 also requires entities to disclose gross write-offs of financing receivables and net investments in leases by year of origination. Omega elected to early adopt ASU 2022-02 on a prospective basis effective January 1, 2022. In the second quarter of 2022, we had one loan modification to a borrower experiencing financial difficulty pursuant to ASU 2022-02, Guardian Healthcare (“Guardian”), that requires additional disclosures. The required disclosures for this loan are included in Note 4 – Contractual Receivables and Other Receivables and Lease Inducements and Note 5 – Mortgage Notes Receivable. We have disclosed our gross write-offs of financing receivables and direct financing leases by year of origination in Note 7 – Allowance for Credit Losses. ASU – 2020-04, Financial Instruments – Reference Rate Reform (Topic 848) On March 12, 2020, the FASB issued ASU 2020-04, which contains optional practical expedients for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting for contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”). The guidance may be elected over time until December 31, 2022, as reference rate reform activities occur. The Company has several derivative instruments (See Note 16 – Derivatives and Hedging), a $1.45 billion senior unsecured multicurrency revolving credit facility, and a $50.0 million senior unsecured term loan facility (See Note 15 – Borrowing Activities and Arrangements) that reference LIBOR. During the first quarter of 2020, we elected to apply the hedge accounting expedients related to probability and the assessments of effectiveness for future LIBOR indexed cash flows to assume that the index upon which future hedged transactions will be based matches the index on the corresponding derivatives. Application of these expedients preserves the presentation of derivatives consistent with past presentation. Our credit facilities that reference LIBOR contain customary LIBOR replacement language, including, but not limited to, the use of rates based on the secured overnight financing rate. The Company continues to evaluate: (i) how the transition away from LIBOR will impact the Company, (ii) whether any additional optional expedients provided by the standards will be adopted, and (iii) the impact that adopting ASU 2020-04 will have on our consolidated financial statements.

REAL ESTATE ASSETS (Tables)

REAL ESTATE ASSETS (Tables)	9 Months Ended
REAL ESTATE ASSETS (Tables)	Sep. 30, 2022
REAL ESTATE ASSETS [Abstract]
Schedule of operating lease income	At September 30, 2022, our leased real estate properties included 649 SNFs, 167 ALFs, 20 ILFs, 16 specialty facilities and two medical office buildings. The following table summarizes the Company’s rental income from operating leases: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (in thousands) (in thousands) Rental income – operating leases $ 203,456 $ 243,831 $ 624,844 $ 697,140 Variable lease income – operating leases 4,132 3,333 11,055 8,740 Total rental income $ 207,588 $ 247,164 $ 635,899 $ 705,880
Summary of asset acquisitions	The following table summarizes the asset acquisitions that occurred during the nine months ended September 30, 2022: Number of Total Real Estate Initial Facilities Assets Acquired Annual Period SNF ALF Specialty Country/State (in millions) Cash Yield (1) Q1 — 1 — U.K. $ 8.7 (2) 8.0 % Q1 — 1 — U.K. 5.0 8.0 % Q1 — 27 — U.K. 86.6 (2) 8.0 % Q1 1 — — MD 8.2 (3) 9.5 % Q3 — 4 — U.K. 28.2 8.0 % Total 1 33 — $ 136.7 (1) Initial annual cash yield reflects the initial annual contractual cash rent divided by the purchase price. (2) The total consideration paid for the one -facility U.K. acquisition and the 27 -facility U.K. acquisition was $8.2 million and $100.0 million, respectively. In connection with these acquisitions, we allocated $0.5 million of the purchase consideration to a deferred tax liability related to the one-facility U.K. acquisition, and $13.4 million to a deferred tax asset related to the 27 -facility U.K. acquisition. See Note 13 – Taxes for additional information. (3) Total consideration for the one -facility Maryland acquisition was paid on December 30, 2021, but the closing of the acquisition did not occur until January 1, 2022.

ASSETS HELD FOR SALE, DISPOSI_2

ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS (Tables)	9 Months Ended
ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS (Tables)	Sep. 30, 2022
ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS [Abstract]
Schedule of Properties Held-for-Sale	The following is a summary of our assets held for sale: September 30, December 31, 2022 2021 Number of facilities held for sale 34 41 Amount of assets held for sale (in thousands) $ 190,723 $ 261,151

CONTRACTUAL RECEIVABLES AND O_2

CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS (Tables)	9 Months Ended
	Sep. 30, 2022
CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS [Abstract]
Schedule of Net Accounts Receivable	A summary of our net receivables and lease inducements by type is as follows: September 30, December 31, 2022 2021 (in thousands) Contractual receivables – net $ 9,945 $ 11,259 Effective yield interest receivables $ 6,208 $ 9,590 Straight-line rent receivables 173,266 148,455 Lease inducements 87,416 93,770 Other receivables and lease inducements $ 266,890 $ 251,815

MORTGAGE NOTES RECEIVABLE (Tabl

MORTGAGE NOTES RECEIVABLE (Tables)	9 Months Ended
MORTGAGE NOTES RECEIVABLE (Tables)	Sep. 30, 2022
Mortgage Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Schedule of Investments	The principal amounts outstanding of mortgage notes receivable, net of allowances, were as follows: September 30, December 31, 2022 2021 (in thousands) Mortgage note due 2031; interest at 11.02% $ 78,309 $ 103,762 Mortgage notes due 2030; interest at 10.96% (1) 503,440 653,564 Other mortgage notes outstanding (2) 149,641 151,361 Mortgage notes receivable, gross 731,390 908,687 Allowance for credit losses on mortgage notes receivable (61,857) (73,601) Total mortgage notes receivable – net $ 669,533 $ 835,086 (1) Approximates the weighted average interest rate on 37 facilities as of September 30, 2022. (2) Other mortgage notes outstanding have a weighted average interest rate of 8.85% per annum as of September 30, 2022 and maturity dates ranging from 2023 through 2032 .

OTHER INVESTMENTS (Tables)

OTHER INVESTMENTS (Tables)	9 Months Ended
OTHER INVESTMENTS (Tables)	Sep. 30, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Summary of other investments income	Interest revenue on other investment loans is included within other investment income on the Consolidated Statement of Operations. A summary of our other investments income by real estate and non-real estate loans, as defined above, is as follows: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 (in thousands) (in thousands) Real estate related loans – interest income $ 10,566 $ 8,036 $ 27,987 $ 23,628 Non-real estate related loans – interest income 3,544 2,744 8,494 10,617 Total other investment income $ 14,110 $ 10,780 $ 36,481 $ 34,245
Other Investment Receivables [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Schedule of Investments	Our other investments consist of fixed and variable rate loans to our operators and/or their principals. These loans may be either unsecured or secured by the collateral of the borrower. A number of the secured loans are collateralized by leasehold mortgages on, or assignments or pledges of the membership interest in, the related properties, corporate guarantees and/or personal guarantees. We deem these to be “real estate related loans” that are included as qualifying assets under our quarterly REIT asset tests. As of September 30, 2022, we had 39 loans with 20 different operators. A summary of our other investments is as follows: September 30, December 31, 2022 2021 (in thousands) Other investment notes due 2024; interest at 13.17% (1) $ 96,456 $ 90,752 Other investment note due 2030; interest at 7.00% 236,218 201,613 Other investment note due 2024; interest at 12.00% (2) — 40,232 Other investment notes due 2022-2025; interest at 12.03% (1) 44,200 9,992 Other investment notes outstanding (3) 20,000 12,084 Real estate related loans – other investments, gross 396,874 354,673 Other investment notes due 2024-2025; interest at 8.12% (1) 55,791 55,791 Other investment notes due 2022-2028; interest at 10.49% (1) 53,560 22,142 Other investment notes outstanding (4) 163,026 106,672 Non-real estate related loans – other investments, gross 272,377 184,605 Total other investments, gross 669,251 539,278 Allowance for credit losses on other investments (61,061) (69,394) Total other investments – net $ 608,190 $ 469,884 (1) Approximates the weighted average interest rate as of September 30, 2022. (2) During the third quarter of 2022, this loan was fully repaid. (3) As of September 30, 2022, includes one real estate related loan with an interest rate of 12.00% and a maturity date of December 2, 2027 . (4) Other investment notes that are non-real estate related loans have a weighted average interest rate of 8.20% as of September 30, 2022 with maturity dates ranging from 2022 through 2032 (with $10.5 million maturing in the remainder of 2022).

ALLOWANCE FOR CREDIT LOSSES (Ta

ALLOWANCE FOR CREDIT LOSSES (Tables)	9 Months Ended
ALLOWANCE FOR CREDIT LOSSES (Tables)	Sep. 30, 2022
Receivables [Abstract]
Schedule of expected credit loss	A rollforward of our allowance for credit losses for the nine months ended September 30, 2022 is as follows: Rating Financial Statement Line Item Allowance for Credit Loss as of December 31, 2021 Provision (recovery) for Credit Loss for the nine months ended September 30, 2022 Write-offs charged against allowance for the nine months ended September 30, 2022 Allowance for Credit Loss as of September 30, 2022 (in thousands) 2 Mortgage notes receivable $ 15 $ (3) $ — $ 12 3 Mortgage notes receivable 1,973 (345) — 1,628 4 Mortgage notes receivable 19,461 (5,746) — 13,715 5 Mortgage notes receivable 135 (86) — 49 6 Mortgage notes receivable 52,017 (5,564) (1) — 46,453 Sub-total 73,601 (11,744) — 61,857 3 Investment in direct financing leases 530 (530) — — 4 Investment in direct financing leases - 785 — 785 Sub-total 530 255 — 785 1 Other investments — 212 — 212 2 Other investments 29 247 — 276 3 Other investments 4,600 3,010 (2) — 7,610 4 Other investments 1,172 157 — 1,329 5 Other investments 7,861 12,522 (3) — 20,383 6 Other investments 55,732 (5) (1,966) (4) (22,515) (5) 31,251 Sub-total 69,394 14,182 (22,515) 61,061 2 Off-balance sheet note commitments 7 94 — 101 3 Off-balance sheet note commitments 458 (209) — 249 4 Off-balance sheet note commitments 216 (216) — — 4 Off-balance sheet mortgage commitments 117 (102) — 15 6 Off-balance sheet note commitments 143 (7) 2,107 (6) (2,250) (7) — Sub-total 941 1,674 (2,250) 365 Total $ 144,466 $ 4,367 $ (24,765) $ 124,068 (1) Amount relates to the recoveries, net of provision, recorded on the Guardian mortgage loan during the nine months ended September 30, 2022. See Note 5 – Mortgage Notes Receivable for additional information on the recoveries recorded. (2) Reflects additional provisions of $0.9 million and $3.2 million recorded on the $20 million WC loan during the three and nine months ended September 30, 2022 as discussed in Note 6 – Other Investments. (3) Reflects additional provisions of $4.8 million and $10.8 million recorded on the Agemo WC Loan during the three and nine months ended September 30, 2022. See Note 6 – Other Investments for additional information on the Agemo WC Loan provision. (4) During the three and nine months ended September 30, 2022, we received $0.5 million and $2.0 million, respectively, of interest and fee payments from Gulf Coast under the $25.0 million senior secured DIP facility, the outstanding principal of which was fully reserved against in the fourth quarter of 2021. The DIP facility is on non-accrual status, and the payments received in the three and nine months ended September 30, 2022 have been applied against the outstanding principal using the cost recovery method. In the three and nine months ended September 30, 2022, we recorded a recovery for credit loss equal to the amount of payments applied against the principal. (5) During the third quarter of 2022, we wrote-off the loan balance and reserve for two loans (the $25.0 million senior secured DIP facility and one other loan) that expired during the quarter which had previously been fully reserved. (6) During the second quarter of 2022, we recorded an additional reserve of $2.2 million related to the remaining commitment under the $25.0 million senior secured DIP facility. (7) During the third quarter of 2022, the remaining commitment under the $25.0 million senior secured DIP facility was funded, and the facility expired, which resulted in a write-off of the loan and reserve balances. A rollforward of our allowance for credit losses for the nine months ended September 30, 2021 is as follows: Rating Financial Statement Line Item Allowance for Credit Loss at December 31, 2020 Provision (recovery) for Credit Loss for the nine months ended September 30, 2021 Write-offs charged against allowance for the nine months ended September 30, 2021 Allowance for Credit Loss as of September 30, 2021 (in thousands) 2 Mortgage notes receivable $ 88 $ (65) $ — $ 23 3 Mortgage notes receivable 954 1,603 — 2,557 4 Mortgage notes receivable 26,865 (1,825) (1) — 25,040 5 Mortgage notes receivable 433 9,025 (1) — 9,458 6 Mortgage notes receivable 4,905 — — 4,905 Sub-total 33,245 8,738 — 41,983 3 Investment in direct financing leases 694 (35) — 659 Sub-total 694 (35) — 659 2 Other investments 94 (38) — 56 3 Other investments 5,113 628 — 5,741 4 Other investments 24,397 (22,675) (2) — 1,722 5 Other investments 1,853 6,260 (3) (95) 8,018 6 Other investments — 35,954 (2) — 35,954 Sub-total 31,457 20,129 (95) 51,491 2 Off-balance sheet note commitments 116 (90) — 26 3 Off-balance sheet note commitments 2,305 (1,300) — 1,005 4 Off-balance sheet note commitments — 373 — 373 4 Off-balance sheet mortgage commitments 24 208 — 232 Sub-total 2,445 (809) — 1,636 Total $ 67,841 $ 28,023 $ (95) $ 95,769 (1) Amount reflects the movement of reserves associated with our mortgage loan with Guardian due to a reduction of our internal risk rating from a 4 to a 5 on the loan in the third quarter of 2021. (2) Amount reflects the movement of $27.2 million of reserves from Other Investments with a rating of 4 to Other Investments with a rating of 6 as a result of a reduction of our internal credit rating from a 4 to a 6 on the Agemo Term Loan and one other loan during the third quarter of 2021. The provision for Other Investments with a rating of 6 also reflects $8.8 million of additional allowance recorded in the third quarter of 2021 to fully reserve the remaining carrying value of the Agemo Term Loan. (3) The provision includes an additional $7.9 million of allowance recorded on the Agemo WC Loan during the third quarter of 2021. We also reduced the internal rating on the Agemo WC Loan from a 4 to a 5 during the third quarter of 2021.
Schedule by segment balance by vintage and credit quality indicator	A summary of our amortized cost basis by year of origination and credit quality indicator is as follows: Rating Financial Statement Line Item 2022 2021 2020 2019 2018 2017 2016 & older Revolving Loans Balance as of September 30, 2022 (in thousands) 1 Mortgage notes receivable $ — $ — $ — $ — $ — $ — $ 64,243 $ — $ 64,243 2 Mortgage notes receivable — — 21,325 — — — — — 21,325 3 Mortgage notes receivable — 72,420 — — — — — — 72,420 4 Mortgage notes receivable 122 25,021 89,501 5,084 29,147 11,291 321,948 — 482,114 5 Mortgage notes receivable — — — — — — 6,602 — 6,602 6 Mortgage notes receivable — — — — — — 84,686 — 84,686 Sub-total 122 97,441 110,826 5,084 29,147 11,291 477,479 — 731,390 4 Investment in direct financing leases — — — — — — 11,345 — 11,345 Sub-total — — — — — — 11,345 — 11,345 1 Other Investments 20,000 — — — — — — — 20,000 2 Other investments 30,000 — — — — — — 51,799 81,799 3 Other investments 35,600 — — 14,563 10,800 — 1,756 251,565 314,284 4 Other investments 39,614 — — 2,422 96,456 — 1,000 20,000 159,492 5 Other investments 25,000 8,235 — — 24,548 — — — 57,783 6 Other investments — — — — 4,650 — 31,243 — 35,893 Sub-total 150,214 8,235 — 16,985 136,454 — 33,999 323,364 669,251 Total $ 150,336 $ 105,676 $ 110,826 $ 22,069 $ 165,601 $ 11,291 $ 522,823 $ 323,364 $ 1,411,986 Year to date gross write-offs $ — $ (18,052) $ — $ — $ (4,463) $ — $ — $ — $ (22,515)

VARIABLE INTEREST ENTITIES (Tab

VARIABLE INTEREST ENTITIES (Tables)	9 Months Ended
VARIABLE INTEREST ENTITIES (Tables)	Sep. 30, 2022
Variable Interest Entities [Abstract]
Schedule of Variable Interest Entities	Below is a summary of our assets, liabilities and collateral associated with these unconsolidated VIEs as of September 30, 2022 and December 31, 2021: September 30, December 31, 2022 2021 (in thousands) Assets Real estate assets – net $ 988,173 $ 1,144,851 Assets held for sale 129,239 191,016 Other investments – net 264,473 230,768 Contractual receivables – net 1,485 1,227 Other receivables and lease inducements 29,311 22,795 Other assets 746 — Total assets 1,413,427 1,590,657 Liabilities Net in-place lease liability (286) (305) Security deposit (4,829) (4,715) Contingent liability (43,915) (43,915) Other liabilities (746) — Total liabilities (49,776) (48,935) Collateral Letters of credit — — Personal guarantee (48,000) (48,000) Other collateral (1) (1,117,412) (1,335,867) Total collateral (1,165,412) (1,383,867) Maximum exposure to loss $ 198,239 $ 157,855 (1) Amount excludes accounts receivable that Omega has a security interest in as collateral under the two working capital loans with operators that are unconsolidated VIEs. The fair value of the accounts receivable available to Omega was $8.3 million and $29.2 million as of September 30, 2022 and December 31, 2021, respectively.
Schedule of Variable Interest Entities revenue	The table below reflects our total revenues from the operators that are considered unconsolidated VIEs for the three and nine months ended September 30, 2022 and 2021: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Revenue Rental income $ 21,120 $ 33,392 $ 63,222 $ 95,292 Other investment income 4,839 3,551 12,940 11,726 Total $ 25,959 $ 36,943 $ 76,162 $ 107,018

INVESTMENT IN JOINT VENTURES (T

INVESTMENT IN JOINT VENTURES (Tables)	9 Months Ended
INVESTMENT IN JOINT VENTURES (Tables)	Sep. 30, 2022
INVESTMENTS IN JOINT VENTURES [Abstract]
Schedule of equity method investments	The following is a summary of our investments in unconsolidated joint ventures (dollars in thousands): Carrying Amount Ownership Initial Investment Facility Facilities at September 30, December 31, Entity % Date Investment (1) Type 9/30/2022 2022 2021 Second Spring Healthcare Investments 15% 11/1/2016 $ 50,032 SNF — $ 10,849 $ 11,355 Second Spring II LLC 15% 3/10/2021 10,330 SNF — — 8 Lakeway Realty, L.L.C. 51% 5/17/2019 73,834 Specialty facility 1 70,465 71,286 Cindat Joint Venture 49% 12/18/2019 105,688 ALF 65 94,870 111,792 OMG Senior Housing, LLC 50% 12/6/2019 — Specialty facility 1 — — OH CHS SNP, Inc. 9% 12/20/2019 1,013 N/A N/A 372 246 $ 240,897 $ 176,556 $ 194,687 (1) Our investment includes our transaction costs, if any. Three Months Ended September 30, Nine Months Ended September 30, Entity 2022 2021 2022 2021 (in thousands) Second Spring Healthcare Investments (1) $ 300 $ 309 $ 882 $ 12,013 Second Spring II LLC — (1) (2) (757) Lakeway Realty, L.L.C. 656 637 1,976 1,923 Cindat Joint Venture 3,339 707 4,972 1,839 OMG Senior Housing, LLC (140) (105) (319) (309) OH CHS SNP, Inc. (38) 5 13 (140) Total $ 4,117 $ 1,552 $ 7,522 $ 14,569 (1) The income from this unconsolidated joint venture for the nine months ended September 30, 2021 includes a $14.9 million gain on sale of real estate investments.

GOODWILL AND OTHER INTANGIBLES

GOODWILL AND OTHER INTANGIBLES (Tables)	9 Months Ended
GOODWILL AND OTHER INTANGIBLES (Tables)	Sep. 30, 2022
Goodwill and Other Intangibles [Abstract]
Schedule of Reconciliation of Goodwill	The following is a summary of our goodwill as of September 30, 2022 and December 31, 2021: (in thousands) Balance as of December 31, 2021 $ 651,417 Foreign currency translation (2,469) Balance as of September 30, 2022 $ 648,948
Schedule of Intangibles	The following is a summary of our intangibles as of September 30, 2022 and December 31, 2021: September 30, December 31, 2022 2021 (in thousands) Assets: Above market leases $ 5,929 $ 5,929 Accumulated amortization (4,445) (4,313) Net above market leases $ 1,484 $ 1,616 Liabilities: Below market leases $ 71,072 $ 66,324 Accumulated amortization (47,093) (38,091) Net below market leases $ 23,979 $ 28,233

STOCKHOLDERS EQUITY (Tables)

STOCKHOLDERS EQUITY (Tables)	9 Months Ended
STOCKHOLDERS EQUITY (Tables)	Sep. 30, 2022
Stockholders Equity [Abstract]
Summary of shares repurchase	The following is a summary of the shares repurchased for the three and nine months ended September 30, 2022 (in millions except average price per share): Average Price Period Ended Shares Repurchased Per Share (1) Repurchase Cost (1) Three Months Ended September 30, 2022 — $ — $ — Nine Months Ended September 30, 2022 5.2 27.32 142.3 (1) Average price per share and repurchase cost includes the cost of commissions.
Schedule of shares issued under ATM Programs	The following is a summary of the shares issued under our former $500 million 2015 At-The-Market Offering Program (“2015 ATM Program”) and our current $1.0 billion 2021 At-The-Market Offering Program (“2021 ATM Program”) for the three and nine months ended September 30, 2022 and 2021 (in millions except average price per share): Average Net Price Period Ended Shares issued Per Share (1) Gross Proceeds Commissions Net Proceeds Three Months Ended September 30, 2021 0.1 $ 32.82 $ 1.3 $ 0.1 $ 1.2 Three Months Ended September 30, 2022 — — — — — Nine Months Ended September 30, 2021 4.2 36.56 155.1 3.3 151.8 Nine Months Ended September 30, 2022 — — — — — (1) Represents the average price per share after commissions.
Schedule of dividend reinvestment and common stock purchase plan	The following is a summary of the shares issued under the Dividend Reinvestment and Common Stock Purchase Plan for the three and nine months ended September 30, 2022 and 2021 (in millions): Period Ended Shares issued Gross Proceeds Three Months Ended September 30, 2021 1.3 $ 47.2 Three Months Ended September 30, 2022 0.1 2.4 Nine Months Ended September 30, 2021 3.3 124.5 Nine Months Ended September 30, 2022 0.3 7.0
Schedule of common stock dividends	The following is a summary of our declared cash dividends on common stock: Record Payment Dividend per Date Date Common Share February 7, 2022 February 15, 2022 $ 0.67 May 2, 2022 May 13, 2022 0.67 August 1, 2022 August 15, 2022 0.67 November 1, 2022 November 15, 2022 0.67
Schedule of accumulated other comprehensive income (loss)	The following is a summary of our accumulated other comprehensive income (loss), net of tax where applicable: As of and for the As of and for the Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in thousands) Foreign Currency Translation: Beginning balance $ (79,670) $ (13,608) $ (24,012) $ (18,427) Translation loss (45,873) (12,646) (100,253) (8,515) Realized (loss) gain (153) (18) (1,431) 670 Ending balance (125,696) (26,272) (125,696) (26,272) Derivative Instruments: Cash flow hedges: Beginning balance 69,429 33,352 30,407 17,718 Unrealized gain 16,499 1,116 53,481 15,407 Realized gain (1) 1,074 779 3,114 2,122 Ending balance 87,002 35,247 87,002 35,247 Net investment hedges: Beginning balance 12,920 (16,024) (9,588) (13,331) Unrealized gain 31,273 7,637 53,781 4,944 Ending balance 44,193 (8,387) 44,193 (8,387) Total accumulated other comprehensive income before noncontrolling interest 5,499 588 5,499 588 Add: portion included in noncontrolling interest 744 888 744 888 Total accumulated other comprehensive income for Omega $ 6,243 $ 1,476 $ 6,243 $ 1,476 (1) Recorded in interest expense on the Consolidated Statements of Operations.

TAXES (Tables)

TAXES (Tables)	9 Months Ended
TAXES (Tables)	Sep. 30, 2022
Taxes [Abstract]
Schedule of components of income tax expense	The following is a summary of our provision for income taxes: Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in millions) Provision for federal, state and local income taxes $ 0.3 $ 0.4 $ 0.9 $ 1.0 Provision for foreign income taxes 0.9 0.6 2.6 1.9 Total provision for income taxes (1) $ 1.2 $ 1.0 $ 3.5 $ 2.9 (1) The above amounts do not include gross receipts or franchise taxes payable to certain states and municipalities.
Schedule of deferred tax assets and liabilities	The following is a summary of deferred tax assets and liabilities (which are recorded in other assets and accrued expenses and other liabilities, respectively, in our Consolidated Balance Sheets): September 30, December 31, 2022 2021 (in thousands) U.S. Federal net operating loss carryforward $ 2,138 $ 2,221 Valuation allowance on deferred tax asset (2,138) (2,221) Foreign net operating loss carryforward 10,456 — Foreign deferred tax liability (1) (5,331) (8,200) Net deferred tax asset (liability) $ 5,125 $ (8,200) (1) The deferred tax liability primarily resulted from inherited basis differences resulting from our acquisition of entities in the U.K. Subsequent adjustments to these accounts result from GAAP to tax differences related to depreciation, indexation and revenue recognition.

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	9 Months Ended
STOCK-BASED COMPENSATION (Tables)	Sep. 30, 2022
Stock-Based Compensation [Abstract]
Summary of stock compensation expense	The following is a summary of our stock-based compensation expense for the three and nine months ended September 30, 2022 and 2021, respectively: Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in thousands) Stock-based compensation expense $ 6,809 $ 5,706 $ 20,515 $ 16,913

BORROWING ACTIVITIES AND ARRA_2

BORROWING ACTIVITIES AND ARRANGEMENTS (Tables)	9 Months Ended
BORROWING ACTIVITIES AND ARRANGEMENTS (Tables)	Sep. 30, 2022
BORROWING ACTIVITIES AND ARRANGEMENTS [Abstract]
Schedule of Borrowings	The following is a summary of our borrowings: Annual Interest Rate as of September 30, September 30, December 31, Maturity 2022 2022 2021 (in thousands) Secured borrowings: HUD mortgages (1)(2) 2046 - 2052 3.01 % $ 346,606 $ 359,806 2023 term loan (3) 2023 6.75 % 2,161 2,275 2024 term loan (4) 2024 8.02 % 19,638 — Total secured borrowings 368,405 362,081 Unsecured borrowings: Revolving credit facility (5)(6) 2025 4.32 % 17,861 — Senior notes and other unsecured borrowings: 2023 notes (5) 2023 4.375 % 350,000 350,000 2024 notes (5) 2024 4.950 % 400,000 400,000 2025 notes (5) 2025 4.500 % 400,000 400,000 2026 notes (5) 2026 5.250 % 600,000 600,000 2027 notes (5) 2027 4.500 % 700,000 700,000 2028 notes (5) 2028 4.750 % 550,000 550,000 2029 notes (5) 2029 3.625 % 500,000 500,000 2031 notes (5) 2031 3.375 % 700,000 700,000 2033 notes (5) 2033 3.250 % 700,000 700,000 OP term loan (7)(8) 2025 4.57 % 50,000 50,000 Deferred financing costs – net (23,451) (26,980) Discount – net (27,940) (31,565) Total senior notes and other unsecured borrowings – net 4,898,609 4,891,455 Total unsecured borrowings – net 4,916,470 4,891,455 Total secured and unsecured borrowings – net (9)(10) $ 5,284,875 $ 5,253,536 (1) Reflects the weighted average annual contractual interest rate on the mortgages at September 30, 2022. Secured by real estate assets with a net carrying value of $505.9 million as of September 30, 2022. During the third quarter of 2022, we paid approximately $7.9 million to retire one mortgage loan guaranteed by HUD that was assumed in 2019 and had a fixed interest rate of 2.92% per annum with a maturity date in 2051 . The payoff included a $0.4 million prepayment fee which is included in loss on debt extinguishment on our Consolidated Statement of Operations. (2) Wholly owned subsidiaries of Omega OP are the obligor on these borrowings. (3) Borrowing is the debt of a consolidated joint venture. (4) Borrowing is the debt of the consolidated joint venture discussed in Note 8 – Variable Interest Entities which was formed in the first quarter of 2022. The borrowing is secured by two ALFs, which are owned by the joint venture. (5) Guaranteed by Omega OP. (6) As of September 30, 2022, borrowings under Omega’s $1.45 billion senior unsecured multicurrency revolving credit facility consisted of £16.0 million British Pounds Sterling (“GBP”). The applicable interest rate on the US Dollar tranche and on the GBP borrowings under the alternative currency tranche of the credit facility were 4.32% and 3.51% as of September 30, 2022, respectively. (7) Omega OP is the obligor on this borrowing. (8) The interest rate swaps, that were cash flow hedges of Omega OP’s $50.0 million senior unsecured term loan facility’s (the “OP term loan”) interest payments and that effectively fixed the interest rate at 3.29% , matured on February 10, 2022 . (9) All borrowings are direct borrowings of Parent unless otherwise noted. (10) Certain of our other secured and unsecured borrowings are subject to customary affirmative and negative covenants, including financial covenants. As of September 30, 2022 and December 31, 2021, we were in compliance with all applicable covenants for our borrowings .

DERIVATIVES AND HEDGING (Tables

DERIVATIVES AND HEDGING (Tables)	9 Months Ended
DERIVATIVES AND HEDGING (Tables)	Sep. 30, 2022
DERIVATIVES AND HEDGING [Abstract]
Location and the fair value of derivative instruments designated as hedges	The location and fair value of derivative instruments designated as hedges, at the respective balance sheet dates, were as follows: September 30, December 31, 2022 2021 Cash flow hedges: (in thousands) Other assets $ 92,561 $ 32,849 Accrued expenses and other liabilities $ — $ 96 Net investment hedges: Other assets $ 60,536 $ 6,754

FINANCIAL INSTRUMENTS (Tables)

FINANCIAL INSTRUMENTS (Tables)	9 Months Ended
FINANCIAL INSTRUMENTS (Tables)	Sep. 30, 2022
Financial Instruments [Abstract]
Schedule of Financial Instruments	At September 30, 2022 and December 31, 2021, the net carrying amounts and fair values of our other financial instruments were as follows: September 30, 2022 December 31, 2021 Carrying Fair Carrying Fair Amount Value Amount Value (in thousands) Assets: Investments in direct financing leases – net $ 10,560 $ 10,560 $ 10,873 $ 10,873 Mortgage notes receivable – net 669,533 671,387 835,086 869,715 Other investments – net 608,190 614,646 469,884 476,664 Total $ 1,288,283 $ 1,296,593 $ 1,315,843 $ 1,357,252 Liabilities: Revolving credit facility $ 17,861 $ 17,861 $ — $ — 2023 term loan 2,161 2,161 2,275 2,275 2024 term loan 19,638 19,750 — — OP term loan 49,737 50,000 49,661 50,000 4.375% notes due 2023 – net 349,527 348,366 349,100 365,243 4.95% notes due 2024 – net 398,483 395,592 397,725 427,184 4.50% notes due 2025 – net 398,256 389,844 397,685 427,440 5.25% notes due 2026 – net 597,671 580,884 597,142 667,524 4.50% notes due 2027 – net 693,472 649,523 692,374 766,003 4.75% notes due 2028 – net 544,664 504,383 543,908 607,249 3.625% notes due 2029 – net 491,588 406,855 490,681 519,430 3.375% notes due 2031 – net 684,935 533,484 683,592 705,810 3.25% notes due 2033 – net 690,276 493,640 689,587 683,151 HUD mortgages – net 346,606 269,508 359,806 394,284 Total $ 5,284,875 $ 4,661,851 $ 5,253,536 $ 5,615,593

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	9 Months Ended
COMMITMENTS AND CONTINGENCIES (Tables)	Sep. 30, 2022
COMMITMENTS AND CONTINGENCIES [Abstract]
Schedule of remaining commitments	We expect the funding of these commitments to be completed over the next several years. Our remaining commitments at September 30, 2022, are outlined in the table below (in thousands): Construction and capital expenditure mortgage loan commitments $ 10,381 Lessor construction and capital commitments under lease agreements 189,757 Other investment loan commitments (1) 88,004 Total remaining commitments (2) $ 288,142 (1) This amount includes $60.0 million related to the $90 million short-term revolving line of credit discussed in Note 6 – Other Investments. (2) Includes finance costs .

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	9 Months Ended
EARNINGS PER SHARE (Tables)	Sep. 30, 2022
Earnings per Share [Abstract]
Schedule of Computation of Basic and Diluted Earnings per Share	The following tables set forth the computation of basic and diluted earnings per share: Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 (in thousands, except per share amounts) Numerator: Net income $ 105,064 $ 142,835 $ 392,135 $ 394,064 Deduct: net income attributable to noncontrolling interests (2,790) (3,888) (10,787) (10,616) Net income available to common stockholders $ 102,274 $ 138,947 $ 381,348 $ 383,448 Denominator: Denominator for basic earnings per share 234,788 239,282 236,721 236,027 Effect of dilutive securities: Common stock equivalents 1,744 634 1,138 903 Noncontrolling interest – Omega OP Units 6,752 6,701 6,863 6,547 Denominator for diluted earnings per share 243,284 246,617 244,722 243,477 Earnings per share – basic: Net income available to common stockholders $ 0.44 $ 0.58 $ 1.61 $ 1.62 Earnings per share – diluted: Net income $ 0.43 $ 0.58 $ 1.60 $ 1.62

SUPPLEMENTAL DISCLOSURE TO CO_2

SUPPLEMENTAL DISCLOSURE TO CONSOLIDATED STATEMENTS OF CASH FLOWS (Tables)	9 Months Ended
	Sep. 30, 2022
Condensed Financial Information of Parent Company Only Disclosure [Abstract]
Schedule of Cash Flow Supplemental Disclosures	The following are supplemental disclosures to the Consolidated Statements of Cash Flows for the nine months ended September 30, 2022 and 2021: Nine Months Ended September 30, 2022 2021 (in thousands) Reconciliation of cash and cash equivalents and restricted cash: Cash and cash equivalents $ 134,855 $ 102,664 Restricted cash 3,323 3,341 Cash, cash equivalents and restricted cash at end of period $ 138,178 $ 106,005 Supplemental information: Interest paid during the period, net of amounts capitalized $ 171,057 $ 166,934 Taxes paid during the period $ 4,627 $ 5,028 Non-cash investing activities: Non-cash acquisition of real estate $ (9,818) $ (49,857) Non-cash placement of mortgages $ — $ (7,000) Non-cash collection of mortgage principal $ — $ 49,587 Non-cash proceeds from other investments $ — $ 7,000 Non-cash financing activities: Non-cash contribution from noncontrolling interest holder in consolidated joint venture $ 2,903 $ — Change in fair value of cash flow hedges $ 113,590 $ 28,450 Remeasurement of debt denominated in a foreign currency $ (5,462) $ 3,010

BASIS OF PRESENTATION AND SIG_3

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Detail)	3 Months Ended					9 Months Ended
	Sep. 30, 2022 USD ($) facility $ / shares	Jun. 30, 2022 loan $ / shares	Mar. 31, 2022 $ / shares	Dec. 31, 2021 USD ($) $ / shares	Sep. 30, 2021 USD ($) $ / shares	Sep. 30, 2022 USD ($) facility segment $ / shares	Sep. 30, 2021 USD ($) $ / shares	Apr. 30, 2021 USD ($)
Basis Of Presentation And Significant Accounting Policies [Line Items]
Number of reportable segment \| segment						1
Number of Operating Segments \| segment						1
Impairment of Real Estate						$ 21,221,000	$ 42,453,000
Cash dividend (per share) \| $ / shares	$ 0.67	$ 0.67	$ 0.67	$ 0.67	$ 0.67	$ 2.01	$ 2.01
Rental income	$ 207,588,000				$ 247,164,000	$ 635,899,000	$ 705,880,000
Real estate tax expense	$ 4,175,000				$ 3,272,000	$ 11,495,000	$ 9,002,000
Number of real estate properties \| facility	941					941
Real estate assets - net	$ 6,462,353,000			$ 6,789,091,000		$ 6,462,353,000
Interest receivable	6,208,000			9,590,000		6,208,000
Unsecured Debt [Member] \| Omega OP Term Loan Facility
Basis Of Presentation And Significant Accounting Policies [Line Items]
Other Loans Payable	50,000,000			$ 50,000,000		50,000,000		$ 50,000,000
Revolving Credit Facility \| Unsecured Debt [Member]
Basis Of Presentation And Significant Accounting Policies [Line Items]
Credit facility, borrowing capacity	$ 1,450,000,000					$ 1,450,000,000		$ 1,450,000,000
Omega OP Units
Basis Of Presentation And Significant Accounting Policies [Line Items]
Ownership by parent	97%					97%
Ownership by noncontrolling interest	3%					3%
Agemo Holdings LLC [Member]
Basis Of Presentation And Significant Accounting Policies [Line Items]
Rental income	$ 0					$ 0
Guardian [Member]
Basis Of Presentation And Significant Accounting Policies [Line Items]
Rental income	$ 3,700,000					$ 7,500,000
Financing receivable, loans modified \| loan		1

REAL ESTATE ASSETS (Narrative)

REAL ESTATE ASSETS (Narrative) (Detail)	Sep. 30, 2022 property facility
Real Estate Properties [Line Items]
Number of Facilities	941
Skilled Nursing Facilities [Member]
Real Estate Properties [Line Items]
Number of Facilities	650
Assisted Living Facilities [Member]
Real Estate Properties [Line Items]
Number of Facilities	167
Independent Living Facilities [Member]
Real Estate Properties [Line Items]
Number of Facilities	20
Specialty Facility
Real Estate Properties [Line Items]
Number of Facilities \| property	16
Medical Office Building [Member]
Real Estate Properties [Line Items]
Number of Facilities	2
Facilities Leased \| Skilled Nursing Facilities [Member]
Real Estate Properties [Line Items]
Number of Facilities	649
Facilities Leased \| Assisted Living Facilities [Member]
Real Estate Properties [Line Items]
Number of Facilities	167
Facilities Leased \| Independent Living Facilities [Member]
Real Estate Properties [Line Items]
Number of Facilities	20
Facilities Leased \| Specialty Facility
Real Estate Properties [Line Items]
Number of Facilities	16
Facilities Leased \| Medical Office Building [Member]
Real Estate Properties [Line Items]
Number of Facilities	2

REAL ESTATE ASSETS (Schedule of

REAL ESTATE ASSETS (Schedule of operating lease income) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating Lease, Lease Income [Abstract]
Rental income - operating leases	$ 203,456	$ 243,831	$ 624,844	$ 697,140
Variable lease income - operating leases	4,132	3,333	11,055	8,740
Total rental income	$ 207,588	$ 247,164	$ 635,899	$ 705,880

REAL ESTATE ASSETS (Schedule _2

REAL ESTATE ASSETS (Schedule of Significant Acquisitions) (Detail) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022 USD ($) facility	Mar. 31, 2022 USD ($) facility	Sep. 30, 2022 USD ($) facility	Jan. 01, 2022 facility	Dec. 31, 2021 USD ($)
Real Estate Properties [Line Items]
Number of real estate properties \| facility	941		941
Total Value of Real Estate Assets Acquired			$ 136,700
Deferred tax assets related to net operating loss carryforwards	$ 10,456	$ 13,400	10,456
Deferred income tax liability	5,331		$ 5,331		$ 8,200
United Kingdom
Real Estate Properties [Line Items]
Real Estate Assets Acquired	$ 28,200
Initial Annual Cash Yield (%)	8%
UNITED KINGDOM One [Member]
Real Estate Properties [Line Items]
Total Value of Real Estate Assets Acquired		$ 8,700
Initial Annual Cash Yield (%)		8%
UNITED KINGDOM Two [Member]
Real Estate Properties [Line Items]
Real Estate Assets Acquired		$ 5,000
Initial Annual Cash Yield (%)		8%
UNITED KINGDOM Three [Member]
Real Estate Properties [Line Items]
Total Value of Real Estate Assets Acquired		$ 86,600
Initial Annual Cash Yield (%)		8%
Maryland
Real Estate Properties [Line Items]
Real Estate Assets Acquired		$ 8,200
Initial Annual Cash Yield (%)		9.50%
Assisted Living Facilities [Member] \| UNITED KINGDOM One [Member]
Real Estate Properties [Line Items]
Number of real estate properties \| facility		1
Facilities Acquired \| Skilled Nursing Facilities [Member]
Real Estate Properties [Line Items]
Number of real estate properties \| facility	1		1
Facilities Acquired \| Skilled Nursing Facilities [Member] \| Maryland
Real Estate Properties [Line Items]
Number of real estate properties \| facility		1		1
Facilities Acquired \| Assisted Living Facilities [Member]
Real Estate Properties [Line Items]
Number of real estate properties \| facility	33		33
Facilities Acquired \| Assisted Living Facilities [Member] \| United Kingdom
Real Estate Properties [Line Items]
Number of real estate properties \| facility	4		4
Facilities Acquired \| Assisted Living Facilities [Member] \| UNITED KINGDOM One [Member]
Real Estate Properties [Line Items]
Number of real estate properties \| facility		1
Real Estate Assets Acquired		$ 8,200
Deferred tax liability		$ 500
Facilities Acquired \| Assisted Living Facilities [Member] \| UNITED KINGDOM Two [Member]
Real Estate Properties [Line Items]
Number of real estate properties \| facility		1
Facilities Acquired \| Assisted Living Facilities [Member] \| UNITED KINGDOM Three [Member]
Real Estate Properties [Line Items]
Number of real estate properties \| facility		27
Real Estate Assets Acquired		$ 100,000
Deferred tax asset, net		$ 13,400

ASSETS HELD FOR SALE, DISPOSI_3

ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS (Narrative) (Details) $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended	9 Months Ended
	Nov. 02, 2022 USD ($) facility	Sep. 30, 2022 USD ($) facility	Mar. 31, 2022 USD ($) facility	Jun. 30, 2022 facility	Sep. 30, 2022 USD ($) facility	Sep. 30, 2021 USD ($)	Dec. 31, 2021 facility
Number of real estate properties \| facility		941			941
Impairment on real estate properties					$ 21,221	$ 42,453
2.2% Operator \| Customer Concentration Risk [Member] \| Revenue, Product and Service Benchmark [Member]
Concentration risk, percentage		2.20%			2.20%	2%
Variable Interest Entity, Primary Beneficiary [Member]
Total proceeds			$ 7,700
Guardian [Member] \| Customer Concentration Risk [Member] \| Revenue, Product and Service Benchmark [Member]
Concentration risk, percentage					1%	3.20%
Facilities Sold \| Scenario, Plan [Member] \| Subsequent Event [Member]
Real estate properties sold \| facility	19
Facilities Sold \| Gulf Coast LLC [Member]
Real estate properties sold \| facility			22
Facilities Sold \| Guardian [Member]
Real estate properties sold \| facility				9	9
Facilities Sold \| Agemo Holdings LLC [Member]
Real estate properties sold \| facility		2
Facilities Sold \| Agemo Holdings LLC [Member] \| Subsequent Event [Member]
Real estate properties sold \| facility	19
Facilities Classified to Asset Held for Sale [Member]
Number of real estate properties \| facility		2			2
Facilities Held for Sale [Member]
Number of real estate properties \| facility		34			34		41
Facilities Held for Sale [Member] \| Agemo Holdings LLC [Member]
Number of real estate properties \| facility		20			20
2 Facilities \| Agemo Holdings LLC [Member]
Total proceeds		$ 42,600
Amount of gain (loss) from sale of facilities		35,600
4 Facilities
Total proceeds		51,400
Amount of gain (loss) from sale of facilities		40,900
Impairment on real estate properties		$ 10,000
4 Facilities \| Facilities Sold
Real estate properties sold \| facility		4
4 Facilities \| Facilities With Impairment Charges [Member]
Number of real estate properties \| facility		4			4
9 Facilities [Member] \| Guardian [Member]
Total proceeds					$ 39,500
Amount of gain (loss) from sale of facilities					13,700
10 Facilities
Impairment on real estate properties					$ 21,200
10 Facilities \| Facilities With Impairment Charges [Member]
Number of real estate properties \| facility		10			10
2 of 10 Facilities
Impairment on real estate properties					$ 3,500
8 of 10 Facilities
Impairment on real estate properties					$ 17,700
8 of 10 Facilities \| Facilities With Impairment Charges [Member]
Number of real estate properties \| facility		8			8
19 of 20 Facilities \| Subsequent Event [Member]
Total proceeds	$ 315,800
22 Facilities \| Gulf Coast LLC [Member]
Total proceeds			$ 303,900
Amount of gain (loss) from sale of facilities			113,500
Potential earnout amount per sales agreement			$ 18,700
44 Facilities
Total proceeds					$ 438,300
Amount of gain (loss) from sale of facilities					$ 179,700
44 Facilities \| Facilities Sold
Real estate properties sold \| facility					44
Assisted Living Facilities [Member]
Number of real estate properties \| facility		167			167
Assisted Living Facilities [Member] \| Variable Interest Entity, Primary Beneficiary [Member]
Number of real estate properties \| facility			2
Assisted Living Facilities [Member] \| Facilities Sold \| Variable Interest Entity, Primary Beneficiary [Member]
Number of real estate properties \| facility			1

ASSETS HELD FOR SALE, DISPOSI_4

ASSETS HELD FOR SALE, DISPOSITIONS AND IMPAIRMENTS (Schedule of Properties Held-for-Sale) (Details) $ in Thousands	Sep. 30, 2022 USD ($) facility	Dec. 31, 2021 USD ($) facility
Number of real estate properties	941
Amount of Assets Held for Sale \| $	$ 190,723	$ 261,151
Facilities Held for Sale [Member]
Number of real estate properties	34	41

CONTRACTUAL RECEIVABLES AND O_3

CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS (Narrative) (Details)			1 Months Ended		3 Months Ended					6 Months Ended	9 Months Ended
	Jul. 01, 2022 USD ($)	Feb. 15, 2022 facility	Nov. 02, 2022 facility	Apr. 30, 2022 USD ($)	Dec. 31, 2022	Sep. 30, 2022 USD ($) contract facility item	Jun. 30, 2022 USD ($)	Mar. 31, 2022 facility item USD ($)	Sep. 30, 2021 USD ($)	Jun. 30, 2022 USD ($) facility	Sep. 30, 2022 USD ($) facility contract item	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($) facility	Oct. 31, 2021 USD ($)	May 07, 2018 USD ($)
Contractual receivables - net						$ 9,945,000					$ 9,945,000		$ 11,259,000
Potential accumulated deferred rent payments - rent portion				$ 12,200,000
Potential accumulated deferred rent payments - interest portion				$ 5,800,000
Number of real estate properties \| facility						941					941
Straight-line rent receivables						$ 173,266,000					$ 173,266,000		148,455,000
Provision for straight-line rent and contractual receivables						$ 13,200,000	$ 8,300,000				$ 23,600,000
Number of non-named operators placed on a cash basis \| item						3					5
Revenues						$ 239,430,000			$ 281,672,000		$ 733,394,000	$ 812,860,000
Rental income						207,588,000			247,164,000		635,899,000	705,880,000
Real estate tax expense						4,175,000			3,272,000		11,495,000	9,002,000
Lease inducements						87,416,000					87,416,000		93,770,000
Restricted cash						$ 3,323,000			3,341,000		$ 3,323,000	$ 3,341,000	3,877,000
Number of operators \| contract						65					65
Percentage of annual escalators				2.25%
Mortgage Receivable [Member]
Other investments, gross						$ 731,390,000					$ 731,390,000		908,687,000
Other Investment Receivables [Member]
Other investments, gross						$ 669,251,000					669,251,000		$ 539,278,000
6 Facilities
Provision for straight-line rent and contractual receivables											3,200,000
Four Operators [Member]
Security deposit used against uncollected receivables											$ 3,400,000
The number of operators in which security deposit was applied to pay rent \| item											4
Two Operators Not Current [Member]
Number of operators \| item						2					2
One Operator Placed On Cash Basis [Member]
Provision for straight-line rent and contractual receivables						$ 2,600,000
Number of operators \| item						1					1
Two Operators Current [Member]
Number of operators \| item						2					2
Operator Placed On Cash Basis [Member]
Number of operators \| item						17					17
3.7% Operator
Potential deferred rent payments percentage											5%
Additional draw on revolving credit facility							4,000,000			$ 4,000,000
3.7% Operator \| Asset Pledged as Collateral with Right [Member] \| Letter of Credit [Member]
Restricted cash						$ 1,000,000					$ 1,000,000
3.7% Operator \| Lease and Mortgage Security Deposits [Member]
Security deposit						150,000					150,000
3.7% Operator \| Financing Receivable Revolving Credit Facility [Member]
Other investments, gross						20,000,000					20,000,000
Financing receivable, face amount						20,000,000					20,000,000
1.4% Operator
Security deposit used against uncollected receivables				$ 2,000,000
Rental income						2,500,000
2.2% Operator
Provision for straight-line rent and contractual receivables						10,500,000
Letter of credit used against uncollectible receivables						3,300,000	600,000			600,000	3,300,000
Short paid amount of uncollectible receivables							600,000			600,000
2.2% Operator \| Asset Pledged as Collateral with Right [Member] \| Letter of Credit [Member]
Restricted cash						1,500,000	$ 5,400,000			$ 5,400,000	$ 1,500,000
0.5% Operator
Provision for straight-line rent and contractual receivables						$ 2,100,000
Facilities Being Transitioned To Existing Operator [Member] \| 6 Facilities
Number of real estate properties								6
Facilities Sold \| Scenario, Plan [Member] \| Subsequent Event [Member]
Real estate properties sold \| facility			19
Facilities Held for Sale [Member]
Number of real estate properties \| facility						34					34		41
Three Facilities Previously Subject To Mortgage Financing From Entity [Member]
Real estate properties sold \| facility		3
Revenue, Product and Service Benchmark [Member] \| Customer Concentration Risk [Member] \| Four Operators [Member]
Concentration risk, percentage											2.80%	3.10%
Revenue, Product and Service Benchmark [Member] \| Customer Concentration Risk [Member] \| Operator Placed On Cash Basis [Member]
Concentration risk, percentage											15.30%
Revenue, Product and Service Benchmark [Member] \| Customer Concentration Risk [Member] \| 3.7% Operator
Concentration risk, percentage						3.70%					3.70%	3.30%
Revenue, Product and Service Benchmark [Member] \| Customer Concentration Risk [Member] \| 1.4% Operator
Concentration risk, percentage											1.40%	2.10%
Revenue, Product and Service Benchmark [Member] \| Customer Concentration Risk [Member] \| 2.2% Operator
Concentration risk, percentage						2.20%					2.20%	2%
Revenue, Product and Service Benchmark [Member] \| Customer Concentration Risk [Member] \| 0.5% Operator
Concentration risk, percentage											0.50%	0.50%
Variable Interest Entity, Not Primary Beneficiary [Member]
Contractual receivables - net						$ 1,485,000					$ 1,485,000		$ 1,227,000
Revenues						25,959,000			36,943,000		76,162,000	$ 107,018,000
Rental income						21,120,000			$ 33,392,000		63,222,000	$ 95,292,000
Agemo Holdings LLC [Member]
Rental income						0					0
Interest income related to loans on non-accrual status						$ 0					$ 0
Agemo Holdings LLC [Member] \| Facilities Sold
Real estate properties sold \| facility						2
Agemo Holdings LLC [Member] \| Facilities Sold \| Subsequent Event [Member]
Real estate properties sold \| facility			19
Agemo Holdings LLC [Member] \| Facilities Held for Sale [Member]
Number of real estate properties \| facility						20					20
Agemo Holdings LLC [Member] \| Variable Interest Entity, Not Primary Beneficiary [Member] \| Operator Placed On Cash Basis [Member]
Potential accumulated deferred rent payments															$ 6,300,000
Deferred aggregate rent						$ 25,200,000					$ 25,200,000
Agemo Holdings LLC [Member] \| Variable Interest Entity, Not Primary Beneficiary [Member] \| Revenue, Product and Service Benchmark [Member] \| Customer Concentration Risk [Member]
Concentration risk, percentage												4.70%
Gulf Coast LLC [Member]
Debtor-in-Possession Financing, Amount Arranged														$ 25,000,000
Gulf Coast LLC [Member] \| Facilities Sold
Real estate properties sold \| facility								22
Guardian [Member]
Rental income						3,700,000					7,500,000
Lease and loan maturity date				Dec. 31, 2031				Jan. 31, 2027
Interest income related to loans on non-accrual status						0					0
Guardian [Member] \| Asset Pledged as Collateral with Right [Member] \| Letter of Credit [Member]
Restricted cash						$ 7,400,000					$ 7,400,000
Guardian [Member] \| Financing Restructuring Agreement And Amendments [Member]
Potential accumulated deferred rent payments				$ 18,000,000
Reduced combined rent and interest following restructuring activities	$ 24,000,000
Restructuring agreement rent	15,000,000
Restructuring agreement mortgage interest	$ 9,000,000
Guardian [Member] \| Forecast [Member]
Lease and loan maturity date					Sep. 30, 2034
Guardian [Member] \| Facilities Transitioned to Other Operators [Member]
Number of real estate properties \| facility								8
Guardian [Member] \| Facilities Transitioned to Other Operators [Member] \| 8 Facilities
Number of operators \| item								2
Guardian [Member] \| Facilities Sold
Real estate properties sold \| facility										9	9
Guardian [Member] \| Three Facilities Previously Subject To Mortgage Financing From Entity [Member]
Real estate properties sold \| facility								3
Guardian [Member] \| Revenue, Product and Service Benchmark [Member] \| Customer Concentration Risk [Member]
Concentration risk, percentage											1%	3.20%

CONTRACTUAL RECEIVABLES AND O_4

CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS (Schedule of Net Accounts Receivable) (Detail) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
CONTRACTUAL RECEIVABLES AND OTHER RECEIVABLES AND LEASE INDUCEMENTS [Abstract]
Contractual receivables - net	$ 9,945	$ 11,259
Effective yield interest receivables	6,208	9,590
Straight-line rent receivables	173,266	148,455
Lease inducements	87,416	93,770
Other receivables and lease inducements	$ 266,890	$ 251,815

MORTGAGE NOTES RECEIVABLE (Narr

MORTGAGE NOTES RECEIVABLE (Narrative) (Detail)	9 Months Ended
MORTGAGE NOTES RECEIVABLE (Narrative) (Detail)	Sep. 30, 2022 item state facility entity
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties \| facility	941
Number of states \| state	42
Facilities Under Fixed Rate Mortgage Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties \| facility	52
Mortgage Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of fixed rate mortgage \| item	7
Number of states \| state	6
Number of independent healthcare operating companies operating under mortgage notes receivable \| entity	6

MORTGAGE NOTES RECEIVABLE (Sche

MORTGAGE NOTES RECEIVABLE (Schedule of Receivables) (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($) facility	Dec. 31, 2021 USD ($)	Sep. 30, 2021 USD ($)	Dec. 31, 2020 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Mortgage Loans on Real Estate, Commercial and Consumer, Net, Total	$ 669,533	$ 835,086
Number of real estate properties \| facility	941
Mortgage Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Mortgage notes receivable	$ 731,390	908,687
Allowance for credit losses	(61,857)	(73,601)	$ (41,983)	$ (33,245)
Mortgage Loans on Real Estate, Commercial and Consumer, Net, Total	669,533	835,086
Mortgage Receivable [Member] \| Mortgage Note Due 2031 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Mortgage notes receivable	$ 78,309	103,762
Mortgage loans on real estate, interest rate	11.02%
Maturity year	2031
Mortgage Receivable [Member] \| Mortgage Note Due 2030 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Mortgage notes receivable	$ 503,440	653,564
Maturity year	2030
Mortgage Receivable [Member] \| Other Mortgage Notes Member
Accounts, Notes, Loans and Financing Receivable [Line Items]
Mortgage notes receivable	$ 149,641	$ 151,361
Minimum [Member] \| Other Mortgage Notes Member
Accounts, Notes, Loans and Financing Receivable [Line Items]
Maturity year	2023
Maximum [Member] \| Other Mortgage Notes Member
Accounts, Notes, Loans and Financing Receivable [Line Items]
Maturity year	2032
Weighted Average [Member] \| Other Mortgage Notes Member
Accounts, Notes, Loans and Financing Receivable [Line Items]
Mortgage loans on real estate, interest rate	8.85%
Weighted Average [Member] \| Mortgage Receivable [Member] \| Mortgage Note Due 2030 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Mortgage loans on real estate, interest rate	10.96%
Facilities Used in Weighted Average Interest Rate [Member] \| Mortgage Receivable [Member] \| Mortgage Note Due 2030 [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties \| facility	37

MORTGAGE NOTES RECEIVABLE (Note

MORTGAGE NOTES RECEIVABLE (Notes Due 2031 Narrative) (Detail) $ in Thousands		3 Months Ended		6 Months Ended	9 Months Ended
	Feb. 15, 2022 USD ($) facility	Sep. 30, 2022 USD ($) facility	Mar. 31, 2022 USD ($) facility	Jun. 30, 2022 facility	Sep. 30, 2022 USD ($) facility	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties \| facility		941			941
Mortgage Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Mortgage notes receivable		$ 731,390			$ 731,390		$ 908,687
Additional reserve (recovery) through provision for credit losses					(11,744)	$ 8,738
Financing receivable, allowance for credit losses		$ 61,857			61,857	41,983	73,601	$ 33,245
Provision (Recovery) for Credit Losses					$ (11,744)	$ 8,738
Facilities Acquired \| Skilled Nursing Facilities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties \| facility		1			1
Facilities Acquired \| Assisted Living Facilities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties \| facility		33			33
Facilities Sold \| 4 Facilities
Accounts, Notes, Loans and Financing Receivable [Line Items]
Real estate properties sold \| facility		4
Facilities Sold \| Guardian [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Real estate properties sold \| facility				9	9
Three Facilities Previously Subject To Mortgage Financing From Entity [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Real estate properties sold \| facility	3
Three Facilities Previously Subject To Mortgage Financing From Entity [Member] \| Guardian [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Real estate properties sold \| facility			3
Additional reserve (recovery) through provision for credit losses			$ (5,100)
Partial paydown received from the sale of facilities in exchange for release of mortgage liens	$ 21,700
Provision (Recovery) for Credit Losses			$ (5,100)
Mortgage Note Due 2031 [Member] \| Guardian [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Mortgage notes receivable		$ 78,300			$ 78,300
Financing receivable, loan percentage of all financing receivables		10.80%			10.80%
Interest payments applied against principal for cost recovery loans		$ 2,300			$ 3,700
Mortgage Note Due 2031 [Member] \| Guardian [Member] \| 4 Facilities
Accounts, Notes, Loans and Financing Receivable [Line Items]
Additional reserve (recovery) through provision for credit losses		1,000
Provision (Recovery) for Credit Losses		1,000
Mortgage Note Due 2031 [Member] \| Mortgage Receivable [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Mortgage notes receivable		$ 78,309			$ 78,309		$ 103,762
Maturity year					2031
Mortgage Note Due 2031 [Member] \| Facilities Covered by Mortgage and Used as Collateral [Member] \| Guardian [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties \| facility		4			4
Mortgage Note Due 2031 [Member] \| Facilities Covered by Mortgage and Used as Collateral [Member] \| Mortgage Receivable [Member] \| Skilled Nursing Facilities [Member] \| Guardian [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties \| facility		3			3
Mortgage Note Due 2031 [Member] \| Facilities Covered by Mortgage and Used as Collateral [Member] \| Mortgage Receivable [Member] \| Assisted Living Facilities [Member] \| Guardian [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of real estate properties \| facility		1			1

MORTGAGE NOTES RECEIVABLE (No_2

MORTGAGE NOTES RECEIVABLE (Notes Due 2030 Narrative) (Detail) $ in Thousands			9 Months Ended
	Sep. 09, 2022 USD ($) facility	Jun. 30, 2022 USD ($) facility	Sep. 30, 2022 USD ($) facility	Sep. 30, 2021 USD ($)
Collection of mortgage principal			$ 187,161	$ 44,039
Number of real estate properties \| facility			941
Mortgage Liens on Facilities Removed [Member] \| Ciena Healthcare [Member]
Number of real estate properties \| facility	2	6
Mortgage Note Due 2030 [Member] \| Ciena Healthcare [Member]
Investment Maturity Date			Jun. 30, 2030
Mortgage Note Due 2030 Master Mortgage [Member] \| Ciena Healthcare [Member]
Collection of mortgage principal	$ 35,300	$ 57,100
Mortgage notes receivable		415,000
Mortgage Note Due 2030 $44.7 Million Mortgage [Member] \| Ciena Healthcare [Member]
Collection of mortgage principal		15,100
Mortgage notes receivable		44,700
Mortgage Note Due 2030 Four Additional Mortgages [Member] \| Ciena Healthcare [Member]
Collection of mortgage principal		$ 41,500
Mortgage Note Due 2030 Three Additional Mortgages [Member] \| Ciena Healthcare [Member]
Collection of mortgage principal	$ 9,500
Mortgage Note Due Two Loans[Member] \| Ciena Healthcare [Member]
Mortgage notes receivable			$ 37,700
Mortgage Note Due Two Loans[Member] \| Ciena Healthcare [Member] \| Minimum [Member]
Investment Maturity Year		2022
Mortgage Note Due Two Loans[Member] \| Ciena Healthcare [Member] \| Maximum [Member]
Investment Maturity Year		2023

OTHER INVESTMENTS (Schedule of

OTHER INVESTMENTS (Schedule of Receivables) (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Jun. 28, 2022	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Schedule of Investments [Line Items]
Total other investments	$ 608,190		$ 469,884
Other Investment Type Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Other investments, gross	396,874		354,673
Other Investment Type Non Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Other investments, gross	272,377		184,605
Other Investment Receivables [Member]
Schedule of Investments [Line Items]
Other investments, gross	669,251		539,278
Allowance for credit losses	(61,061)		(69,394)	$ (51,491)	$ (31,457)
Other Investment Note Due 2022 Through 2025 [Member] \| Other Investment Type Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Other investments, gross	44,200		9,992
Interest rate		12%
Investment Maturity Date		Jun. 30, 2025
Other Investment Note Due 2022 Through 2028 [Member]
Schedule of Investments [Line Items]
Other investments, gross	30,000
Other Investment Note Due 2022 Through 2028 [Member] \| Other Investment Type Non Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Other investments, gross	53,560		22,142
Other Investment Note Due 2024 at 13.17% Interest [Member] \| Other Investment Type Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Other investments, gross	$ 96,456		90,752
Maturity year	2024
Other Investment Note Due 2024 at 12.00% Interest [Member] \| Other Investment Type Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Other investments, gross			40,232
Interest rate	12%
Maturity year	2024
Other Investment Note Due 2024 Through 2025 [Member] \| Other Investment Type Non Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Other investments, gross	$ 55,791		55,791
Other Investments Note Due 2030 [Member] \| Other Investment Type Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Other investments, gross	$ 236,218		201,613
Interest rate	7%
Maturity year	2030
Other investment notes outstanding [Member] \| Other Investment Type Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Other investments, gross	$ 20,000		12,084
Interest rate	12%
Investment Maturity Date	Dec. 02, 2027
Other investment notes outstanding [Member] \| Other Investment Type Non Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Other investments, gross	$ 163,026		$ 106,672
Other investment notes outstanding maturing in 2022 [Member] \| Other Investment Type Non Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Other investments, gross	$ 10,500
Minimum [Member] \| Other Investment Note Due 2022 Through 2025 [Member] \| Other Investment Type Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Maturity year	2022
Minimum [Member] \| Other Investment Note Due 2022 Through 2028 [Member] \| Other Investment Type Non Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Maturity year	2022
Minimum [Member] \| Other Investment Note Due 2024 Through 2025 [Member] \| Other Investment Type Non Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Maturity year	2024
Minimum [Member] \| Other investment notes outstanding [Member] \| Other Investment Type Non Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Maturity year	2022
Maximum [Member] \| Other Investment Note Due 2022 Through 2025 [Member] \| Other Investment Type Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Maturity year	2025
Maximum [Member] \| Other Investment Note Due 2022 Through 2028 [Member] \| Other Investment Type Non Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Maturity year	2028
Maximum [Member] \| Other Investment Note Due 2024 Through 2025 [Member] \| Other Investment Type Non Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Maturity year	2025
Maximum [Member] \| Other investment notes outstanding [Member] \| Other Investment Type Non Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Maturity year	2032
Weighted Average [Member] \| Other Investment Note Due 2022 Through 2025 [Member] \| Other Investment Type Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Interest rate	12.03%
Weighted Average [Member] \| Other Investment Note Due 2022 Through 2028 [Member] \| Other Investment Type Non Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Interest rate	10.49%
Weighted Average [Member] \| Other Investment Note Due 2024 at 13.17% Interest [Member] \| Other Investment Type Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Interest rate	13.17%
Weighted Average [Member] \| Other Investment Note Due 2024 Through 2025 [Member] \| Other Investment Type Non Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Interest rate	8.12%
Weighted Average [Member] \| Other investment notes outstanding [Member] \| Other Investment Type Non Real Estate Related Loans [Member]
Schedule of Investments [Line Items]
Interest rate	8.20%

OTHER INVESTMENTS (Summary of o

OTHER INVESTMENTS (Summary of other investments income) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Other investment income	$ 14,110	$ 10,780	$ 36,481	$ 34,245
Other Investment Type Real Estate Related Loans [Member]
Other investment income	10,566	8,036	27,987	23,628
Other Investment Type Non Real Estate Related Loans [Member]
Other investment income	$ 3,544	$ 2,744	$ 8,494	$ 10,617

OTHER INVESTMENTS (Notes Due 20

OTHER INVESTMENTS (Notes Due 2030 Narrative) (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Jun. 22, 2022	Jun. 21, 2022	Dec. 31, 2021
Rental income	$ 207,588	$ 247,164	$ 635,899	$ 705,880
Other Investment Receivables [Member]
Other investments, gross	669,251		669,251				$ 539,278
Maplewood Real Estate Holdings \| Other Investments Note Due 2030 [Member]
Financing receivable, face amount					$ 250,500	$ 220,500
Interest rate					7%
Other investments, gross	$ 236,200		$ 236,200
Investment Maturity Date					Jun. 30, 2030

OTHER INVESTMENTS (Other invest

OTHER INVESTMENTS (Other investments notes due 2024-2025) (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Other Investment Type Real Estate Related Loans [Member]
Other investments, gross	$ 396,874	$ 396,874		$ 354,673
Other Investment Type Non Real Estate Related Loans [Member]
Other investments, gross	272,377	272,377		184,605
Other Investment Receivables [Member]
Other investments, gross	669,251	669,251		539,278
Provision (Recovery) for Credit Losses		14,182	$ 20,129
Other investment notes outstanding [Member] \| Other Investment Type Real Estate Related Loans [Member]
Other investments, gross	$ 20,000	$ 20,000		12,084
Investment Maturity Date	Dec. 02, 2027	Dec. 02, 2027
Other investment notes outstanding [Member] \| Other Investment Type Non Real Estate Related Loans [Member]
Other investments, gross	$ 163,026	$ 163,026		106,672
Other Investment Note Due 2024 Through 2025 [Member] \| Other Investment Type Non Real Estate Related Loans [Member]
Other investments, gross	55,791	55,791		$ 55,791
Variable Interest Entity, Not Primary Beneficiary [Member] \| Other Investment Note Due 2025 Working Capital Loan [Member] \| Agemo Holdings LLC [Member]
Provision (Recovery) for Credit Losses	$ 4,800	$ 10,800

OTHER INVESTMENTS (Other inve_2

OTHER INVESTMENTS (Other investments notes due 2022-2025) (Narrative) (Details) - Other Investment Note Due 2022 Through 2025 [Member] $ in Millions	Jun. 28, 2022 USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, face amount	$ 35.6
Quarterly expected payment amount to be received	$ 1
Other Investment Type Real Estate Related Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest rate	12%
Investment Maturity Date	Jun. 30, 2025

OTHER INVESTMENTS (Other inve_3

OTHER INVESTMENTS (Other investments notes due 2022-2028) (Narrative) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Jun. 28, 2022	Dec. 31, 2021
Other Investment Receivables [Member]
Other investments, gross	$ 669,251		$ 539,278
Other Investment Note Due 2022 Through 2025 [Member]
Financing receivable, face amount		$ 35,600
Other Investment Note Due 2022 Through 2028 [Member]
Financing receivable, face amount	90,000	90,000
Other investments, gross	$ 30,000
Other Investment Secured Revolving Credit Facility Related to Other Investment Note Due 2022 And 2028 Tranche One[Member]
Financing receivable, face amount		$ 45,000
Interest rate		10%
Investment Maturity Date		Jun. 30, 2023
Other Investment Secured Revolving Credit Facility Related to Other Investment Note Due 2022 And 2028 Tranche Two [Member]
Financing receivable, face amount		$ 45,000
Interest rate		12%
Investment Maturity Date		Jun. 01, 2023

OTHER INVESTMENTS (Other Inve_4

OTHER INVESTMENTS (Other Investment Note Outstanding Narrative) (Detail) $ in Thousands			1 Months Ended	3 Months Ended	4 Months Ended		7 Months Ended	9 Months Ended
	Sep. 01, 2022 USD ($)	Mar. 25, 2022 USD ($)	Oct. 31, 2023 USD ($)	Sep. 30, 2022 USD ($) facility item contract loan	Sep. 30, 2023 USD ($)	Oct. 31, 2022 USD ($)	May 31, 2023 USD ($)	Sep. 30, 2022 USD ($) facility item contract loan	Sep. 30, 2021 USD ($)	Aug. 25, 2022 USD ($)	Jun. 02, 2022 USD ($)	Dec. 31, 2021 USD ($)	Nov. 30, 2021 USD ($) facility	Jul. 31, 2019 USD ($)
Number of real estate properties \| facility				941				941
Number of other investment notes or loans outstanding \| loan				39				39
Number of operators \| contract				65				65
Other Investment Type Real Estate Related Loans [Member]
Other investments, gross				$ 396,874				$ 396,874				$ 354,673
Other Investment Type Non Real Estate Related Loans [Member]
Other investments, gross				272,377				272,377				184,605
Other Investment Type Non Real Estate Related Loans [Member] \| Gulf Coast LLC [Member] \| New Manager of Gulf Coast Facilities [Member]
Number of real estate properties \| facility													23
Other Investment Receivables [Member]
Other investments, gross				669,251				669,251				539,278
Provision (Recovery) for Credit Losses								14,182	$ 20,129
Other Investment Receivables [Member] \| Gulf Coast LLC [Member]
Provision (Recovery) for Credit Losses				(500)				(2,000)
Other Investment Receivables [Member] \| Other Investment Type Non Real Estate Related Loans [Member] \| LaVie Care Centers LLC (f/k/a Consulate Health Care)
Investment Maturity Date		Mar. 31, 2032
Other investment notes outstanding [Member] \| Other Investment Type Real Estate Related Loans [Member]
Other investments, gross				$ 20,000				$ 20,000				12,084
Interest rate				12%				12%
Investment Maturity Date				Dec. 02, 2027				Dec. 02, 2027
Other investment notes outstanding [Member] \| Other Investment Type Non Real Estate Related Loans [Member]
Other investments, gross				$ 163,026				$ 163,026				$ 106,672
Other Investment Notes Outstanding With Operators [Member]
Number of operators \| item				20				20
Other Investment Notes Outstanding Joint Venture [Member] \| Other Investment Type Real Estate Related Loans [Member]
Interest rate											12%
Financing receivable, face amount											$ 20,000
Working Capital Loans [Member] \| Other Investment Type Non Real Estate Related Loans [Member] \| New Manager of Gulf Coast Facilities [Member]
Other investments, gross				$ 5,800				$ 5,800
Provision (Recovery) for Credit Losses				900				3,200
Financing receivable, face amount				20,000				20,000					$ 20,000
Interest payments received applied against principal				32,700
Other Investment Term Loans [Member] \| Other Investment Type Non Real Estate Related Loans [Member] \| LaVie Care Centers LLC (f/k/a Consulate Health Care)
Other investments, gross				$ 25,000				$ 25,000
Interest rate		8.50%
Quarterly expected payment amount to be received		$ 1,300
Financing receivable, face amount		$ 25,000
Other Investment Mezzanine Loan [Member] \| Other Investment Type Non Real Estate Related Loans [Member]
Interest rate	12%
Investment Maturity Date	Sep. 14, 2027
Financing receivable, face amount	$ 40,000
Semi annual expected payment amount to be received	$ 1,700
Other Investment Revolving Credit Facility [Member] \| Other Investment Type Non Real Estate Related Loans [Member]
Interest rate										7.50%
Investment Maturity Date										Dec. 31, 2024				Jul. 08, 2022
Financing receivable, face amount										$ 45,000				$ 15,000
Other Investment Revolving Credit Facility [Member] \| Other Investment Type Non Real Estate Related Loans [Member] \| Scenario, Plan [Member]
Monthly expected payment amount to be received			$ 2,500		$ 1,500	$ 500	$ 1,000

ALLOWANCE FOR CREDIT LOSSES (Na

ALLOWANCE FOR CREDIT LOSSES (Narrative) (Detail) - USD ($)	3 Months Ended	9 Months Ended
ALLOWANCE FOR CREDIT LOSSES (Narrative) (Detail) - USD ($)	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Accrued investment income receivable	$ 10,000,000	$ 10,000,000
Effective yield interest receivables	6,208,000	6,208,000		$ 9,590,000
Guardian [Member]
Interest income related to loans on non-accrual status	0	0
Agemo Holdings LLC [Member]
Interest income related to loans on non-accrual status	$ 0	0
Other Investment Receivables [Member]
Write-offs of Financing Receivable Charged Against Allowance		22,515,000	$ 95,000
Additional reserve (recovery) through provision for credit losses		$ 14,182,000	$ 20,129,000

ALLOWANCE FOR CREDIT LOSSES (Sc

ALLOWANCE FOR CREDIT LOSSES (Schedule of expected credit loss per segment) (Detail) $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2022 USD ($) facility	Jun. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) facility	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)	Nov. 30, 2021 USD ($)	Oct. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Number of real estate properties \| facility	941			941
Direct Financing Lease, Net Investment in Lease, Allowance for Credit Loss [Roll Forward]
Direct Financing Lease, Net Investment in Lease, Allowance for Credit Loss, Beginning Balance				$ 530	$ 694
Provision (recovery) on direct financing leases				255	(35)
Direct Financing Lease, Net Investment in Lease, Allowance for Credit Loss, Ending Balance	$ 785		$ 659	785	659
Off-Balance-Sheet, Credit Loss, Liability [Roll Forward]
ECL Beginning balance, off-balance sheet				941	2,445
Provision (Recovery) for Credit Losses, off-balance sheet				1,674	(809)
Write-offs charged against allowance for the period ended, off-balance sheet				(2,250)
ECL Ending balance, off-balance sheet	365		1,636	365	1,636
ECL balance, total receivables	124,068		95,769	124,068	95,769	$ 144,466			$ 67,841
Provision (Recovery) for Credit Losses, total receivables				4,367	28,023
Write-offs charged against allowance for the period ended, total receivables				(24,765)	(95)
Other Investment Type Non Real Estate Related Loans [Member]
Mortgage notes receivable	272,377			272,377		184,605
Gulf Coast LLC [Member]
Debtor-in-Possession Financing, Amount Arranged								$ 25,000
Off Balance Sheet Financing Receivable Segment Note Commitment [Member] \| Gulf Coast LLC [Member]
Off-Balance-Sheet, Credit Loss, Liability [Roll Forward]
Provision (Recovery) for Credit Losses, off-balance sheet		$ 2,200
Mortgage Receivable [Member]
Mortgage notes receivable	731,390			731,390		908,687
Financing Receivable, Allowance for Credit Loss [Roll Forward]
ECL Beginning balance				73,601	33,245
Provision (Recovery) for Credit Losses				(11,744)	8,738
ECL Ending balance	61,857		41,983	61,857	41,983
Other Investment Receivables [Member]
Mortgage notes receivable	669,251			669,251		539,278
Financing Receivable, Allowance for Credit Loss [Roll Forward]
ECL Beginning balance				69,394	31,457
Provision (Recovery) for Credit Losses				14,182	20,129
Write-offs charged against allowance for the period ended				(22,515)	(95)
ECL Ending balance	61,061		51,491	61,061	51,491
Other Investment Receivables [Member] \| Gulf Coast LLC [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Provision (Recovery) for Credit Losses	(500)			(2,000)
Other Investment Note Due 2024 Through 2025 [Member] \| Other Investment Type Non Real Estate Related Loans [Member]
Mortgage notes receivable	55,791			55,791		$ 55,791
Other Investment Note Due 2025 Working Capital Loan [Member] \| Variable Interest Entity, Not Primary Beneficiary [Member] \| Agemo Holdings LLC [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Provision (Recovery) for Credit Losses	4,800			10,800
Working Capital Loans [Member] \| New Manager of Gulf Coast Facilities [Member] \| Other Investment Type Non Real Estate Related Loans [Member]
Mortgage notes receivable	5,800			5,800
Financing receivable, face amount	20,000			20,000			$ 20,000
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Provision (Recovery) for Credit Losses	900			3,200
Internal Credit Rating One [Member] \| Mortgage Receivable [Member]
Mortgage notes receivable	64,243			64,243
Internal Credit Rating One [Member] \| Other Investment Receivables [Member]
Mortgage notes receivable	20,000			20,000
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Provision (Recovery) for Credit Losses				212
ECL Ending balance	212			212
Internal Credit Rating Two [Member] \| Off Balance Sheet Financing Receivable Segment Note Commitment [Member]
Off-Balance-Sheet, Credit Loss, Liability [Roll Forward]
ECL Beginning balance, off-balance sheet				7	116
Provision (Recovery) for Credit Losses, off-balance sheet				94	(90)
ECL Ending balance, off-balance sheet	101		26	101	26
Internal Credit Rating Two [Member] \| Mortgage Receivable [Member]
Mortgage notes receivable	21,325			21,325
Financing Receivable, Allowance for Credit Loss [Roll Forward]
ECL Beginning balance				15	88
Provision (Recovery) for Credit Losses				(3)	(65)
ECL Ending balance	12		23	12	23
Internal Credit Rating Two [Member] \| Other Investment Receivables [Member]
Mortgage notes receivable	81,799			81,799
Financing Receivable, Allowance for Credit Loss [Roll Forward]
ECL Beginning balance				29	94
Provision (Recovery) for Credit Losses				247	(38)
ECL Ending balance	276		56	276	56
Internal Credit Rating Three [Member]
Direct Financing Lease, Net Investment in Lease, Allowance for Credit Loss [Roll Forward]
Direct Financing Lease, Net Investment in Lease, Allowance for Credit Loss, Beginning Balance				530	694
Provision (recovery) on direct financing leases				(530)	(35)
Direct Financing Lease, Net Investment in Lease, Allowance for Credit Loss, Ending Balance			659		659
Internal Credit Rating Three [Member] \| Off Balance Sheet Financing Receivable Segment Note Commitment [Member]
Off-Balance-Sheet, Credit Loss, Liability [Roll Forward]
ECL Beginning balance, off-balance sheet				458	2,305
Provision (Recovery) for Credit Losses, off-balance sheet				(209)	(1,300)
ECL Ending balance, off-balance sheet	249		1,005	249	1,005
Internal Credit Rating Three [Member] \| Mortgage Receivable [Member]
Mortgage notes receivable	72,420			72,420
Financing Receivable, Allowance for Credit Loss [Roll Forward]
ECL Beginning balance				1,973	954
Provision (Recovery) for Credit Losses				(345)	1,603
ECL Ending balance	1,628		2,557	1,628	2,557
Internal Credit Rating Three [Member] \| Other Investment Receivables [Member]
Mortgage notes receivable	314,284			314,284
Financing Receivable, Allowance for Credit Loss [Roll Forward]
ECL Beginning balance				4,600	5,113
Provision (Recovery) for Credit Losses				3,010	628
ECL Ending balance	7,610		5,741	7,610	5,741
Internal Credit Rating Four [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Provision (Recovery) for Credit Losses				785
ECL Ending balance	785			785
Internal Credit Rating Four [Member] \| Off Balance Sheet Financing Receivable Segment Mortgage Commitment [Member]
Off-Balance-Sheet, Credit Loss, Liability [Roll Forward]
ECL Beginning balance, off-balance sheet				117	24
Provision (Recovery) for Credit Losses, off-balance sheet				102	208
ECL Ending balance, off-balance sheet	15		232	15	232
Internal Credit Rating Four [Member] \| Off Balance Sheet Financing Receivable Segment Note Commitment [Member]
Off-Balance-Sheet, Credit Loss, Liability [Roll Forward]
ECL Beginning balance, off-balance sheet				216
Provision (Recovery) for Credit Losses, off-balance sheet				(216)	373
ECL Ending balance, off-balance sheet			373		373
Internal Credit Rating Four [Member] \| Mortgage Receivable [Member]
Mortgage notes receivable	482,114			482,114
Financing Receivable, Allowance for Credit Loss [Roll Forward]
ECL Beginning balance				19,461	26,865
Provision (Recovery) for Credit Losses				(5,746)	(1,825)
ECL Ending balance	13,715		25,040	13,715	25,040
Internal Credit Rating Four [Member] \| Other Investment Receivables [Member]
Mortgage notes receivable	159,492			159,492
Financing Receivable, Allowance for Credit Loss [Roll Forward]
ECL Beginning balance				1,172	24,397
Provision (Recovery) for Credit Losses				157	(22,675)
ECL Ending balance	1,329		1,722	1,329	1,722
Internal Credit Rating Four [Member] \| Other Investment Note Due 2024 Term Loan and One Additional Loan [Member] \| Agemo Holdings LLC [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Provision (Recovery) for Credit Losses			(27,200)
Internal Credit Rating Five [Member] \| Mortgage Receivable [Member]
Mortgage notes receivable	6,602			6,602
Financing Receivable, Allowance for Credit Loss [Roll Forward]
ECL Beginning balance				135	433
Provision (Recovery) for Credit Losses				(86)	9,025
ECL Ending balance	49		9,458	49	9,458
Internal Credit Rating Five [Member] \| Other Investment Receivables [Member]
Mortgage notes receivable	57,783			57,783
Financing Receivable, Allowance for Credit Loss [Roll Forward]
ECL Beginning balance				7,861	1,853
Provision (Recovery) for Credit Losses				12,522	6,260
Write-offs charged against allowance for the period ended					(95)
ECL Ending balance	20,383		8,018	20,383	8,018
Internal Credit Rating Five [Member] \| Other Investment Note Due 2025 Working Capital Loan [Member] \| Agemo Holdings LLC [Member]
Off-Balance-Sheet, Credit Loss, Liability [Roll Forward]
Provision (Recovery) for Credit Losses, total receivables			7,900
Internal Credit Rating Six [Member] \| Off Balance Sheet Financing Receivable Segment Note Commitment [Member]
Off-Balance-Sheet, Credit Loss, Liability [Roll Forward]
ECL Beginning balance, off-balance sheet				143
Provision (Recovery) for Credit Losses, off-balance sheet				2,107
Write-offs charged against allowance for the period ended, off-balance sheet				(2,250)
Internal Credit Rating Six [Member] \| Mortgage Receivable [Member]
Mortgage notes receivable	84,686			84,686
Financing Receivable, Allowance for Credit Loss [Roll Forward]
ECL Beginning balance				52,017	4,905
Provision (Recovery) for Credit Losses				(5,564)
ECL Ending balance	46,453		4,905	46,453	4,905
Internal Credit Rating Six [Member] \| Other Investment Receivables [Member]
Mortgage notes receivable	35,893			35,893
Financing Receivable, Allowance for Credit Loss [Roll Forward]
ECL Beginning balance				55,732
Provision (Recovery) for Credit Losses				(1,966)	35,954
Write-offs charged against allowance for the period ended				(22,515)
ECL Ending balance	$ 31,251		35,954	$ 31,251	$ 35,954
Internal Credit Rating Six [Member] \| Other Investment Note Due 2024 Term Loan and One Additional Loan [Member] \| Agemo Holdings LLC [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Provision (Recovery) for Credit Losses			27,200
Internal Credit Rating Six [Member] \| Other Investment Note Due 2024 Term Loan [Member] \| Agemo Holdings LLC [Member]
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Provision (Recovery) for Credit Losses			$ 8,800

ALLOWANCE FOR CREDIT LOSSES (_2

ALLOWANCE FOR CREDIT LOSSES (Schedule by segment balance by vintage and credit quality indicator) (Detail) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Total 2022	$ 150,336
Total 2021	105,676
Total 2020	110,826
Total 2019	22,069
Total 2018	165,601
Total 2017	11,291
Total 2016 & older	522,823
Total receivable Revolving	323,364
Total receivables	1,411,986
2022, current-period gross write-offs
2021, current-period gross write-offs	(18,052)
2020, current-period gross write-offs
2019, current-period gross write-offs
2018, current-period gross write-offs	(4,463)
2017, current-period gross write-offs
2016 & older, current-period gross write-offs
Revolving, current-period gross write-offs
Total write offs, current period	(22,515)
Direct Financing Lease, Net Investment in Lease, before Allowance for Credit Loss [Abstract]
2016 & older, Investment in direct financing leases	11,345
Investment in direct financing leases	11,345
Internal Credit Rating Four [Member]
Direct Financing Lease, Net Investment in Lease, before Allowance for Credit Loss [Abstract]
2016 & older, Investment in direct financing leases	11,345
Investment in direct financing leases	11,345
Mortgage Receivable [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2022	122
2021	97,441
2020	110,826
2019	5,084
2018	29,147
2017	11,291
2016 & older	477,479
Total Balance at September 30, 2022	731,390	$ 908,687
Mortgage Receivable [Member] \| Internal Credit Rating One [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2016 & older	64,243
Total Balance at September 30, 2022	64,243
Mortgage Receivable [Member] \| Internal Credit Rating Two [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2020	21,325
Total Balance at September 30, 2022	21,325
Mortgage Receivable [Member] \| Internal Credit Rating Three [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2021	72,420
Total Balance at September 30, 2022	72,420
Mortgage Receivable [Member] \| Internal Credit Rating Four [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2022	122
2021	25,021
2020	89,501
2019	5,084
2018	29,147
2017	11,291
2016 & older	321,948
Total Balance at September 30, 2022	482,114
Mortgage Receivable [Member] \| Internal Credit Rating Five [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2016 & older	6,602
Total Balance at September 30, 2022	6,602
Mortgage Receivable [Member] \| Internal Credit Rating Six [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2016 & older	84,686
Total Balance at September 30, 2022	84,686
Other Investment Receivables [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2022	150,214
2021	8,235
2019	16,985
2018	136,454
2016 & older	33,999
Revolving Loans	323,364
Total Balance at September 30, 2022	669,251	$ 539,278
Other Investment Receivables [Member] \| Internal Credit Rating One [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2022	20,000
Total Balance at September 30, 2022	20,000
Other Investment Receivables [Member] \| Internal Credit Rating Two [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2022	30,000
Revolving Loans	51,799
Total Balance at September 30, 2022	81,799
Other Investment Receivables [Member] \| Internal Credit Rating Three [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2022	35,600
2019	14,563
2018	10,800
2016 & older	1,756
Revolving Loans	251,565
Total Balance at September 30, 2022	314,284
Other Investment Receivables [Member] \| Internal Credit Rating Four [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2022	39,614
2019	2,422
2018	96,456
2016 & older	1,000
Revolving Loans	20,000
Total Balance at September 30, 2022	159,492
Other Investment Receivables [Member] \| Internal Credit Rating Five [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2022	25,000
2021	8,235
2018	24,548
Total Balance at September 30, 2022	57,783
Other Investment Receivables [Member] \| Internal Credit Rating Six [Member]
Financing Receivable, before Allowance for Credit Loss, by Origination Year [Abstract]
2018	4,650
2016 & older	31,243
Total Balance at September 30, 2022	$ 35,893

VARIABLE INTEREST ENTITIES (Sch

VARIABLE INTEREST ENTITIES (Schedule of variable interest entities) (Detail)	3 Months Ended				9 Months Ended
	Sep. 30, 2022 USD ($) facility	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($) facility	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) facility	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)	May 17, 2019
Assets
Real estate assets - net	$ 6,462,353,000				$ 6,462,353,000		$ 6,789,091,000
Assets held for sale	190,723,000				190,723,000		261,151,000
Other investments - net	608,190,000				608,190,000		469,884,000
Contractual receivables - net	9,945,000				9,945,000		11,259,000
Other receivables and lease inducements	266,890,000				266,890,000		251,815,000
Lease inducements	87,416,000				87,416,000		93,770,000
Other assets	293,829,000				293,829,000		138,804,000
Total assets	9,475,705,000				9,475,705,000		9,638,478,000
Liabilities
Total Liabilities	(5,580,329,000)				(5,580,329,000)		(5,530,252,000)
Restricted cash	3,323,000			$ 3,341,000	3,323,000	$ 3,341,000	3,877,000
Rental income	207,588,000			247,164,000	635,899,000	705,880,000
Other investment income	14,110,000			10,780,000	36,481,000	34,245,000
Total revenues	239,430,000			281,672,000	733,394,000	812,860,000
Provision for straight-line rent and contractual receivables	$ 13,200,000	$ 8,300,000			$ 23,600,000
Number of Facilities \| facility	941				941
Lakeway Realty LLC [Member]
Liabilities
Equity Method Investment, Ownership Percentage								51%
Assisted Living Facilities [Member]
Liabilities
Number of Facilities \| facility	167				167
Agemo Holdings LLC [Member]
Liabilities
Rental income	$ 0				$ 0
Variable Interest Entity, Primary Beneficiary [Member]
Assets
Total assets	25,600,000				25,600,000
Liabilities
Total Liabilities	(20,200,000)				(20,200,000)
Noncontrolling Interest in Joint Ventures			$ 2,900,000
Total proceeds			$ 7,700,000
Variable Interest Entity, Primary Beneficiary [Member] \| Joint Venture That Owns Two Assisted Living Facilities [Member]
Liabilities
Equity Method Investment, Ownership Percentage			52.40%
Variable Interest Entity, Primary Beneficiary [Member] \| Assisted Living Facilities [Member]
Liabilities
Number of Facilities \| facility			2
Payment for interest in consolidate joint venture			$ 3,200,000
Variable Interest Entity, Primary Beneficiary [Member] \| Facilities Sold \| Assisted Living Facilities [Member]
Liabilities
Number of Facilities \| facility			1
Variable Interest Entity, Not Primary Beneficiary [Member]
Assets
Real estate assets - net	988,173,000				988,173,000		1,144,851,000
Assets held for sale	129,239,000				129,239,000		191,016,000
Other investments - net	264,473,000				264,473,000		230,768,000
Contractual receivables - net	1,485,000				1,485,000		1,227,000
Other receivables and lease inducements	29,311,000				29,311,000		22,795,000
Other assets	746,000				746,000
Total assets	1,413,427,000				1,413,427,000		1,590,657,000
Liabilities
Net in-place lease liability	(286,000)				(286,000)		(305,000)
Security deposit	(4,829,000)				(4,829,000)		(4,715,000)
Contingent liability	(43,915,000)				(43,915,000)		(43,915,000)
Other liabilities	(746,000)				(746,000)
Total Liabilities	(49,776,000)				(49,776,000)		(48,935,000)
Total collateral	(1,165,412,000)				(1,165,412,000)		(1,383,867,000)
Maximum exposure to loss	198,239,000				198,239,000		157,855,000
Rental income	$ 21,120,000			$ 33,392,000	$ 63,222,000	$ 95,292,000
Rental income, Statement of Income [Extensible Enumeration]	Rental income			Rental income	Rental income	Rental income
Total revenues	$ 25,959,000			$ 36,943,000	$ 76,162,000	$ 107,018,000
Variable Interest Entity, Not Primary Beneficiary [Member] \| Asset Pledged as Collateral with Right [Member] \| Notes Payable, Other Payables [Member]
Liabilities
Accounts receivable	8,300,000				8,300,000		29,200,000
Variable Interest Entity, Not Primary Beneficiary [Member] \| Other Investment Income [Member]
Liabilities
Other investment income	4,839,000			$ 3,551,000	12,940,000	$ 11,726,000
Variable Interest Entity, Not Primary Beneficiary [Member] \| Personal Guarantee Collateral [Member]
Liabilities
Total collateral	(48,000,000)				(48,000,000)		(48,000,000)
Variable Interest Entity, Not Primary Beneficiary [Member] \| Other Collateral [Member]
Liabilities
Total collateral	$ (1,117,412,000)				$ (1,117,412,000)		$ (1,335,867,000)

INVESTMENT IN JOINT VENTURES (N

INVESTMENT IN JOINT VENTURES (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
INVESTMENTS IN JOINT VENTURES [Abstract]
Assets management fees recognized	$ 0.1	$ 0.2	$ 0.5	$ 0.7

INVESTMENT IN JOINT VENTURES (S

INVESTMENT IN JOINT VENTURES (Schedule of equity method investments) (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022 USD ($) contract facility	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) contract facility	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)	May 17, 2019
Investment			$ 240,897
Number of real estate properties \| facility	941		941
Investments in unconsolidated joint ventures	$ 176,556		$ 176,556		$ 194,687
Number of operators \| contract	65		65
Income (loss) from unconsolidated joint ventures	$ 4,117	$ 1,552	$ 7,522	$ 14,569
Second Spring Healthcare Investments [Member]
Income (loss) from unconsolidated joint ventures	300	309	882	12,013
Second Spring II LLC [Member]
Income (loss) from unconsolidated joint ventures		(1)	(2)	(757)
Lakeway Realty LLC [Member]
Ownership %						51%
Income (loss) from unconsolidated joint ventures	656	637	1,976	1,923
Cindat Ice Portfolio JV GP Limited [Member]
Income (loss) from unconsolidated joint ventures	3,339	707	4,972	1,839
OMG Senior Housing LLC [Member]
Income (loss) from unconsolidated joint ventures	$ (140)	(105)	$ (319)	(309)
OH CHS SNP Inc [Member]
Ownership %	9%		9%
Initial Investment Date			Dec. 20, 2019
Investment			$ 1,013
Investments in unconsolidated joint ventures	$ 372		372		246
Income (loss) from unconsolidated joint ventures	$ (38)	$ 5	$ 13	(140)
Skilled Nursing Facilities [Member] \| Second Spring Healthcare Investments [Member]
Ownership %	15%		15%
Initial Investment Date			Nov. 01, 2016
Investment			$ 50,032
Investments in unconsolidated joint ventures	$ 10,849		$ 10,849		11,355
Skilled Nursing Facilities [Member] \| Second Spring II LLC [Member]
Ownership %	15%		15%
Initial Investment Date			Mar. 10, 2021
Investment			$ 10,330
Investments in unconsolidated joint ventures					8
Specialty [Member] \| Lakeway Realty LLC [Member]
Ownership %	51%		51%
Initial Investment Date			May 17, 2019
Investment			$ 73,834
Number of real estate properties \| facility	1		1
Investments in unconsolidated joint ventures	$ 70,465		$ 70,465		71,286
Assisted Living Facilities [Member] \| Cindat Ice Portfolio JV GP Limited [Member]
Ownership %	49%		49%
Initial Investment Date			Dec. 18, 2019
Investment			$ 105,688
Number of real estate properties \| facility	65		65
Investments in unconsolidated joint ventures	$ 94,870		$ 94,870		111,792
Specialty Facility \| OMG Senior Housing LLC [Member]
Ownership %	50%		50%
Initial Investment Date			Dec. 06, 2019
Number of real estate properties \| facility	1		1
16 Facilities \| Second Spring Healthcare Investments [Member]
Amount of gain (loss) from sale of facilities				$ 14,900
Other Investment Receivables [Member]
Financing Receivable, Gross	$ 669,251		$ 669,251		539,278
Mortgage Receivable [Member]
Financing Receivable, Gross	$ 731,390		$ 731,390		$ 908,687
Facilities Acquired \| Skilled Nursing Facilities [Member]
Number of real estate properties \| facility	1		1
Facilities Acquired \| Assisted Living Facilities [Member]
Number of real estate properties \| facility	33		33

GOODWILL AND OTHER INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLES (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net amortization of intangible assets	$ 1	$ 1.1	$ 3.6	$ 8.5
Remainder 2022	1		1
2023	3.9		3.9
2024	3.7		3.7
2025	3.5		3.5
2026	$ 2.7		$ 2.7
Below market leases, weighted average remaining amortization, period			7 years
Above market leases
Weighted average remaining amortization			10 years

GOODWILL AND OTHER INTANGIBLE_3

GOODWILL AND OTHER INTANGIBLES (Schedule of Reconciliation of Goodwill) (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)
Goodwill [Roll Forward]
Balance	$ 651,417
Foreign currency translation	(2,469)
Balance	$ 648,948

GOODWILL AND OTHER INTANGIBLE_4

GOODWILL AND OTHER INTANGIBLES (Schedule of Intangibles) (Detail) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Assets:
Gross intangible assets	$ 5,929	$ 5,929
Accumulated amortization	(4,445)	(4,313)
Net intangible assets	1,484	1,616
Liabilities:
Below market leases	71,072	66,324
Accumulated amortization	(47,093)	(38,091)
Net intangible liabilities	$ 23,979	$ 28,233

CONCENTRATION OF RISK (Narrativ

CONCENTRATION OF RISK (Narrative) (Detail) $ in Thousands	3 Months Ended		9 Months Ended
CONCENTRATION OF RISK (Narrative) (Detail) $ in Thousands	Sep. 30, 2022 USD ($) property facility contract state item	Sep. 30, 2021	Sep. 30, 2022 USD ($) property facility contract state item	Sep. 30, 2021	Dec. 31, 2021 USD ($)
Concentration Risk [Line Items]
Number of real estate properties	941		941
Number of operators that met or exceeded ten percent of investments \| item	2		2
Number of states \| state	42		42
Number of operators \| contract	65		65
Gross investment in facilities, net of impairments and reserves for uncollectible loans \| $	$ 9,600,000		$ 9,600,000
Other investments \| $	608,190		608,190		$ 469,884
Investment in unconsolidated joint venture \| $	$ 176,556		$ 176,556		194,687
Number of unconsolidated joint ventures \| item	6		6
Variable Interest Entity, Not Primary Beneficiary [Member]
Concentration Risk [Line Items]
Other investments \| $	$ 264,473		$ 264,473		$ 230,768
Skilled Nursing Facilities [Member]
Concentration Risk [Line Items]
Number of real estate properties	650		650
Assisted Living Facilities [Member]
Concentration Risk [Line Items]
Number of real estate properties	167		167
Independent Living Facilities [Member]
Concentration Risk [Line Items]
Number of real estate properties	20		20
Specialty Facility
Concentration Risk [Line Items]
Number of real estate properties \| property	16		16
Medical Office Building [Member]
Concentration Risk [Line Items]
Number of real estate properties	2		2
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| LaVie Care Centers LLC (f/k/a Consulate Health Care)
Concentration Risk [Line Items]
Concentration percentage	11.50%	9.30%	11.40%	9.30%
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Maplewood Real Estate Holdings \| Variable Interest Entity, Not Primary Beneficiary [Member]
Concentration Risk [Line Items]
Concentration percentage	9.30%	7.90%	9.10%	7.70%
Assets, Total [Member] \| Geographic Concentration Risk [Member] \| Florida
Concentration Risk [Line Items]
Concentration percentage			13.10%
Assets, Total [Member] \| Geographic Concentration Risk [Member] \| Texas
Concentration Risk [Line Items]
Concentration percentage			10.30%
Assets, Total [Member] \| Geographic Concentration Risk [Member] \| Indiana
Concentration Risk [Line Items]
Concentration percentage			6.60%
Assets, Total [Member] \| Product Concentration Risk [Member] \| Real Estate Investment
Concentration Risk [Line Items]
Concentration percentage			97%
Facilities Under Fixed Rate Mortgage Loans [Member]
Concentration Risk [Line Items]
Number of real estate properties	52		52
Facilities Under Fixed Rate Mortgage Loans [Member] \| Skilled Nursing Facilities [Member]
Concentration Risk [Line Items]
Number of real estate properties \| property	48		48
Facilities Under Fixed Rate Mortgage Loans [Member] \| Assisted Living Facilities [Member]
Concentration Risk [Line Items]
Number of real estate properties \| property	2		2
Facilities Under Fixed Rate Mortgage Loans [Member] \| Specialty Facility
Concentration Risk [Line Items]
Number of real estate properties	2		2
Facilities Held for Sale or Closed [Member]
Concentration Risk [Line Items]
Number of real estate properties	34		34

STOCKHOLDERS EQUITY (Common Sto

STOCKHOLDERS EQUITY (Common Stock Repurchase) (Narrative) (Detail) $ in Millions	Jan. 27, 2022 USD ($)
Stockholders Equity [Abstract]
Stock repurchase program, authorized amount	$ 500

STOCKHOLDERS EQUITY (Common S_2

STOCKHOLDERS EQUITY (Common Stock Repurchase) (Summary of shares repurchase) (Detail) $ / shares in Units, $ in Thousands, shares in Millions	9 Months Ended
	Sep. 30, 2022 USD ($) $ / shares shares
Stockholders Equity [Abstract]
Shares Repurchased \| shares	5.2
Average Price per Share \| $ / shares	$ 27.32
Net Repurchase Cost \| $	$ 142,267

STOCKHOLDERS EQUITY (Schedule o

STOCKHOLDERS EQUITY (Schedule of Common Stock Dividends) (Details) - $ / shares	3 Months Ended					9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Stockholders Equity [Abstract]
Dividends Declared, Date Of Record	Nov. 01, 2022	Aug. 01, 2022	May 02, 2022	Feb. 07, 2022
Dividends Payable, Date to be Paid	Nov. 15, 2022	Aug. 15, 2022	May 13, 2022	Feb. 15, 2022
Common Stock, Dividends, Per Share, Declared	$ 0.67	$ 0.67	$ 0.67	$ 0.67	$ 0.67	$ 2.01	$ 2.01

STOCKHOLDERS EQUITY (Schedule_2

STOCKHOLDERS EQUITY (Schedule of dividend reinvestment and common stock purchase plan) (Detail) - Dividend Reinvestment And Common Stock Purchase Plan [Member] - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Shares issued	0.1	1.3	0.3	3.3
Gross Proceeds	$ 2.4	$ 47.2	$ 7	$ 124.5

STOCKHOLDERS EQUITY (At The Mar

STOCKHOLDERS EQUITY (At The Market Program Schedule and Narrative) (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2015
$500 Million and $1 Billion ATM Programs
Issuance of common stock (in shares)	0.1	4.2
Average issue price per share	$ 32.82	$ 36.56
Gross proceeds	$ 1.3	$ 155.1
Commissions	0.1	3.3
Proceeds from issuance of common stock	$ 1.2	$ 151.8
$500 Million ATM Program
Sales price, equity distribution agreement				$ 500
$1 Billion ATM Program
Sales price, equity distribution agreement			$ 1,000

STOCKHOLDERS EQUITY (Schedule_3

STOCKHOLDERS EQUITY (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	$ 3,940,712	$ 4,210,026	$ 4,108,226	$ 4,036,607
Balance ending	3,895,376	4,237,468	3,895,376	4,237,468
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Stockholders Equity/AOCI	3,697,968		3,697,968		$ 3,906,838
Add: portion included in noncontrolling interest	197,408		197,408		201,388
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	3,895,376	4,237,468	3,895,376	4,237,468	4,108,226
Foreign Currency Translation [Member]
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	(79,670)	(13,608)	(24,012)	(18,427)
Translation loss	(45,873)	(12,646)	(100,253)	(8,515)
Realized (loss) gain	(153)	(18)	(1,431)	670
Balance ending	(125,696)	(26,272)	(125,696)	(26,272)
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	(125,696)	(26,272)	(125,696)	(26,272)	(24,012)
Cash Flow Hedges [Member]
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	69,429	33,352	30,407	17,718
Unrealized gain	16,499	1,116	53,481	15,407
Realized gain	1,074	779	3,114	2,122
Balance ending	87,002	35,247	87,002	35,247
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	87,002	35,247	87,002	35,247	30,407
Net Investment Hedges [Member]
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	12,920	(16,024)	(9,588)	(13,331)
Unrealized gain	31,273	7,637	53,781	4,944
Balance ending	44,193	(8,387)	44,193	(8,387)
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	44,193	(8,387)	44,193	(8,387)	(9,588)
Accumulated Other Comprehensive Income (Loss)[Member]
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	3,501	4,523	(2,200)	(12,768)
Balance ending	6,243	1,476	6,243	1,476
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Stockholders Equity/AOCI	5,499	588	5,499	588
Add: portion included in noncontrolling interest	744	888	744	888
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$ 6,243	$ 1,476	$ 6,243	$ 1,476	$ (2,200)

TAXES (Narrative) (Detail)

TAXES (Narrative) (Detail) $ in Thousands	9 Months Ended
TAXES (Narrative) (Detail) $ in Thousands	Sep. 30, 2022 USD ($) subsidiary	Mar. 31, 2022 USD ($)
Taxes [Line Items]
Minimum number of subsequent years the company may not be able to qualify as a REIT	4 years
Percentage of income subject to federal taxation	100%
Number of TSRs subject to federal, state and local income taxes with net operating loss carryforwards \| subsidiary	1
Deferred tax assets related to net operating loss carryforwards	$ 10,456	$ 13,400
Taxable REIT Subsidiaries [Member]
Taxes [Line Items]
Net operating loss carry-forward	$ 10,200
Foreign Tax Authority
Taxes [Line Items]
Net operating loss carry-forward		$ 55,000
Net operating loss carryforwards period	no

TAXES (Schedule of deferred tax

TAXES (Schedule of deferred tax assets and liabilities) (Detail) - USD ($) $ in Thousands	Sep. 30, 2022	Mar. 31, 2022	Dec. 31, 2021
Deferred tax assets:
Federal net operating loss carryforward	$ 2,138		$ 2,221
Valuation allowance on deferred tax asset	(2,138)		(2,221)
Foreign net operating loss carryforward	10,456	$ 13,400
Deferred tax liability:
Foreign deferred tax liability	(5,331)		(8,200)
Net deferred tax liabilities			$ 8,200
Net deferred tax asset	$ 5,125

TAXES (Schedule of components o

TAXES (Schedule of components of income tax expense) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Taxes [Abstract]
Provision for federal, state and local income taxes	$ 0.3	$ 0.4	$ 0.9	$ 1
Provision for foreign income taxes	0.9	0.6	2.6	1.9
Total provision for income taxes	$ 1.2	$ 1	$ 3.5	$ 2.9

STOCK-BASED COMPENSATION (Narra

STOCK-BASED COMPENSATION (Narrative) (Details) - shares	9 Months Ended
STOCK-BASED COMPENSATION (Narrative) (Details) - shares	Sep. 30, 2022	Mar. 31, 2022
Performance Based Profit Interest Units [Member]
Vesting period, years	4 years
Performance Based Profit Interest Units [Member] \| Certain Officers and Key Employees [Member]
Shares awarded, other than options		1,545,070
Performance period used for performance based awards	3 years
Time Based Restricted Equity Awards \| Certain Officers and Key Employees [Member]
Shares awarded, other than options		31,685
Time Based Profit Interest Units [Member] \| Certain Officers and Key Employees [Member]
Shares awarded, other than options		170,294
Vesting period, years	3 years

STOCK-BASED COMPENSATION (Summa

STOCK-BASED COMPENSATION (Summary of stock based compensation) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Stock-Based Compensation [Abstract]
Stock-based compensation expense	$ 6,809	$ 5,706	$ 20,515	$ 16,913

BORROWING ACTIVITIES AND ARRA_3

BORROWING ACTIVITIES AND ARRANGEMENTS (Schedule of Borrowings) (Details) $ in Thousands, £ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022 USD ($) facility	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) facility	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)	Sep. 30, 2022 GBP (£) facility	Feb. 10, 2022	Apr. 30, 2021 USD ($)
Debt Instrument [Line Items]
Total secured borrowings	$ 368,405		$ 368,405		$ 362,081
Revolving credit facility	17,861		17,861
Total senior notes and other unsecured borrowings - net	4,898,609		4,898,609		4,891,455
Total secured and unsecured borrowings - net	5,284,875		5,284,875		5,253,536
Real estate assets - net	6,462,353		6,462,353		$ 6,789,091
Loss on extinguishment of debt	$ 376	$ 642	$ 389	$ 30,707
Debt instrument, covenant compliance			As of September 30, 2022 and December 31, 2021, we were in compliance with all applicable covenants for our borrowings		As of September 30, 2022 and December 31, 2021, we were in compliance with all applicable covenants for our borrowings
Number of Facilities \| facility	941		941			941
Repayments of Long-term Debt			$ 587,394	$ 2,121,429
Assisted Living Facilities [Member]
Debt Instrument [Line Items]
Number of Facilities \| facility	167		167			167
Hud Mortgage \| Asset Pledged as Collateral [Member]
Debt Instrument [Line Items]
Real estate assets - net	$ 505,900		$ 505,900
4.375% notes due 2023
Debt Instrument [Line Items]
Rate	4.375%		4.375%		4.375%	4.375%
4.950% notes due 2024
Debt Instrument [Line Items]
Rate	4.95%		4.95%		4.95%	4.95%
4.50% notes due 2025
Debt Instrument [Line Items]
Rate	4.50%		4.50%		4.50%	4.50%
5.25% notes due 2026
Debt Instrument [Line Items]
Rate	5.25%		5.25%		5.25%	5.25%
4.50% notes due 2027
Debt Instrument [Line Items]
Rate	4.50%		4.50%		4.50%	4.50%
4.75% notes due 2028
Debt Instrument [Line Items]
Rate	4.75%		4.75%		4.75%	4.75%
3.625% notes due 2029
Debt Instrument [Line Items]
Rate	3.625%		3.625%		3.625%	3.625%
3.375% notes due 2031
Debt Instrument [Line Items]
Rate	3.375%		3.375%		3.375%	3.375%
3.25% notes due 2033
Debt Instrument [Line Items]
Rate	3.25%		3.25%		3.25%	3.25%
Secured Debt [Member]
Debt Instrument [Line Items]
Total secured borrowings	$ 368,405		$ 368,405		$ 362,081
Secured Debt [Member] \| Hud Mortgage
Debt Instrument [Line Items]
Rate	3.01%		3.01%			3.01%
Total secured borrowings	$ 346,606		$ 346,606		359,806
Secured Debt [Member] \| Hud Mortgage Assumed Maturity 2051 [Member]
Debt Instrument [Line Items]
Maturity	2051
Rate	2.92%		2.92%			2.92%
Loss on extinguishment of debt	$ 400
Repayments of Long-term Debt	$ 7,900
Secured Debt [Member] \| Term Loan Maturity 2023 [Member]
Debt Instrument [Line Items]
Maturity			2023
Rate	6.75%		6.75%			6.75%
Total secured borrowings	$ 2,161		$ 2,161		2,275
Secured Debt [Member] \| Term Loan Maturity 2024 [Member]
Debt Instrument [Line Items]
Maturity			2024
Rate	8.02%		8.02%			8.02%
Total secured borrowings	$ 19,638		$ 19,638
Secured Debt [Member] \| Term Loan Maturity 2024 [Member] \| Assisted Living Facilities [Member] \| Facilities Related to Joint Venture [Member]
Debt Instrument [Line Items]
Number of Facilities \| facility	2		2			2
Unsecured Debt [Member]
Debt Instrument [Line Items]
Deferred financing costs - net	$ (23,451)		$ (23,451)		(26,980)
Discount - net	(27,940)		(27,940)		(31,565)
Total senior notes and other unsecured borrowings - net	4,898,609		4,898,609		4,891,455
Total unsecured borrowings - net	$ 4,916,470		$ 4,916,470		4,891,455
Unsecured Debt [Member] \| Omega OP Term Loan Facility
Debt Instrument [Line Items]
Maturity			2025
Rate	4.57%		4.57%			4.57%
Total term loans - net	$ 50,000		$ 50,000		50,000			$ 50,000
Debt instrument, interest rate, effective percentage							3.29%
Senior Notes [Member] \| 4.375% notes due 2023
Debt Instrument [Line Items]
Maturity			2023
Rate	4.375%		4.375%			4.375%
Long-term debt, gross	$ 350,000		$ 350,000		350,000
Senior Notes [Member] \| 4.950% notes due 2024
Debt Instrument [Line Items]
Maturity			2024
Rate	4.95%		4.95%			4.95%
Long-term debt, gross	$ 400,000		$ 400,000		400,000
Senior Notes [Member] \| 4.50% notes due 2025
Debt Instrument [Line Items]
Maturity			2025
Rate	4.50%		4.50%			4.50%
Long-term debt, gross	$ 400,000		$ 400,000		400,000
Senior Notes [Member] \| 5.25% notes due 2026
Debt Instrument [Line Items]
Maturity			2026
Rate	5.25%		5.25%			5.25%
Long-term debt, gross	$ 600,000		$ 600,000		600,000
Senior Notes [Member] \| 4.50% notes due 2027
Debt Instrument [Line Items]
Maturity			2027
Rate	4.50%		4.50%			4.50%
Long-term debt, gross	$ 700,000		$ 700,000		700,000
Senior Notes [Member] \| 4.75% notes due 2028
Debt Instrument [Line Items]
Maturity			2028
Rate	4.75%		4.75%			4.75%
Long-term debt, gross	$ 550,000		$ 550,000		550,000
Senior Notes [Member] \| 3.625% notes due 2029
Debt Instrument [Line Items]
Maturity			2029
Rate	3.625%		3.625%			3.625%
Long-term debt, gross	$ 500,000		$ 500,000		500,000
Senior Notes [Member] \| 3.375% notes due 2031
Debt Instrument [Line Items]
Maturity			2031
Rate	3.375%		3.375%			3.375%
Long-term debt, gross	$ 700,000		$ 700,000		700,000
Senior Notes [Member] \| 3.25% notes due 2033
Debt Instrument [Line Items]
Maturity			2033
Rate	3.25%		3.25%			3.25%
Long-term debt, gross	$ 700,000		$ 700,000		$ 700,000
Omega OP \| Unsecured Debt [Member]
Debt Instrument [Line Items]
Debt instrument, face amount	50,000		$ 50,000
Debt instrument, maturity date			Feb. 10, 2022
Minimum [Member] \| Hud Mortgage
Debt Instrument [Line Items]
Maturity			2046
Maximum [Member] \| Hud Mortgage
Debt Instrument [Line Items]
Maturity			2052
Revolving Credit Facility \| Unsecured Debt [Member]
Debt Instrument [Line Items]
Revolving credit facility \| £						£ 16
Maximum borrowing capacity	$ 1,450,000		$ 1,450,000					$ 1,450,000
Revolving Credit Facility \| Unsecured Debt [Member] \| United States Dollar Tranche [Member]
Debt Instrument [Line Items]
Rate	4.32%		4.32%			4.32%
Revolving Credit Facility \| Unsecured Debt [Member] \| British Pound Sterling Tranche [Member]
Debt Instrument [Line Items]
Rate	3.51%		3.51%			3.51%
Revolving Credit Facility \| Unsecured Debt [Member] \| Revolving Credit Facility Due 2025 [Member]
Debt Instrument [Line Items]
Maturity			2025
Rate	4.32%		4.32%			4.32%
Revolving credit facility	$ 17,861		$ 17,861

DERIVATIVES AND HEDGING (Narrat

DERIVATIVES AND HEDGING (Narrative) (Details) $ in Thousands, £ in Millions		9 Months Ended
	May 17, 2022 GBP (£) contract	Sep. 30, 2022 USD ($) contract	Sep. 30, 2022 GBP (£) contract	Dec. 31, 2021 USD ($)	Apr. 30, 2021 USD ($)	May 31, 2019 USD ($) contract
3.375% notes due 2031
Interest rate		3.375%	3.375%	3.375%
3.375% notes due 2031 \| Senior Notes [Member]
Interest rate		3.375%	3.375%
Maturity		2031
3.25% notes due 2033
Interest rate		3.25%	3.25%	3.25%
3.25% notes due 2033 \| Senior Notes [Member]
Interest rate		3.25%	3.25%
Maturity		2033
Omega OP Term Loan Facility \| Unsecured Debt [Member]
Term loans - net \| $		$ 50,000		$ 50,000	$ 50,000
Interest rate		4.57%	4.57%
Maturity		2025
Interest Rate Swap \| Cash Flow Hedging [Member] \| Forward Starting Swaps [Member]
Derivative, notional amount \| $		$ 400,000
Derivative, fixed interest rate		0.8675%	0.8675%
Derivative, Number of Instruments Held \| contract		5	5
Interest Rate Swap \| Cash Flow Hedging [Member] \| Omega OP Term Loan Facility
Derivative, notional amount \| $						$ 50,000
Derivative, Number of Instruments Held \| contract						2
Foreign Exchange Forward [Member] \| Net Investment Hedging [Member]
Derivative, notional amount \| £	£ 76		£ 250
Derivative, maturity Date	May 21, 2029
Derivative, forward exchange rate	1.3071	1.3641	1.3641
Derivative, Number of Instruments Held \| contract	2	6	6

DERIVATIVES AND HEDGING (Locati

DERIVATIVES AND HEDGING (Location and the fair value of derivative instruments designated as hedges) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Other Assets [Member] \| Cash Flow Hedging [Member]
Cash flow hedges recorded at fair value, asset	$ 92,561	$ 32,849
Other Assets [Member] \| Net Investment Hedging [Member]
Cash flow hedges recorded at fair value, asset	$ 60,536	6,754
Accounts Payable and Accrued Liabilities [Member] \| Cash Flow Hedging [Member]
Cash flow hedges recorded at fair value, liability		$ 96

FINANCIAL INSTRUMENTS (Schedule

FINANCIAL INSTRUMENTS (Schedule of Financial Instruments) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
4.375% notes due 2023
Liabilities:
Notes issued, interest rate	4.375%	4.375%
4.950% notes due 2024
Liabilities:
Notes issued, interest rate	4.95%	4.95%
4.50% notes due 2025
Liabilities:
Notes issued, interest rate	4.50%	4.50%
5.25% notes due 2026
Liabilities:
Notes issued, interest rate	5.25%	5.25%
4.50% notes due 2027
Liabilities:
Notes issued, interest rate	4.50%	4.50%
4.75% notes due 2028
Liabilities:
Notes issued, interest rate	4.75%	4.75%
3.625% notes due 2029
Liabilities:
Notes issued, interest rate	3.625%	3.625%
3.375% notes due 2031
Liabilities:
Notes issued, interest rate	3.375%	3.375%
3.25% notes due 2033
Liabilities:
Notes issued, interest rate	3.25%	3.25%
Carrying (Reported) Amount, Fair Value Disclosure [Member]
Assets:
Investments in direct financing leases - net	$ 10,560	$ 10,873
Mortgage notes receivable - net	669,533	835,086
Other investments - net	608,190	469,884
Total	1,288,283	1,315,843
Liabilities:
Revolving line of credit	17,861
Omega OP term loan	49,737	49,661
Total	5,284,875	5,253,536
Carrying (Reported) Amount, Fair Value Disclosure [Member] \| 4.375% notes due 2023
Liabilities:
Notes Payable	349,527	349,100
Carrying (Reported) Amount, Fair Value Disclosure [Member] \| 4.950% notes due 2024
Liabilities:
Notes Payable	398,483	397,725
Carrying (Reported) Amount, Fair Value Disclosure [Member] \| 4.50% notes due 2025
Liabilities:
Notes Payable	398,256	397,685
Carrying (Reported) Amount, Fair Value Disclosure [Member] \| 5.25% notes due 2026
Liabilities:
Notes Payable	597,671	597,142
Carrying (Reported) Amount, Fair Value Disclosure [Member] \| 4.50% notes due 2027
Liabilities:
Notes Payable	693,472	692,374
Carrying (Reported) Amount, Fair Value Disclosure [Member] \| 4.75% notes due 2028
Liabilities:
Notes Payable	544,664	543,908
Carrying (Reported) Amount, Fair Value Disclosure [Member] \| 3.625% notes due 2029
Liabilities:
Notes Payable	491,588	490,681
Carrying (Reported) Amount, Fair Value Disclosure [Member] \| 3.375% notes due 2031
Liabilities:
Notes Payable	684,935	683,592
Carrying (Reported) Amount, Fair Value Disclosure [Member] \| 3.25% notes due 2033
Liabilities:
Notes Payable	690,276	689,587
Carrying (Reported) Amount, Fair Value Disclosure [Member] \| Hud Mortgage
Liabilities:
HUD debt - net	346,606	359,806
Carrying (Reported) Amount, Fair Value Disclosure [Member] \| Term Loan Maturity 2023 [Member]
Liabilities:
Term loan	2,161	2,275
Carrying (Reported) Amount, Fair Value Disclosure [Member] \| Term Loan Maturity 2024 [Member]
Liabilities:
Term loan	19,638
Estimate Of Fair Value, Fair Value Disclosure [Member]
Assets:
Investments in direct financing leases - net	10,560	10,873
Mortgage notes receivable - net	671,387	869,715
Other investments - net	614,646	476,664
Total	1,296,593	1,357,252
Liabilities:
Revolving line of credit	17,861
Omega OP term loan	50,000	50,000
Total	4,661,851	5,615,593
Estimate Of Fair Value, Fair Value Disclosure [Member] \| 4.375% notes due 2023
Liabilities:
Notes Payable	348,366	365,243
Estimate Of Fair Value, Fair Value Disclosure [Member] \| 4.950% notes due 2024
Liabilities:
Notes Payable	395,592	427,184
Estimate Of Fair Value, Fair Value Disclosure [Member] \| 4.50% notes due 2025
Liabilities:
Notes Payable	389,844	427,440
Estimate Of Fair Value, Fair Value Disclosure [Member] \| 5.25% notes due 2026
Liabilities:
Notes Payable	580,884	667,524
Estimate Of Fair Value, Fair Value Disclosure [Member] \| 4.50% notes due 2027
Liabilities:
Notes Payable	649,523	766,003
Estimate Of Fair Value, Fair Value Disclosure [Member] \| 4.75% notes due 2028
Liabilities:
Notes Payable	504,383	607,249
Estimate Of Fair Value, Fair Value Disclosure [Member] \| 3.625% notes due 2029
Liabilities:
Notes Payable	406,855	519,430
Estimate Of Fair Value, Fair Value Disclosure [Member] \| 3.375% notes due 2031
Liabilities:
Notes Payable	533,484	705,810
Estimate Of Fair Value, Fair Value Disclosure [Member] \| 3.25% notes due 2033
Liabilities:
Notes Payable	493,640	683,151
Estimate Of Fair Value, Fair Value Disclosure [Member] \| Hud Mortgage
Liabilities:
HUD debt - net	269,508	394,284
Estimate Of Fair Value, Fair Value Disclosure [Member] \| Term Loan Maturity 2023 [Member]
Liabilities:
Term loan	2,161	$ 2,275
Estimate Of Fair Value, Fair Value Disclosure [Member] \| Term Loan Maturity 2024 [Member]
Liabilities:
Term loan	$ 19,750

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Narrative) (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
	Sep. 29, 2020	Sep. 30, 2022	Jun. 30, 2022	Sep. 30, 2022	May 17, 2019
Indemnification Agreement [Member]
Total commitments		$ 3.9		$ 3.9
Lakeway Realty LLC [Member]
Litigation settlement, amount awarded to other party	$ 1.1
Securities Class Action [Member]
Increase in legal reserve		31
Increase in insurance receivable		$ 31
Lakeway Realty LLC [Member]
Percentage of ownership interest					51%
Increase in legal reserve			$ 3
Minimum [Member] \| Indemnification Agreement [Member]
Indemnification agreement occurrence period				18 months
Maximum [Member] \| Indemnification Agreement [Member]
Indemnification agreement occurrence period				72 months

COMMITMENTS AND CONTINGENCIES_3

COMMITMENTS AND CONTINGENCIES (Schedule of remaining commitments) (Detail) - USD ($) $ in Thousands	Sep. 30, 2022	Jun. 28, 2022
Remaining commitments	$ 288,142
Other Investment Note Due 2022 Through 2028 [Member]
Remaining commitments	60,000
Financing receivable, face amount	90,000	$ 90,000
Construction and capital expenditure mortgage loan commitments
Remaining commitments	10,381
Lessor construction and capital commitments under lease agreements
Remaining commitments	189,757
Other investment loan commitments
Remaining commitments	$ 88,004

EARNINGS PER SHARE (Schedule of

EARNINGS PER SHARE (Schedule of Computation of Basic and Diluted Earnings per Share) (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Numerator:
Net income	$ 105,064	$ 142,835	$ 392,135	$ 394,064
Deduct: net income attributable to noncontrolling interests	(2,790)	(3,888)	(10,787)	(10,616)
Net income available to common stockholders	$ 102,274	$ 138,947	$ 381,348	$ 383,448
Denominator:
Denominator for basic earnings per share	234,788	239,282	236,721	236,027
Effect of dilutive securities:
Common stock equivalents	1,744	634	1,138	903
Noncontrolling interest - Omega OP Units	6,752	6,701	6,863	6,547
Denominator for diluted earnings per share	243,284	246,617	244,722	243,477
Earnings per share - basic:
Net income available to common stockholders	$ 0.44	$ 0.58	$ 1.61	$ 1.62
Earnings per share - diluted:
Net income	$ 0.43	$ 0.58	$ 1.60	$ 1.62

SUPPLEMENTAL DISCLOSURE TO CO_3

SUPPLEMENTAL DISCLOSURE TO CONSOLIDATED STATEMENTS OF CASH FLOWS (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Reconciliation of cash and cash equivalents and restricted cash:
Cash and cash equivalents	$ 134,855	$ 102,664	$ 20,534
Restricted cash	3,323	3,341	3,877
Cash, cash equivalents and restricted cash at end of period	138,178	106,005	$ 24,411	$ 167,558
Supplemental Information:
Interest paid during the period, net of amounts capitalized	171,057	166,934
Taxes paid during the period	4,627	5,028
Non cash investing activities
Non cash acquisition of real estate	(9,818)	(49,857)
Non cash placement of mortgage principal		(7,000)
Non cash collection of mortgage principal		49,587
Non cash proceeds from other investments		7,000
Non cash financing activities
Non-cash contribution from noncontrolling interest holder in consolidated joint venture	2,903
Change in fair value of cash flow hedges	113,590	28,450
Remeasurement of debt denominated in a foreign currency	$ (5,462)	$ 3,010

SUBSEQUENT EVENTS (Narrative) (

SUBSEQUENT EVENTS (Narrative) (Details) $ in Millions	1 Months Ended	3 Months Ended
SUBSEQUENT EVENTS (Narrative) (Details) $ in Millions	Nov. 02, 2022 USD ($) facility	Sep. 30, 2022 facility
Agemo Holdings LLC [Member] \| Facilities Sold
Real estate properties sold \| facility		2
Subsequent Event [Member] \| Agemo Holdings LLC [Member] \| Facilities Sold
Real estate properties sold \| facility	19
Subsequent Event [Member] \| Other investment notes outstanding maturing in September 2027 [Member]
Interest rate	9%
Investment Maturity Date	Sep. 30, 2027
Subsequent Event [Member] \| Other Investment Notes Outstanding $2.5 Million Maturing in September 2027 [Member]
Financing receivable, face amount	$ 2.5
Subsequent Event [Member] \| Other Investment Notes Outstanding $17.0 Million Maturing in September 2027 [Member]
Financing receivable, face amount	17
Subsequent Event [Member] \| Other investment notes outstanding maturing in October 2027 [Member]
Financing receivable, face amount	$ 5
Interest rate	10%
Investment Maturity Date	Oct. 29, 2027